ID   I17RC_HUMAN             Reviewed;         791 AA.
AC   Q8NAC3; A8BWC1; A8BWC9; A8BWD5; E9PHG1; E9PHJ6; Q6UVY3; Q6UWD4; Q8NFS1;
AC   Q9BR97;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   09-APR-2025, entry version 170.
DE   RecName: Full=Interleukin-17 receptor C;
DE            Short=IL-17 receptor C;
DE            Short=IL-17RC;
DE   AltName: Full=Interleukin-17 receptor homolog;
DE            Short=IL17Rhom;
DE   AltName: Full=Interleukin-17 receptor-like protein;
DE            Short=IL-17RL;
DE   AltName: Full=ZcytoR14;
DE   Flags: Precursor;
GN   Name=IL17RC; ORFNames=UNQ6118/PRO20040/PRO38901;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5; 6 AND 7), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND ALTERNATIVE SPLICING.
RX   PubMed=17911633; DOI=10.4049/jimmunol.179.8.5462;
RA   Kuestner R.E., Taft D.W., Haran A., Brandt C.S., Brender T., Lum K.,
RA   Harder B., Okada S., Ostrander C.D., Kreindler J.L., Aujla S.J.,
RA   Reardon B., Moore M., Shea P., Schreckhise R., Bukowski T.R., Presnell S.,
RA   Guerra-Lewis P., Parrish-Novak J., Ellsworth J.L., Jaspers S., Lewis K.E.,
RA   Appleby M., Kolls J.K., Rixon M., West J.W., Gao Z., Levin S.D.;
RT   "Identification of the IL-17 receptor related molecule IL-17RC as the
RT   receptor for IL-17F.";
RL   J. Immunol. 179:5462-5473(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8).
RA   Presnell S.R., Burkhead S.K., Pownder S.L.;
RL   Patent number JP2003504058, 04-FEB-2003.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT LEU-182.
RA   Gilbert J.M., Gorman D.M.;
RT   "Identification of novel IL-17 related receptors.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LEU-182.
RC   TISSUE=Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 21-35.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [9]
RP   ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=11706037; DOI=10.1074/jbc.m109372200;
RA   Haudenschild D., Moseley T., Rose L., Reddi A.H.;
RT   "Soluble and transmembrane isoforms of novel interleukin-17 receptor-like
RT   protein by RNA splicing and expression in prostate cancer.";
RL   J. Biol. Chem. 277:4309-4316(2002).
RN   [10]
RP   INDUCTION BY HGF AND VEGF.
RX   PubMed=14504135; DOI=10.1038/sj.bjp.0705494;
RA   Gerritsen M.E., Tomlinson J.E., Zlot C., Ziman M., Hwang S.;
RT   "Using gene expression profiling to identify the molecular basis of the
RT   synergistic actions of hepatocyte growth factor and vascular endothelial
RT   growth factor in human endothelial cells.";
RL   Br. J. Pharmacol. 140:595-610(2003).
RN   [11]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=16785495; DOI=10.4049/jimmunol.177.1.36;
RA   Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J.,
RA   Tocker J., Peschon J.;
RT   "Interleukin 17 signals through a heteromeric receptor complex.";
RL   J. Immunol. 177:36-39(2006).
RN   [12]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=18684971; DOI=10.4049/jimmunol.181.4.2799;
RA   Wright J.F., Bennett F., Li B., Brooks J., Luxenberg D.P., Whitters M.J.,
RA   Tomkinson K.N., Fitz L.J., Wolfman N.M., Collins M.,
RA   Dunussi-Joannopoulos K., Chatterjee-Kishore M., Carreno B.M.;
RT   "The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-
RT   17RA/IL-17RC receptor complex.";
RL   J. Immunol. 181:2799-2805(2008).
RN   [13]
RP   INTERACTION WITH TRAF3IP2.
RX   PubMed=24120361; DOI=10.1016/j.immuni.2013.09.002;
RA   Boisson B., Wang C., Pedergnana V., Wu L., Cypowyj S., Rybojad M.,
RA   Belkadi A., Picard C., Abel L., Fieschi C., Puel A., Li X., Casanova J.L.;
RT   "An ACT1 mutation selectively abolishes interleukin-17 responses in humans
RT   with chronic mucocutaneous candidiasis.";
RL   Immunity 39:676-686(2013).
RN   [14]
RP   INTERACTION WITH IL17A AND IL17F.
RX   PubMed=28827714; DOI=10.1038/s41598-017-08360-9;
RA   Goepfert A., Lehmann S., Wirth E., Rondeau J.M.;
RT   "The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor
RT   recognition properties.";
RL   Sci. Rep. 7:8906-8906(2017).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 279-538 IN COMPLEX WITH IL17F,
RP   DISULFIDE BOND, INTERACTION WITH IL17RA; IL17F AND IL17A, AND FUNCTION.
RX   PubMed=32187518; DOI=10.1016/j.immuni.2020.02.004;
RA   Goepfert A., Lehmann S., Blank J., Kolbinger F., Rondeau J.M.;
RT   "Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric
RT   Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling.";
RL   Immunity 52:499-512.e5(2020).
RN   [16]
RP   INVOLVEMENT IN CANDF9.
RX   PubMed=25918342; DOI=10.1084/jem.20141065;
RA   Ling Y., Cypowyj S., Aytekin C., Galicchio M., Camcioglu Y., Nepesov S.,
RA   Ikinciogullari A., Dogu F., Belkadi A., Levy R., Migaud M., Boisson B.,
RA   Bolze A., Itan Y., Goudin N., Cottineau J., Picard C., Abel L.,
RA   Bustamante J., Casanova J.L., Puel A.;
RT   "Inherited IL-17RC deficiency in patients with chronic mucocutaneous
RT   candidiasis.";
RL   J. Exp. Med. 212:619-631(2015).
CC   -!- FUNCTION: Receptor for IL17A and IL17F, major effector cytokines of
CC       innate and adaptive immune system involved in antimicrobial host
CC       defense and maintenance of tissue integrity (By similarity). Receptor
CC       for IL17A and IL17F, major effector cytokines of innate and adaptive
CC       immune system involved in antimicrobial host defense and maintenance of
CC       tissue integrity. Receptor for IL17A and IL17F homodimers as part of a
CC       heterodimeric complex with IL17RA (PubMed:16785495). Receptor for the
CC       heterodimer formed by IL17A and IL17B as part of a heterodimeric
CC       complex with IL17RA (PubMed:18684971). Has also been shown to be the
CC       cognate receptor for IL17F and to bind IL17A with high affinity without
CC       the need for IL17RA (PubMed:17911633). Upon binding of IL17F homodimer
CC       triggers downstream activation of TRAF6 and NF-kappa-B signaling
CC       pathway (PubMed:16785495, PubMed:32187518). Induces transcriptional
CC       activation of IL33, a potent cytokine that stimulates group 2 innate
CC       lymphoid cells and adaptive T-helper 2 cells involved in pulmonary
CC       allergic response to fungi (By similarity). Promotes sympathetic
CC       innervation of peripheral organs by coordinating the communication
CC       between gamma-delta T cells and parenchymal cells. Stimulates
CC       sympathetic innervation of thermogenic adipose tissue by driving TGFB1
CC       expression (By similarity). Binding of IL17A-IL17F to IL17RA-IL17RC
CC       heterodimeric receptor complex triggers homotypic interaction of IL17RA
CC       and IL17RC chains with TRAF3IP2 adapter through SEFIR domains. This
CC       leads to downstream TRAF6-mediated activation of NF-kappa-B and
CC       MAPkinase pathways ultimately resulting in transcriptional activation
CC       of cytokines, chemokines, antimicrobial peptides and matrix
CC       metalloproteinases, with potential strong immune inflammation
CC       (PubMed:17911633, PubMed:18684971). Primarily induces neutrophil
CC       activation and recruitment at infection and inflammatory sites (By
CC       similarity). Stimulates the production of antimicrobial beta-defensins
CC       DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the
CC       entry of microbes through the epithelial barriers (By similarity).
CC       {ECO:0000250|UniProtKB:Q8K4C2, ECO:0000269|PubMed:16785495,
CC       ECO:0000269|PubMed:17911633, ECO:0000269|PubMed:18684971,
CC       ECO:0000269|PubMed:32187518}.
CC   -!- FUNCTION: [Isoform 5]: Receptor for both IL17A and IL17F.
CC       {ECO:0000269|PubMed:16785495}.
CC   -!- FUNCTION: [Isoform 6]: Does not bind IL17A or IL17F.
CC       {ECO:0000269|PubMed:16785495}.
CC   -!- FUNCTION: [Isoform 7]: Does not bind IL17A or IL17F.
CC       {ECO:0000269|PubMed:16785495}.
CC   -!- FUNCTION: [Isoform 8]: Receptor for both IL17A and IL17F.
CC       {ECO:0000269|PubMed:16785495}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked (PubMed:32187518). Heterodimer
CC       with IL17RA (PubMed:16785495, PubMed:18684971). Heterodimerization with
CC       IL17RA is independent of the cytoplasmic tail (By similarity).
CC       Associates with non-glycosylated IL17RA constitutively (By similarity).
CC       Binding of IL17A and IL17F induces association with glycosylated IL17RA
CC       (By similarity). Forms complexes with 2:1 binding stoichiometry: two
CC       receptor chains for one interleukin molecule (PubMed:28827714,
CC       PubMed:32187518). IL17A homodimer preferentially drives the formation
CC       of IL17RA-IL17RC heterodimeric receptor complex, whereas IL17F
CC       homodimer forms predominantly complexes with IL17RC homodimer
CC       (PubMed:32187518). IL17A-IL17F forms complexes with IL17RA-IL17RC, but
CC       with lower affinity when compared to IL17A homodimer (PubMed:32187518).
CC       IL17RC chain cannot distinguish between IL17A and IL17F molecules,
CC       potentially enabling the formation of topologically distinct complexes
CC       (PubMed:28827714). Interacts (through SEFIR domain and extended
CC       downstream region) with TRAF3IP2/ACT1 (phosphorylated)
CC       (PubMed:24120361). {ECO:0000250|UniProtKB:Q8K4C2,
CC       ECO:0000269|PubMed:16785495, ECO:0000269|PubMed:18684971,
CC       ECO:0000269|PubMed:24120361, ECO:0000269|PubMed:28827714,
CC       ECO:0000269|PubMed:32187518}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:17911633};
CC       Single-pass type I membrane protein {ECO:0000255}. Note=Soluble
CC       isoforms may be produced.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q8NAC3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NAC3-2; Sequence=VSP_014138;
CC       Name=3;
CC         IsoId=Q8NAC3-3; Sequence=VSP_014138, VSP_014139;
CC       Name=4;
CC         IsoId=Q8NAC3-4; Sequence=VSP_014138, VSP_014139, VSP_014140,
CC                                  VSP_014141;
CC       Name=5; Synonyms=IL17RC {ECO:0000303|PubMed:17911633};
CC         IsoId=Q8NAC3-5; Sequence=VSP_014138, VSP_047292;
CC       Name=6; Synonyms=IL17RC-delta7,12 {ECO:0000303|PubMed:17911633};
CC         IsoId=Q8NAC3-6; Sequence=VSP_014138, VSP_014139, VSP_047291;
CC       Name=7; Synonyms=IL17RC-delta12 {ECO:0000303|PubMed:17911633};
CC         IsoId=Q8NAC3-7; Sequence=VSP_014138, VSP_047291, VSP_047292;
CC       Name=8; Synonyms=IL17RC-delta7 {ECO:0000303|PubMed:17911633};
CC         IsoId=Q8NAC3-8; Sequence=VSP_014138, VSP_014139, VSP_047292;
CC   -!- TISSUE SPECIFICITY: Expressed in prostate, skeletal muscle, kidney and
CC       placenta (at protein level) (PubMed:11706037). Expressed in brain,
CC       cartilage, colon, heart, intestine, kidney, liver, lung, muscle,
CC       placenta, and prostate (PubMed:11706037). Also detected in thyroid,
CC       trachea and adrenal gland (PubMed:17911633). Low expression in thymus
CC       and leukocytes (PubMed:11706037). {ECO:0000269|PubMed:11706037,
CC       ECO:0000269|PubMed:17911633}.
CC   -!- INDUCTION: By HGF and VEGF. {ECO:0000269|PubMed:14504135}.
CC   -!- DISEASE: Candidiasis, familial, 9 (CANDF9) [MIM:616445]: A disorder
CC       characterized by altered immune responses and impaired clearance of
CC       fungal infections, selective against Candida. It is characterized by
CC       persistent and/or recurrent infections of the skin, nails and mucous
CC       membranes caused by organisms of the genus Candida, mainly Candida
CC       albicans. {ECO:0000269|PubMed:25918342}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF676032; ABV44615.1; -; mRNA.
DR   EMBL; EF676033; ABV44616.1; -; mRNA.
DR   EMBL; EF676034; ABV44617.1; -; mRNA.
DR   EMBL; BD292072; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF458065; AAM77569.1; -; mRNA.
DR   EMBL; AY358840; AAQ89199.1; -; mRNA.
DR   EMBL; AY359098; AAQ89456.1; -; mRNA.
DR   EMBL; AK092907; BAC04001.1; -; mRNA.
DR   EMBL; AC018809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006411; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS2590.1; -. [Q8NAC3-1]
DR   CCDS; CCDS2591.2; -. [Q8NAC3-3]
DR   CCDS; CCDS46746.1; -. [Q8NAC3-2]
DR   CCDS; CCDS56240.1; -. [Q8NAC3-5]
DR   CCDS; CCDS56241.1; -. [Q8NAC3-6]
DR   CCDS; CCDS74898.1; -. [Q8NAC3-7]
DR   CCDS; CCDS93202.1; -. [Q8NAC3-8]
DR   RefSeq; NP_001190192.1; NM_001203263.1. [Q8NAC3-5]
DR   RefSeq; NP_001190192.2; NM_001203263.2. [Q8NAC3-5]
DR   RefSeq; NP_001190193.1; NM_001203264.1. [Q8NAC3-7]
DR   RefSeq; NP_001190193.2; NM_001203264.2. [Q8NAC3-7]
DR   RefSeq; NP_001190194.1; NM_001203265.1. [Q8NAC3-6]
DR   RefSeq; NP_001190194.2; NM_001203265.2. [Q8NAC3-6]
DR   RefSeq; NP_001354209.1; NM_001367280.1. [Q8NAC3-8]
DR   RefSeq; NP_116121.2; NM_032732.5. [Q8NAC3-3]
DR   RefSeq; NP_116121.3; NM_032732.6. [Q8NAC3-3]
DR   RefSeq; NP_703190.1; NM_153460.3. [Q8NAC3-2]
DR   RefSeq; NP_703190.2; NM_153460.4. [Q8NAC3-2]
DR   RefSeq; NP_703191.1; NM_153461.3. [Q8NAC3-1]
DR   RefSeq; NP_703191.2; NM_153461.4. [Q8NAC3-1]
DR   RefSeq; XP_016862835.1; XM_017007346.1.
DR   PDB; 6HG4; X-ray; 3.32 A; B=95-538.
DR   PDB; 6HG9; X-ray; 3.62 A; B=95-538.
DR   PDB; 6HGA; X-ray; 2.60 A; B=279-538.
DR   PDB; 7UWN; EM; 3.01 A; G=95-536.
DR   PDB; 7ZAN; X-ray; 5.06 A; D=95-538.
DR   PDBsum; 6HG4; -.
DR   PDBsum; 6HG9; -.
DR   PDBsum; 6HGA; -.
DR   PDBsum; 7UWN; -.
DR   PDBsum; 7ZAN; -.
DR   AlphaFoldDB; Q8NAC3; -.
DR   EMDB; EMD-26837; -.
DR   SMR; Q8NAC3; -.
DR   BioGRID; 124278; 53.
DR   ComplexPortal; CPX-8776; Interleukin-17A-F receptor-ligand complex.
DR   ComplexPortal; CPX-9201; Interleukin-17A receptor-ligand complex.
DR   ComplexPortal; CPX-9202; Interleukin-17F receptor-ligand complex.
DR   IntAct; Q8NAC3; 49.
DR   STRING; 9606.ENSP00000295981; -.
DR   DrugCentral; Q8NAC3; -.
DR   GlyCosmos; Q8NAC3; 9 sites, No reported glycans.
DR   GlyGen; Q8NAC3; 9 sites, 1 N-linked glycan (2 sites).
DR   iPTMnet; Q8NAC3; -.
DR   PhosphoSitePlus; Q8NAC3; -.
DR   BioMuta; IL17RC; -.
DR   DMDM; 229462881; -.
DR   jPOST; Q8NAC3; -.
DR   MassIVE; Q8NAC3; -.
DR   PaxDb; 9606-ENSP00000295981; -.
DR   PeptideAtlas; Q8NAC3; -.
DR   ProteomicsDB; 20526; -.
DR   ProteomicsDB; 20554; -.
DR   ProteomicsDB; 72669; -. [Q8NAC3-1]
DR   ProteomicsDB; 72670; -. [Q8NAC3-2]
DR   ProteomicsDB; 72671; -. [Q8NAC3-3]
DR   ProteomicsDB; 72672; -. [Q8NAC3-4]
DR   Antibodypedia; 10412; 375 antibodies from 34 providers.
DR   DNASU; 84818; -.
DR   Ensembl; ENST00000295981.7; ENSP00000295981.3; ENSG00000163702.21. [Q8NAC3-1]
DR   Ensembl; ENST00000383812.9; ENSP00000373323.4; ENSG00000163702.21. [Q8NAC3-3]
DR   Ensembl; ENST00000403601.8; ENSP00000384969.3; ENSG00000163702.21. [Q8NAC3-2]
DR   Ensembl; ENST00000413608.2; ENSP00000396064.1; ENSG00000163702.21. [Q8NAC3-5]
DR   Ensembl; ENST00000416074.6; ENSP00000395315.3; ENSG00000163702.21. [Q8NAC3-7]
DR   Ensembl; ENST00000455057.5; ENSP00000407894.1; ENSG00000163702.21. [Q8NAC3-6]
DR   Ensembl; ENST00000483582.5; ENSP00000512844.1; ENSG00000163702.21. [Q8NAC3-4]
DR   Ensembl; ENST00000696816.1; ENSP00000512897.1; ENSG00000163702.21. [Q8NAC3-8]
DR   GeneID; 84818; -.
DR   KEGG; hsa:84818; -.
DR   MANE-Select; ENST00000403601.8; ENSP00000384969.3; NM_153460.4; NP_703190.2. [Q8NAC3-2]
DR   UCSC; uc003btz.4; human. [Q8NAC3-1]
DR   AGR; HGNC:18358; -.
DR   CTD; 84818; -.
DR   DisGeNET; 84818; -.
DR   GeneCards; IL17RC; -.
DR   HGNC; HGNC:18358; IL17RC.
DR   HPA; ENSG00000163702; Low tissue specificity.
DR   MalaCards; IL17RC; -.
DR   MIM; 610925; gene.
DR   MIM; 616445; phenotype.
DR   neXtProt; NX_Q8NAC3; -.
DR   OpenTargets; ENSG00000163702; -.
DR   Orphanet; 1334; Chronic mucocutaneous candidiasis.
DR   PharmGKB; PA134986616; -.
DR   VEuPathDB; HostDB:ENSG00000163702; -.
DR   eggNOG; ENOG502RYE0; Eukaryota.
DR   GeneTree; ENSGT00730000111286; -.
DR   HOGENOM; CLU_026893_1_0_1; -.
DR   InParanoid; Q8NAC3; -.
DR   OMA; RTEEWMH; -.
DR   OrthoDB; 9949622at2759; -.
DR   PhylomeDB; Q8NAC3; -.
DR   TreeFam; TF335852; -.
DR   PathwayCommons; Q8NAC3; -.
DR   Reactome; R-HSA-448424; Interleukin-17 signaling.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   SignaLink; Q8NAC3; -.
DR   SIGNOR; Q8NAC3; -.
DR   BioGRID-ORCS; 84818; 14 hits in 1156 CRISPR screens.
DR   ChiTaRS; IL17RC; human.
DR   GeneWiki; IL17RC; -.
DR   GenomeRNAi; 84818; -.
DR   Pharos; Q8NAC3; Tclin.
DR   PRO; PR:Q8NAC3; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8NAC3; protein.
DR   Bgee; ENSG00000163702; Expressed in adenohypophysis and 168 other cell types or tissues.
DR   ExpressionAtlas; Q8NAC3; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015026; F:coreceptor activity; IDA:UniProt.
DR   GO; GO:0030368; F:interleukin-17 receptor activity; IDA:MGI.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:Ensembl.
DR   GO; GO:0050832; P:defense response to fungus; IEA:Ensembl.
DR   GO; GO:0071621; P:granulocyte chemotaxis; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0038173; P:interleukin-17A-mediated signaling pathway; IDA:UniProt.
DR   GO; GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; IEA:Ensembl.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl.
DR   FunFam; 3.40.50.11530:FF:000001; interleukin-17 receptor C isoform X1; 1.
DR   Gene3D; 3.40.50.11530; -; 1.
DR   InterPro; IPR039465; IL-17_rcpt-like.
DR   InterPro; IPR027841; IL-17_rcpt_C/E_N.
DR   InterPro; IPR013568; SEFIR_dom.
DR   PANTHER; PTHR15583; INTERLEUKIN-17 RECEPTOR; 1.
DR   PANTHER; PTHR15583:SF12; INTERLEUKIN-17 RECEPTOR C; 1.
DR   Pfam; PF15037; IL17_R_N; 1.
DR   Pfam; PF08357; SEFIR; 1.
DR   PROSITE; PS51534; SEFIR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Inflammatory response; Membrane; Proteomics identification; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           21..791
FT                   /note="Interleukin-17 receptor C"
FT                   /id="PRO_0000011034"
FT   TOPO_DOM        21..538
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        539..559
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        560..791
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          583..735
FT                   /note="SEFIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00867"
FT   REGION          762..791
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        777..791
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        189
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        284
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        324
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        334
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        420
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        443
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        477
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        265..277
FT                   /evidence="ECO:0000269|PubMed:32187518,
FT                   ECO:0007744|PDB:6HG4"
FT   DISULFID        341..391
FT                   /evidence="ECO:0000269|PubMed:32187518,
FT                   ECO:0007744|PDB:6HG4"
FT   DISULFID        343..359
FT                   /evidence="ECO:0000269|PubMed:32187518,
FT                   ECO:0007744|PDB:6HG4"
FT   DISULFID        400..409
FT                   /evidence="ECO:0000269|PubMed:32187518,
FT                   ECO:0007744|PDB:6HG4"
FT   DISULFID        439..453
FT                   /evidence="ECO:0000269|PubMed:32187518,
FT                   ECO:0007744|PDB:6HG4"
FT   DISULFID        481..488
FT                   /evidence="ECO:0000269|PubMed:32187518,
FT                   ECO:0007744|PDB:6HG4"
FT   DISULFID        515..529
FT                   /evidence="ECO:0000269|PubMed:32187518,
FT                   ECO:0007744|PDB:6HG4"
FT   VAR_SEQ         36..106
FT                   /note="Missing (in isoform 2, isoform 3, isoform 4, isoform
FT                   5, isoform 6, isoform 7 and isoform 8)"
FT                   /evidence="ECO:0000269|PubMed:17911633,
FT                   ECO:0000303|PubMed:12975309, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17911633"
FT                   /id="VSP_014138"
FT   VAR_SEQ         264..278
FT                   /note="Missing (in isoform 3, isoform 4, isoform 6 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000269|PubMed:17911633,
FT                   ECO:0000303|PubMed:12975309, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014139"
FT   VAR_SEQ         425..441
FT                   /note="Missing (in isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000269|PubMed:17911633, ECO:0000305"
FT                   /id="VSP_047291"
FT   VAR_SEQ         566..578
FT                   /note="Missing (in isoform 5, isoform 7 and isoform 8)"
FT                   /evidence="ECO:0000269|PubMed:17911633, ECO:0000305"
FT                   /id="VSP_047292"
FT   VAR_SEQ         579..624
FT                   /note="AAARGRAALLLYSADDSGFERLVGALASALCQLPLRVAVDLWSRRE -> GE
FT                   WEQALGGGPPPGSQACASSPLPSPSVFSGSGRQGPRGSAPLLSR (in isoform
FT                   4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014140"
FT   VAR_SEQ         625..791
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014141"
FT   VARIANT         182
FT                   /note="S -> L (in dbSNP:rs708567)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17911633"
FT                   /id="VAR_022680"
FT   CONFLICT        241
FT                   /note="E -> G (in Ref. 4; AAQ89199)"
FT   CONFLICT        378
FT                   /note="Q -> R (in Ref. 1; ABV44615/ABV44616/ABV44617, 2;
FT                   BD292072, 3; AAM77569, 4; AAQ89199/AAQ89456 and 5;
FT                   BAC04001)"
FT                   /evidence="ECO:0000305"
FT   STRAND          102..104
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          106..112
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          115..117
FT                   /evidence="ECO:0007829|PDB:6HG4"
FT   STRAND          131..144
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          152..164
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          194..198
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          209..214
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   HELIX           217..219
FT                   /evidence="ECO:0007829|PDB:6HG4"
FT   STRAND          222..235
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          241..250
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          256..261
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   HELIX           270..273
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   HELIX           275..278
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   STRAND          283..286
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          289..296
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          303..312
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          313..315
FT                   /evidence="ECO:0007829|PDB:6HG4"
FT   STRAND          321..333
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   HELIX           335..337
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          342..350
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          356..358
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   TURN            360..363
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   HELIX           365..373
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          376..381
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          384..388
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          395..401
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          409..411
FT                   /evidence="ECO:0007829|PDB:7UWN"
FT   TURN            413..415
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          419..421
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          425..427
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          438..444
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          447..452
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   TURN            454..458
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          465..473
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   TURN            474..476
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          477..479
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          481..483
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          485..492
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          495..497
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   HELIX           498..501
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   HELIX           503..511
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          515..521
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   STRAND          524..530
FT                   /evidence="ECO:0007829|PDB:6HGA"
FT   HELIX           532..534
FT                   /evidence="ECO:0007829|PDB:6HGA"
SQ   SEQUENCE   791 AA;  86240 MW;  E9A4032C17ECD4AF CRC64;
     MPVPWFLLSL ALGRSPVVLS LERLVGPQDA THCSPVSLEP WGDEERLRVQ FLAQQSLSLA
     PVTAATARTA LSGLSGADGR REERGRGKSW VCLSLGGSGN TEPQKKGLSC RLWDSDILCL
     PGDIVPAPGP VLAPTHLQTE LVLRCQKETD CDLCLRVAVH LAVHGHWEEP EDEEKFGGAA
     DSGVEEPRNA SLQAQVVLSF QAYPTARCVL LEVQVPAALV QFGQSVGSVV YDCFEAALGS
     EVRIWSYTQP RYEKELNHTQ QLPDCRGLEV WNSIPSCWAL PWLNVSADGD NVHLVLNVSE
     EQHFGLSLYW NQVQGPPKPR WHKNLTGPQI ITLNHTDLVP CLCIQVWPLE PDSVRTNICP
     FREDPRAHQN LWQAARLQLL TLQSWLLDAP CSLPAEAALC WRAPGGDPCQ PLVPPLSWEN
     VTVDKVLEFP LLKGHPNLCV QVNSSEKLQL QECLWADSLG PLKDDVLLLE TRGPQDNRSL
     CALEPSGCTS LPSKASTRAA RLGEYLLQDL QSGQCLQLWD DDLGALWACP MDKYIHKRWA
     LVWLACLLFA AALSLILLLK KDHAKGWLRL LKQDVRSGAA ARGRAALLLY SADDSGFERL
     VGALASALCQ LPLRVAVDLW SRRELSAQGP VAWFHAQRRQ TLQEGGVVVL LFSPGAVALC
     SEWLQDGVSG PGAHGPHDAF RASLSCVLPD FLQGRAPGSY VGACFDRLLH PDAVPALFRT
     VPVFTLPSQL PDFLGALQQP RAPRSGRLQE RAEQVSRALQ PALDSYFHPP GTPAPGRGVG
     PGAGPGAGDG T
//
ID   B7Z661_HUMAN            Unreviewed;       358 AA.
AC   B7Z661;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   02-APR-2025, entry version 72.
DE   SubName: Full=cDNA FLJ54658, highly similar to Limbic system-associated membrane protein {ECO:0000313|EMBL:BAH13147.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH13147.1};
RN   [1] {ECO:0000313|EMBL:BAH13147.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAH13147.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK299851; BAH13147.1; -; mRNA.
DR   RefSeq; NP_001305844.1; NM_001318915.1.
DR   RefSeq; NP_002329.2; NM_002338.4.
DR   AlphaFoldDB; B7Z661; -.
DR   PeptideAtlas; B7Z661; -.
DR   DNASU; 4045; -.
DR   GeneID; 4045; -.
DR   KEGG; hsa:4045; -.
DR   CTD; 4045; -.
DR   DisGeNET; 4045; -.
DR   OrthoDB; 6159398at2759; -.
DR   BioGRID-ORCS; 4045; 6 hits in 1142 CRISPR screens.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   CDD; cd00096; Ig; 1.
DR   FunFam; 2.60.40.10:FF:000013; cell adhesion molecule 1 isoform X1; 1.
DR   FunFam; 2.60.40.10:FF:000500; limbic system-associated membrane protein isoform X1; 1.
DR   FunFam; 2.60.40.10:FF:000113; Opioid-binding protein/cell adhesion molecule; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR050876; IgLON_domain.
DR   PANTHER; PTHR42757; IGLON FAMILY OF IMMUNOGLOBULIN SUPERFAMILY-RELATED; 1.
DR   PANTHER; PTHR42757:SF22; LIMBIC SYSTEM-ASSOCIATED MEMBRANE PROTEIN; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF13927; Ig_3; 2.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   2: Evidence at transcript level;
KW   Immunoglobulin domain {ECO:0000256|ARBA:ARBA00023319};
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           24..358
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002866756"
FT   TRANSMEM        334..355
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          25..119
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          129..211
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          216..301
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
SQ   SEQUENCE   358 AA;  39714 MW;  0D21313EE36C52B2 CRC64;
     MRTYWLHSVW VLGFFLSLFS LQGLPVRSVD FNRGTDNITV RQGDTAILRC VVEDKNSKVA
     WLNRSGIIFA GHDKWSLDPR VELEKRHSLE YSLRIQKVDV YDEGSYTCSV QTQHEPKTSQ
     VYLIVQVPPK ISNISSDVTV NEGSNVTLVC MANGRPEPVI TWRHLTPTGR EFEGEEEYLE
     ILGITREQSG KYECKAANEV PSADVKQVKV TVNYPPTITE SKSNEATTGR QASLKCEASA
     VPAPDFEWYR DDTRINSANG LEIKSTEGQS SLTVTNVTEE HYGNYTCVAA NKLGVTNASL
     VLFKRVLPTI PHPIQEIGTT VHFKQKGPGS VRGINGSISL AVPLWLLAAS LLCLLSKC
//
ID   RFESD_HUMAN             Reviewed;         157 AA.
AC   Q8TAC1; J3KPH1;
DT   15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   09-APR-2025, entry version 152.
DE   RecName: Full=Rieske domain-containing protein;
GN   Name=RFESD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-153 (ISOFORM 2).
RC   TISSUE=Fetal pancreas;
RA   Melton D., Brown J., Kenty G., Permutt A., Lee C., Kaestner K.,
RA   Lemishka I., Scearce M., Brestelli J., Gradwohl G., Clifton S., Hillier L.,
RA   Marra M., Pape D., Wylie T., Martin J., Blistain A., Schmitt A.,
RA   Theising B., Ritter E., Ronko I., Bennett J., Cardenas M., Gibbons M.,
RA   McCann R., Cole R., Tsagareishvili R., Williams T., Jackson Y., Bowers Y.;
RT   "Endocrine pancreas consortium.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- COFACTOR:
CC       Name=[2Fe-2S] cluster; Xref=ChEBI:CHEBI:190135;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00628};
CC       Note=Binds 1 [2Fe-2S] cluster per subunit. {ECO:0000255|PROSITE-
CC       ProRule:PRU00628};
CC   -!- INTERACTION:
CC       Q8TAC1; P09105: HBQ1; NbExp=9; IntAct=EBI-10271664, EBI-10193656;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TAC1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TAC1-2; Sequence=VSP_044452;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC008547; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471084; EAW96043.1; -; Genomic_DNA.
DR   EMBL; CH471084; EAW96045.1; -; Genomic_DNA.
DR   EMBL; BC024023; AAH24023.1; -; mRNA.
DR   EMBL; BC035110; AAH35110.1; -; mRNA.
DR   EMBL; BC048979; AAH48979.1; -; mRNA.
DR   EMBL; BM263054; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS4075.1; -. [Q8TAC1-1]
DR   CCDS; CCDS47248.1; -. [Q8TAC1-2]
DR   RefSeq; NP_001124537.1; NM_001131065.1. [Q8TAC1-2]
DR   RefSeq; NP_001124538.1; NM_001131066.2. [Q8TAC1-2]
DR   RefSeq; NP_001362323.1; NM_001375394.1. [Q8TAC1-1]
DR   RefSeq; NP_775498.1; NM_173362.3. [Q8TAC1-1]
DR   RefSeq; XP_011541662.1; XM_011543360.3. [Q8TAC1-2]
DR   RefSeq; XP_011541663.1; XM_011543361.2.
DR   RefSeq; XP_016864902.1; XM_017009413.2. [Q8TAC1-2]
DR   RefSeq; XP_047273093.1; XM_047417137.1. [Q8TAC1-1]
DR   RefSeq; XP_054208463.1; XM_054352488.1. [Q8TAC1-2]
DR   RefSeq; XP_054208464.1; XM_054352489.1. [Q8TAC1-2]
DR   RefSeq; XP_054208465.1; XM_054352490.1. [Q8TAC1-1]
DR   AlphaFoldDB; Q8TAC1; -.
DR   SMR; Q8TAC1; -.
DR   BioGRID; 130435; 12.
DR   IntAct; Q8TAC1; 7.
DR   STRING; 9606.ENSP00000413592; -.
DR   iPTMnet; Q8TAC1; -.
DR   PhosphoSitePlus; Q8TAC1; -.
DR   BioMuta; RFESD; -.
DR   DMDM; 74730342; -.
DR   jPOST; Q8TAC1; -.
DR   MassIVE; Q8TAC1; -.
DR   PaxDb; 9606-ENSP00000413592; -.
DR   PeptideAtlas; Q8TAC1; -.
DR   ProteomicsDB; 73854; -. [Q8TAC1-1]
DR   Pumba; Q8TAC1; -.
DR   Antibodypedia; 4298; 215 antibodies from 19 providers.
DR   DNASU; 317671; -.
DR   Ensembl; ENST00000311364.9; ENSP00000309229.4; ENSG00000175449.15. [Q8TAC1-1]
DR   Ensembl; ENST00000380005.9; ENSP00000369341.4; ENSG00000175449.15. [Q8TAC1-2]
DR   Ensembl; ENST00000458310.2; ENSP00000413592.1; ENSG00000175449.15. [Q8TAC1-2]
DR   Ensembl; ENST00000511684.6; ENSP00000422520.2; ENSG00000175449.15. [Q8TAC1-1]
DR   GeneID; 317671; -.
DR   KEGG; hsa:317671; -.
DR   MANE-Select; ENST00000380005.9; ENSP00000369341.4; NM_001131066.2; NP_001124538.1. [Q8TAC1-2]
DR   UCSC; uc003klf.4; human. [Q8TAC1-1]
DR   AGR; HGNC:29587; -.
DR   CTD; 317671; -.
DR   DisGeNET; 317671; -.
DR   GeneCards; RFESD; -.
DR   HGNC; HGNC:29587; RFESD.
DR   HPA; ENSG00000175449; Tissue enhanced (bone).
DR   neXtProt; NX_Q8TAC1; -.
DR   OpenTargets; ENSG00000175449; -.
DR   PharmGKB; PA162401171; -.
DR   VEuPathDB; HostDB:ENSG00000175449; -.
DR   eggNOG; ENOG502S06W; Eukaryota.
DR   GeneTree; ENSGT00390000018225; -.
DR   HOGENOM; CLU_113767_0_0_1; -.
DR   InParanoid; Q8TAC1; -.
DR   OMA; SAVPKWC; -.
DR   OrthoDB; 426882at2759; -.
DR   PhylomeDB; Q8TAC1; -.
DR   TreeFam; TF333320; -.
DR   PathwayCommons; Q8TAC1; -.
DR   SignaLink; Q8TAC1; -.
DR   BioGRID-ORCS; 317671; 6 hits in 1115 CRISPR screens.
DR   GenomeRNAi; 317671; -.
DR   Pharos; Q8TAC1; Tdark.
DR   PRO; PR:Q8TAC1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q8TAC1; protein.
DR   Bgee; ENSG00000175449; Expressed in secondary oocyte and 112 other cell types or tissues.
DR   ExpressionAtlas; Q8TAC1; baseline and differential.
DR   GO; GO:0051537; F:2 iron, 2 sulfur cluster binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   CDD; cd03467; Rieske; 1.
DR   FunFam; 2.102.10.10:FF:000009; Rieske Fe-S domain containing; 1.
DR   Gene3D; 2.102.10.10; Rieske [2Fe-2S] iron-sulphur domain; 1.
DR   InterPro; IPR017941; Rieske_2Fe-2S.
DR   InterPro; IPR036922; Rieske_2Fe-2S_sf.
DR   InterPro; IPR054716; Sol_Rieske_ferrdox_dom.
DR   PANTHER; PTHR21496; FERREDOXIN-RELATED; 1.
DR   PANTHER; PTHR21496:SF0; RIESKE DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF22543; Rieske_4; 1.
DR   SUPFAM; SSF50022; ISP domain; 1.
DR   PROSITE; PS51296; RIESKE; 1.
PE   1: Evidence at protein level;
KW   2Fe-2S; Acetylation; Alternative splicing; Iron; Iron-sulfur;
KW   Metal-binding; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat.
FT   CHAIN           1..157
FT                   /note="Rieske domain-containing protein"
FT                   /id="PRO_0000313813"
FT   DOMAIN          16..94
FT                   /note="Rieske 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   DOMAIN          17..131
FT                   /note="Rieske 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         57
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         59
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         80
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   BINDING         83
FT                   /ligand="[2Fe-2S] cluster"
FT                   /ligand_id="ChEBI:CHEBI:190135"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00628"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1
FT                   /note="M -> MLKCFRNCLRPSSLSTLPLQYGILFPKLLACLVHLHFGHFSSAVISV
FT                   TSFYLSM (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_044452"
SQ   SEQUENCE   157 AA;  17762 MW;  E959948673E776F8 CRC64;
     MNLDGSAQDP EKREYSSVCV GREDDIKKSE RMTAVVHDRE VVIFYHKGEY HAMDIRCYHS
     GGPLHLGDIE DFDGRPCIVC PWHKYKITLA TGEGLYQSIN PKDPSAKPKW CSKGIKQRIH
     TVTVDNGNIY VTLSNEPFKC DSDFYATGDF KVIKSSS
//
ID   S35U4_HUMAN             Reviewed;         103 AA.
AC   L0R6Q1;
DT   15-MAR-2017, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2013, sequence version 1.
DT   05-FEB-2025, entry version 53.
DE   RecName: Full=SLC35A4 upstream open reading frame protein {ECO:0000305};
DE   AltName: Full=SLC35A4 microprotein {ECO:0000303|PubMed:38580077};
DE            Short=SLC35A4-MP {ECO:0000303|PubMed:38580077};
GN   Name=SLC35A4 {ECO:0000312|HGNC:HGNC:20753};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE INITIATION (ISOFORM 2).
RX   PubMed=23950983; DOI=10.1371/journal.pone.0070698;
RA   Vanderperre B., Lucier J.-F., Motard J., Tremblay G., Vanderperre S.,
RA   Wisztorski M., Salzet M., Boisvert F.-M., Roucou X.;
RT   "Direct detection of alternative open reading frames translation products
RT   in human significantly expands the proteome.";
RL   PLoS ONE 8:E70698-E70698(2013).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3]
RP   ALTERNATIVE INITIATION (ISOFORM 2).
RX   PubMed=25621764; DOI=10.7554/elife.03971;
RA   Andreev D.E., O'Connor P.B., Fahey C., Kenny E.M., Terenin I.M.,
RA   Dmitriev S.E., Cormican P., Morris D.W., Shatsky I.N., Baranov P.V.;
RT   "Translation of 5' leaders is pervasive in genes resistant to eIF2
RT   repression.";
RL   Elife 4:E03971-E03971(2015).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=38580077; DOI=10.1016/j.jmb.2024.168559;
RA   Rocha A.L., Pai V., Perkins G., Chang T., Ma J., De Souza E.V., Chu Q.,
RA   Vaughan J.M., Diedrich J.K., Ellisman M.H., Saghatelian A.;
RT   "An Inner Mitochondrial Membrane Microprotein from the SLC35A4 Upstream ORF
RT   Regulates Cellular Metabolism.";
RL   J. Mol. Biol. 436:168559-168559(2024).
CC   -!- FUNCTION: Required to maintain cellular respiration.
CC       {ECO:0000269|PubMed:38580077}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000269|PubMed:38580077}; Single-pass membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=2;
CC       Name=2; Synonyms=uORF {ECO:0000303|PubMed:25621764};
CC         IsoId=L0R6Q1-1; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q96G79-1; Sequence=External;
CC   -!- MISCELLANEOUS: [Isoform 2]: Product of the upstream open reading frame
CC       of this bicistronic gene. This may be the major product of the gene
CC       under normal conditions. {ECO:0000269|PubMed:25621764}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HF548106; CCO13817.1; -; Genomic_DNA.
DR   EMBL; AC011399; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC116353; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; L0R6Q1; -.
DR   SMR; L0R6Q1; -.
DR   BioMuta; SLC35A4; -.
DR   jPOST; L0R6Q1; -.
DR   MassIVE; L0R6Q1; -.
DR   PeptideAtlas; L0R6Q1; -.
DR   Pumba; L0R6Q1; -.
DR   Antibodypedia; 45451; 28 antibodies from 14 providers.
DR   MANE-Select; ENST00000715679.1; ENSP00000520497.1; NM_001394034.2; NP_001380963.1.
DR   UCSC; uc063hwg.1; human. [L0R6Q1-1]
DR   AGR; HGNC:20753; -.
DR   GeneCards; SLC35A4; -.
DR   HGNC; HGNC:20753; SLC35A4.
DR   HPA; ENSG00000176087; Low tissue specificity.
DR   neXtProt; NX_L0R6Q1; -.
DR   VEuPathDB; HostDB:ENSG00000176087; -.
DR   GeneTree; ENSGT00390000007844; -.
DR   HOGENOM; CLU_2262814_0_0_1; -.
DR   OrthoDB; 419167at2759; -.
DR   PathwayCommons; L0R6Q1; -.
DR   SignaLink; L0R6Q1; -.
DR   ChiTaRS; SLC35A4; human.
DR   Pharos; L0R6Q1; Tdark.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000176087; Expressed in islet of Langerhans and 180 other cell types or tissues.
DR   ExpressionAtlas; L0R6Q1; baseline and differential.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; HTP:FlyBase.
DR   GO; GO:1901857; P:positive regulation of cellular respiration; IMP:UniProtKB.
DR   GO; GO:0032056; P:positive regulation of translation in response to stress; IDA:UniProtKB.
DR   InterPro; IPR027854; STMP1.
DR   Pfam; PF15054; DUF4535; 1.
PE   1: Evidence at protein level;
KW   Alternative initiation; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Proteomics identification;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..103
FT                   /note="SLC35A4 upstream open reading frame protein"
FT                   /id="PRO_0000439345"
FT   TRANSMEM        62..84
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   103 AA;  11133 MW;  7097D4CC63748FE3 CRC64;
     MADDKDSLPK LKDLAFLKNQ LESLQRRVED EVNSGVGQDG SLLSSPFLKG FLAGYVVAKL
     RASAVLGFAV GTCTGIYAAQ AYAVPNVEKT LRDYLQLLRK GPD
//
ID   A0AAQ5BIE6_HUMAN        Unreviewed;       144 AA.
AC   A0AAQ5BIE6;
DT   02-OCT-2024, integrated into UniProtKB/TrEMBL.
DT   02-OCT-2024, sequence version 1.
DT   02-APR-2025, entry version 4.
DE   SubName: Full=Family with sequence similarity 153 member C, pseudogene {ECO:0000313|Ensembl:ENSP00000520384.1};
GN   Name=FAM153CP {ECO:0000313|Ensembl:ENSP00000520384.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000520384.1, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000520384.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000520384.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000520384.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000520384.1}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   -!- INTERACTION:
CC       A0AAQ5BIE6; A8K222; NbExp=3; IntAct=EBI-10174196, EBI-10174203;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC136632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136940; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   IntAct; A0AAQ5BIE6; 1.
DR   Ensembl; ENST00000507848.7; ENSP00000520379.1; ENSG00000204677.14.
DR   Ensembl; ENST00000650646.2; ENSP00000520389.1; ENSG00000204677.14.
DR   Ensembl; ENST00000651447.3; ENSP00000520384.1; ENSG00000204677.14.
DR   Ensembl; ENST00000651496.3; ENSP00000520387.1; ENSG00000204677.14.
DR   Ensembl; ENST00000651508.2; ENSP00000520380.1; ENSG00000204677.14.
DR   Ensembl; ENST00000652181.3; ENSP00000520383.1; ENSG00000204677.14.
DR   Ensembl; ENST00000652262.3; ENSP00000520386.1; ENSG00000204677.14.
DR   Ensembl; ENST00000652372.2; ENSP00000520382.1; ENSG00000204677.14.
DR   Ensembl; ENST00000652571.3; ENSP00000520385.1; ENSG00000204677.14.
DR   AGR; HGNC:33936; -.
DR   HGNC; HGNC:33936; FAM153CP.
DR   GeneTree; ENSGT00940000166337; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   InterPro; IPR023249; FAM153.
DR   PANTHER; PTHR40712; FAMILY WITH SEQUENCE SIMILARITY 153 MEMBER C-RELATED; 1.
DR   PANTHER; PTHR40712:SF2; PROTEIN FAM153A-RELATED; 1.
DR   Pfam; PF15722; FAM153; 1.
DR   PRINTS; PR02041; PROTEINF153.
PE   1: Evidence at protein level;
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REGION          58..131
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        83..92
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        93..102
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        104..116
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        117..131
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   144 AA;  16640 MW;  6BFABA738DBFCD6A CRC64;
     MVDKDTERDI EMKRQLRRLR ELHLYSTWKK YQEAMKTSLG VPQRGDLEDL EEHLPGQTVS
     EEATGVHMMQ VDPATPAKKL EDSTITGSHQ QMSASPSSAP AEEATEKTKV EEEVKTRKPK
     KKTRKPSKKS RWNVLKCWDI FNIF
//
ID   B4DSL7_HUMAN            Unreviewed;       198 AA.
AC   B4DSL7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   02-APR-2025, entry version 67.
DE   SubName: Full=HCG2040263, isoform CRA_b {ECO:0000313|EMBL:EAW55298.1};
DE   SubName: Full=cDNA FLJ53537 {ECO:0000313|EMBL:BAG61679.1};
GN   ORFNames=hCG_2040263 {ECO:0000313|EMBL:EAW55298.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG61679.1};
RN   [1] {ECO:0000313|EMBL:EAW55298.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW55298.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAG61679.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG61679.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK299804; BAG61679.1; -; mRNA.
DR   EMBL; CH471087; EAW55298.1; -; Genomic_DNA.
DR   AlphaFoldDB; B4DSL7; -.
DR   SMR; B4DSL7; -.
DR   IntAct; B4DSL7; 1.
DR   iPTMnet; B4DSL7; -.
DR   PeptideAtlas; B4DSL7; -.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   InterPro; IPR050863; CenT-Element_Derived.
DR   InterPro; IPR009057; Homeodomain-like_sf.
DR   InterPro; IPR006600; HTH_CenpB_DNA-bd_dom.
DR   PANTHER; PTHR19303:SF74; POGO TRANSPOSABLE ELEMENT WITH KRAB DOMAIN; 1.
DR   PANTHER; PTHR19303; TRANSPOSON; 1.
DR   Pfam; PF03221; HTH_Tnp_Tc5; 1.
DR   SMART; SM00674; CENPB; 1.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   PROSITE; PS51253; HTH_CENPB; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|ARBA:ARBA00023125}.
FT   DOMAIN          58..131
FT                   /note="HTH CENPB-type"
FT                   /evidence="ECO:0000259|PROSITE:PS51253"
SQ   SEQUENCE   198 AA;  22511 MW;  06A0E52B554FF1BC CRC64;
     MSSKRSHYDS ALKRKVIVYA EKHGNRAAGR TFDISEANIR RWRNDRNSIF SCKATTKCFT
     GPKKGRYPQV DEAVLRFVSE TRAKGLPITR QAMQLKAGEV AKTLGIDETK FKATRGWCDR
     FMRRAGLSLR HQTSFCPKLP TAIKQKTVLE HSFKKCCITS TLDNTGRDVL WKNADINDCG
     LKSDSEELDS EYEVIIIT
//
ID   A0A3F2YNX1_HUMAN        Unreviewed;        44 AA.
AC   A0A3F2YNX1;
DT   16-JAN-2019, integrated into UniProtKB/TrEMBL.
DT   16-JAN-2019, sequence version 1.
DT   02-APR-2025, entry version 25.
DE   RecName: Full=Protein tyrosine phosphatase 4A1 {ECO:0008006|Google:ProtNLM};
GN   Name=LOC128125822 {ECO:0000313|Ensembl:ENSP00000359685.4};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000359685.4, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000359685.4, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000359685.4, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., Oliver K.,
RA   Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., Ranby S.A.,
RA   Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., Skuce C.D.,
RA   Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., Sycamore N.,
RA   Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., White S.S.,
RA   Whitehead S.L., Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M.,
RA   Wray P.W., Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [3] {ECO:0000313|Ensembl:ENSP00000359685.4, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000359685.4}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL135905; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001401988.1; NM_001415059.2.
DR   AlphaFoldDB; A0A3F2YNX1; -.
DR   Ensembl; ENST00000370651.8; ENSP00000359685.4; ENSG00000285976.4.
DR   Ensembl; ENST00000715520.1; ENSP00000520460.1; ENSG00000285976.4.
DR   GeneID; 128125822; -.
DR   MANE-Select; ENST00000715520.1; ENSP00000520460.1; NM_001415059.2; NP_001401988.1.
DR   GeneCards; LOC128125822; -.
DR   VEuPathDB; HostDB:ENSG00000285976; -.
DR   GeneTree; ENSGT01120000272289; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000285976; Expressed in gastrocnemius and 104 other cell types or tissues.
DR   ExpressionAtlas; A0A3F2YNX1; baseline and differential.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0007829|PeptideAtlas:A0A3F2YNX1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   44 AA;  5004 MW;  FE573391AE49EC65 CRC64;
     MIRPQSSMSK HIPQFCGVLG HTFMEFLKGS GDYCQAQHDL YADK
//
ID   EPM2A_HUMAN             Reviewed;         331 AA.
AC   O95278; B3KMU5; B4DRZ2; O95483; Q5T3F5; Q6IS15; Q8IU96; Q8IX24; Q8IX25;
AC   Q9BS66; Q9UEN2;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 2.
DT   09-APR-2025, entry version 199.
DE   RecName: Full=Laforin {ECO:0000303|PubMed:11001928};
DE            EC=3.1.3.- {ECO:0000269|PubMed:16901901, ECO:0000269|PubMed:23922729, ECO:0000269|PubMed:25538239, ECO:0000269|PubMed:25544560, ECO:0000269|PubMed:26231210};
DE            EC=3.1.3.16 {ECO:0000305|PubMed:11001928};
DE            EC=3.1.3.48 {ECO:0000269|PubMed:11001928, ECO:0000269|PubMed:11220751};
DE   AltName: Full=Glucan phosphatase {ECO:0000303|PubMed:16901901, ECO:0000303|PubMed:25538239};
DE   AltName: Full=Glycogen phosphatase {ECO:0000303|PubMed:25538239, ECO:0000303|PubMed:25544560};
DE   AltName: Full=Lafora PTPase;
DE            Short=LAFPTPase {ECO:0000303|PubMed:11175283};
GN   Name=EPM2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), ALTERNATIVE SPLICING, TISSUE
RP   SPECIFICITY, VARIANTS MELF1 CYS-108; SER-279 AND LEU-293, AND VARIANT
RP   ASP-114.
RX   PubMed=9771710; DOI=10.1038/2470;
RA   Minassian B.A., Lee J.R., Herbrick J.-A., Huizenga J., Soder S.,
RA   Mungall A.J., Dunham I., Gardner R., Fong C.G., Carpenter S., Jardim L.,
RA   Satishchandra P., Andermann E., Snead O.C. III, Lopes-Cendes I.,
RA   Tsui L.-C., Delgado-Escueta A.V., Rouleau G.A., Scherer S.W.;
RT   "Mutations in a gene encoding a novel protein tyrosine phosphatase cause
RT   progressive myoclonus epilepsy.";
RL   Nat. Genet. 20:171-174(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTIONAL CHARACTERIZATION,
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANTS
RP   MELF1 HIS-171 AND LEU-293.
RC   TISSUE=Fetal brain;
RX   PubMed=11001928; DOI=10.1093/oxfordjournals.hmg.a018916;
RA   Ganesh S., Agarwala K.L., Ueda K., Akagi T., Shoda K., Usui T.,
RA   Hashikawa T., Osada H., Delgado-Escueta A.V., Yamakawa K.;
RT   "Laforin, defective in the progressive myoclonus epilepsy of Lafora type,
RT   is a dual-specificity phosphatase associated with polyribosomes.";
RL   Hum. Mol. Genet. 9:2251-2261(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Lee J.R., Scherer S.W.;
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 8), AND NUCLEOTIDE SEQUENCE [MRNA] OF
RP   25-331 (ISOFORM 4).
RC   TISSUE=Cerebellum, and Fetal brain;
RA   Ganesh S., Yamakawa K.;
RT   "Cloning of differentially spliced transcripts of the EPM2A gene.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 7 AND 8).
RC   TISSUE=Fetal brain, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 6).
RC   TISSUE=Hypothalamus, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 82-331 (ISOFORMS 1 AND 2), AND VARIANTS MELF1
RP   HIS-171; ILE-194; SER-279 AND ASN-294.
RX   PubMed=9931343; DOI=10.1093/hmg/8.2.345;
RA   Serratosa J.M., Gomez-Garre P., Gallardo M.E., Anta B., de Bernabe D.B.,
RA   Lindhout D., Augustijn P.B., Tassinari C.A., Malafosse R.M., Topcu M.,
RA   Grid D., Dravet C., Berkovic S.F., de Cordoba S.R.;
RT   "A novel protein tyrosine phosphatase gene is mutated in progressive
RT   myoclonus epilepsy of the Lafora type (EPM2).";
RL   Hum. Mol. Genet. 8:345-352(1999).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, MUTAGENESIS OF CYS-266,
RP   AND ACTIVE SITE.
RX   PubMed=11220751;
RX   DOI=10.1002/1531-8249(20010201)49:2<271::aid-ana52>3.3.co;2-4;
RA   Minassian B.A., Andrade D.M., Ianzano L., Young E.J., Chan E.,
RA   Ackerley C.A., Scherer S.W.;
RT   "Laforin is a cell membrane and endoplasmic reticulum-associated protein
RT   tyrosine phosphatase.";
RL   Ann. Neurol. 49:271-275(2001).
RN   [11]
RP   ALTERNATIVE SPLICING, AND SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=11883934; DOI=10.1006/bbrc.2002.6590;
RA   Ganesh S., Suzuki T., Yamakawa K.;
RT   "Alternative splicing modulates subcellular localization of laforin.";
RL   Biochem. Biophys. Res. Commun. 291:1134-1137(2002).
RN   [12]
RP   GLYCOGEN-BINDING, DOMAIN, SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANT
RP   MELF1 GLY-32, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF LYS-87
RP   AND CYS-266.
RX   PubMed=11739371; DOI=10.1074/jbc.c100686200;
RA   Wang J., Stuckey J.A., Wishart M.J., Dixon J.E.;
RT   "A unique carbohydrate binding domain targets the Lafora disease
RT   phosphatase to glycogen.";
RL   J. Biol. Chem. 277:2377-2380(2002).
RN   [13]
RP   INTERACTION WITH EPM2AIP1.
RX   PubMed=12782127; DOI=10.1016/s0888-7543(03)00094-6;
RA   Ianzano L., Zhao X.C., Minassian B.A., Scherer S.W.;
RT   "Identification of a novel protein interacting with laforin, the EPM2A
RT   progressive myoclonus epilepsy gene product.";
RL   Genomics 81:579-587(2003).
RN   [14]
RP   INTERACTION WITH HIRIP5.
RX   PubMed=12915448; DOI=10.1093/hmg/ddg253;
RA   Ganesh S., Tsurutani N., Suzuki T., Ueda K., Agarwala K.L., Osada H.,
RA   Delgado-Escueta A.V., Yamakawa K.;
RT   "The Lafora disease gene product laforin interacts with HIRIP5, a
RT   phylogenetically conserved protein containing a NifU-like domain.";
RL   Hum. Mol. Genet. 12:2359-2368(2003).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, SELF-INTERACTION, SUBCELLULAR LOCATION,
RP   GLYCOGEN-BINDING, INTERACTION WITH PPP1R3C, TISSUE SPECIFICITY, MUTAGENESIS
RP   OF ASP-235 AND CYS-266, ACTIVE SITE, AND CHARACTERIZATION OF VARIANTS MELF1
RP   GLY-32; LEU-84; CYS-108; ILE-194; SER-240; SER-279; LEU-293; ASN-294 AND
RP   LEU-301.
RX   PubMed=14532330; DOI=10.1093/hmg/ddg340;
RA   Fernandez-Sanchez M.E., Criado-Garcia O., Heath K.E., Garcia-Fojeda B.,
RA   Medrano-Fernandez I., Gomez-Garre P., Sanz P., Serratosa J.M.,
RA   Rodriguez de Cordoba S.;
RT   "Laforin, the dual-phosphatase responsible for Lafora disease, interacts
RT   with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances
RT   glycogen accumulation.";
RL   Hum. Mol. Genet. 12:3161-3171(2003).
RN   [16]
RP   BINDING TO GLYCOGEN AND LAFORA BODIES, DOMAIN, CHARACTERIZATION OF VARIANTS
RP   MELF1 PRO-25; LYS-28; GLY-32 AND LEU-88, AND CHARACTERIZATION OF VARIANT
RP   PRO-46.
RX   PubMed=14706656; DOI=10.1016/j.bbrc.2003.12.043;
RA   Ganesh S., Tsurutani N., Suzuki T., Hoshii Y., Ishihara T.,
RA   Delgado-Escueta A.V., Yamakawa K.;
RT   "The carbohydrate-binding domain of Lafora disease protein targets Lafora
RT   polyglucosan bodies.";
RL   Biochem. Biophys. Res. Commun. 313:1101-1109(2004).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, AND BINDING TO LAFORA GLUCAN BODIES.
RX   PubMed=15102711; DOI=10.1093/hmg/ddh130;
RA   Chan E.M., Ackerley C.A., Lohi H., Ianzano L., Cortez M.A., Shannon P.,
RA   Scherer S.W., Minassian B.A.;
RT   "Laforin preferentially binds the neurotoxic starch-like polyglucosans,
RT   which form in its absence in progressive myoclonus epilepsy.";
RL   Hum. Mol. Genet. 13:1117-1129(2004).
RN   [18]
RP   INTERACTION WITH NHLRC1, AND POLYUBIQUITINATION.
RX   PubMed=15930137; DOI=10.1073/pnas.0503285102;
RA   Gentry M.S., Worby C.A., Dixon J.E.;
RT   "Insights into Lafora disease: malin is an E3 ubiquitin ligase that
RT   ubiquitinates and promotes the degradation of laforin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8501-8506(2005).
RN   [19]
RP   FUNCTION AS A GLUCAN PHOSPHATASE, CATALYTIC ACTIVITY, AND INTERACTION WITH
RP   PPP1R3B; PPP1R3C AND PPP1R3D.
RX   PubMed=16901901; DOI=10.1074/jbc.m606117200;
RA   Worby C.A., Gentry M.S., Dixon J.E.;
RT   "Laforin, a dual specificity phosphatase that dephosphorylates complex
RT   carbohydrates.";
RL   J. Biol. Chem. 281:30412-30418(2006).
RN   [20]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=16971387; DOI=10.1074/jbc.m607778200;
RA   Liu Y., Wang Y., Wu C., Liu Y., Zheng P.;
RT   "Dimerization of Laforin is required for its optimal phosphatase activity,
RT   regulation of GSK3beta phosphorylation, and Wnt signaling.";
RL   J. Biol. Chem. 281:34768-34774(2006).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17908927; DOI=10.1101/gad.1553207;
RA   Cheng A., Zhang M., Gentry M.S., Worby C.A., Dixon J.E., Saltiel A.R.;
RT   "A role for AGL ubiquitination in the glycogen storage disorders of Lafora
RT   and Cori's disease.";
RL   Genes Dev. 21:2399-2409(2007).
RN   [22]
RP   FUNCTION (ISOFORMS 1 AND 2), CATALYTIC ACTIVITY, HOMODIMERIZATION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH NHLRC1 AND GLYCOGEN.
RX   PubMed=18617530; DOI=10.1093/hmg/ddn199;
RA   Dubey D., Ganesh S.;
RT   "Modulation of functional properties of laforin phosphatase by alternative
RT   splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive
RT   myoclonus epilepsy.";
RL   Hum. Mol. Genet. 17:3010-3020(2008).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH PPP1R3C.
RX   PubMed=18070875; DOI=10.1074/jbc.m708712200;
RA   Worby C.A., Gentry M.S., Dixon J.E.;
RT   "Malin decreases glycogen accumulation by promoting the degradation of
RT   protein targeting to glycogen (PTG).";
RL   J. Biol. Chem. 283:4069-4076(2008).
RN   [24]
RP   FUNCTION, AND COMPLEX FORMATION WITH NHLRC1 AND HSP70.
RX   PubMed=19036738; DOI=10.1093/hmg/ddn398;
RA   Garyali P., Siwach P., Singh P.K., Puri R., Mittal S., Sengupta S.,
RA   Parihar R., Ganesh S.;
RT   "The malin-laforin complex suppresses the cellular toxicity of misfolded
RT   proteins by promoting their degradation through the ubiquitin-proteasome
RT   system.";
RL   Hum. Mol. Genet. 18:688-700(2009).
RN   [25]
RP   INTERACTION WITH MAPT.
RX   PubMed=19542233; DOI=10.1074/jbc.m109.009688;
RA   Puri R., Suzuki T., Yamakawa K., Ganesh S.;
RT   "Hyperphosphorylation and aggregation of Tau in laforin-deficient mice, an
RT   animal model for Lafora disease.";
RL   J. Biol. Chem. 284:22657-22663(2009).
RN   [26]
RP   FUNCTION.
RX   PubMed=20453062; DOI=10.1093/hmg/ddq190;
RA   Aguado C., Sarkar S., Korolchuk V.I., Criado O., Vernia S., Boya P.,
RA   Sanz P., de Cordoba S.R., Knecht E., Rubinsztein D.C.;
RT   "Laforin, the most common protein mutated in Lafora disease, regulates
RT   autophagy.";
RL   Hum. Mol. Genet. 19:2867-2876(2010).
RN   [27]
RP   PHOSPHORYLATION AT SER-25, MUTAGENESIS OF SER-25; SER-168; THR-187 AND
RP   THR-194, AND INTERACTION WITH NHLRC1; PPP1R3C AND PRKAA2.
RX   PubMed=21728993; DOI=10.1042/bj20110150;
RA   Roma-Mateo C., Solaz-Fuster Mdel C., Gimeno-Alcaniz J.V., Dukhande V.V.,
RA   Donderis J., Worby C.A., Marina A., Criado O., Koller A.,
RA   Rodriguez De Cordoba S., Gentry M.S., Sanz P.;
RT   "Laforin, a dual-specificity phosphatase involved in Lafora disease, is
RT   phosphorylated at Ser25 by AMP-activated protein kinase.";
RL   Biochem. J. 439:265-275(2011).
RN   [28]
RP   INTERACTION WITH PRDM8.
RX   PubMed=22961547; DOI=10.1093/brain/aws205;
RA   Turnbull J., Girard J.M., Lohi H., Chan E.M., Wang P., Tiberia E., Omer S.,
RA   Ahmed M., Bennett C., Chakrabarty A., Tyagi A., Liu Y., Pencea N., Zhao X.,
RA   Scherer S.W., Ackerley C.A., Minassian B.A.;
RT   "Early-onset Lafora body disease.";
RL   Brain 135:2684-2698(2012).
RN   [29]
RP   ALTERNATIVE SPLICING (ISOFORMS 4; 5; 6; 7 AND 9), FUNCTION (ISOFORMS 2 AND
RP   7), INTERACTION WITH NHLRC1 AND GLYCOGEN, SUBCELLULAR LOCATION, SUBUNIT,
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF CYS-266, AND ACTIVE SITE.
RX   PubMed=22036712; DOI=10.1016/j.ygeno.2011.10.001;
RA   Dubey D., Parihar R., Ganesh S.;
RT   "Identification and characterization of novel splice variants of the human
RT   EPM2A gene mutated in Lafora progressive myoclonus epilepsy.";
RL   Genomics 99:36-43(2012).
RN   [30]
RP   FUNCTION, AND INTERACTION WITH PPP1R3D.
RX   PubMed=23624058; DOI=10.1016/j.biocel.2013.04.019;
RA   Rubio-Villena C., Garcia-Gimeno M.A., Sanz P.;
RT   "Glycogenic activity of R6, a protein phosphatase 1 regulatory subunit, is
RT   modulated by the laforin-malin complex.";
RL   Int. J. Biochem. Cell Biol. 45:1479-1488(2013).
RN   [31]
RP   CATALYTIC ACTIVITY, FUNCTION, INTERACTION WITH NHLRC1, SUBUNIT, AND
RP   MUTAGENESIS OF 109-CYS-CYS-110; CYS-123; CYS-169; CYS-205; CYS-250;
RP   CYS-266; CYS-329 AND 329-CYS--CYS-331.
RX   PubMed=23922729; DOI=10.1371/journal.pone.0069523;
RA   Sanchez-Martin P., Raththagala M., Bridges T.M., Husodo S., Gentry M.S.,
RA   Sanz P., Roma-Mateo C.;
RT   "Dimerization of the glucan phosphatase laforin requires the participation
RT   of cysteine 329.";
RL   PLoS ONE 8:E69523-E69523(2013).
RN   [32]
RP   CATALYTIC ACTIVITY, FUNCTION, MOTIF, AND CHARACTERIZATION OF VARIANT MELF1
RP   GLY-32.
RX   PubMed=26231210; DOI=10.1074/jbc.m115.658203;
RA   Meekins D.A., Raththagala M., Auger K.D., Turner B.D., Santelia D.,
RA   Koetting O., Gentry M.S., Vander Kooi C.W.;
RT   "Mechanistic insights into glucan phosphatase activity against polyglucan
RT   substrates.";
RL   J. Biol. Chem. 290:23361-23370(2015).
RN   [33] {ECO:0007744|PDB:4R30}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 148-331, FUNCTION AS GLUCAN
RP   PHOSPHATASE, CATALYTIC ACTIVITY, SUBUNIT, AND MUTAGENESIS OF CYS-169;
RP   ARG-171; ASP-197; ASP-235; CYS-266; ARG-272 AND CYS-329.
RX   PubMed=25538239; DOI=10.1074/jbc.m114.627406;
RA   Sankhala R.S., Koksal A.C., Ho L., Nitschke F., Minassian B.A.,
RA   Cingolani G.;
RT   "Dimeric quaternary structure of human laforin.";
RL   J. Biol. Chem. 290:4552-4559(2015).
RN   [34] {ECO:0007744|PDB:4RKK}
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 1-329 IN COMPLEX WITH
RP   MALTOHEXAOSE AND PHOSPHATE, CATALYTIC ACTIVITY, FUNCTION, SUBUNIT,
RP   MUTAGENESIS OF VAL-8; LYS-87; TRP-99; ILE-126; THR-142; ASP-197; MET-236
RP   AND CYS-266, AND CHARACTERIZATION OF VARIANTS MELF1 GLY-32; HIS-171;
RP   SER-240; ASN-294 AND LEU-301.
RX   PubMed=25544560; DOI=10.1016/j.molcel.2014.11.020;
RA   Raththagala M., Brewer M.K., Parker M.W., Sherwood A.R., Wong B.K., Hsu S.,
RA   Bridges T.M., Paasch B.C., Hellman L.M., Husodo S., Meekins D.A.,
RA   Taylor A.O., Turner B.D., Auger K.D., Dukhande V.V., Chakravarthy S.,
RA   Sanz P., Woods V.L. Jr., Li S., Vander Kooi C.W., Gentry M.S.;
RT   "Structural mechanism of laforin function in glycogen dephosphorylation and
RT   lafora disease.";
RL   Mol. Cell 57:261-272(2015).
RN   [35]
RP   VARIANTS MELF1 LEU-84; SER-240 AND LEU-301.
RX   PubMed=11175283; DOI=10.1038/sj.ejhg.5200571;
RA   Gomez-Garre P., Sanz Y., Rodriguez de Cordoba S.R., Serratosa J.M.;
RT   "Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of
RT   Lafora: high degree of allelic heterogeneity and prevalence of deletions.";
RL   Eur. J. Hum. Genet. 8:946-954(2000).
RN   [36]
RP   VARIANT PRO-46.
RX   PubMed=11735300; DOI=10.1006/mcpr.2001.0371;
RA   Ganesh S., Shoda K., Amano K., Uchiyama A., Kumada S., Moriyama N.,
RA   Hirose S., Yamakawa K.;
RT   "Mutation screening for Japanese Lafora's disease patients: identification
RT   of novel sequence variants in the coding and upstream regulatory regions of
RT   EPM2A gene.";
RL   Mol. Cell. Probes 15:281-289(2001).
RN   [37]
RP   VARIANTS MELF1 PRO-25; CYS-108; HIS-171 AND LEU-293, AND CHARACTERIZATION
RP   OF VARIANTS MELF1 GLY-32; CYS-108; ILE-194; SER-279 AND ASN-294.
RX   PubMed=12019207; DOI=10.1093/hmg/11.11.1263;
RA   Ganesh S., Delgado-Escueta A.V., Suzuki T., Francheschetti S., Riggio C.,
RA   Avanzini G., Rabinowicz A., Bohlega S., Bailey J., Alonso M.E.,
RA   Rasmussen A., Thomson A.E., Ochoa A., Prado A.J., Medina M.T., Yamakawa K.;
RT   "Genotype-phenotype correlations for EPM2A mutations in Lafora's
RT   progressive myoclonus epilepsy: exon 1 mutations associate with an early-
RT   onset cognitive deficit subphenotype.";
RL   Hum. Mol. Genet. 11:1263-1271(2002).
RN   [38]
RP   VARIANT MELF1 ALA-187.
RX   PubMed=12560877; DOI=10.1007/s100380300006;
RA   Ki C.S., Kong S.Y., Seo D.W., Hong S.B., Kim H.J., Kim J.W.;
RT   "Two novel mutations in the EPM2A gene in a Korean patient with Lafora's
RT   progressive myoclonus epilepsy.";
RL   J. Hum. Genet. 48:51-54(2003).
RN   [39]
RP   VARIANT MELF1 PRO-91.
RX   PubMed=15009235; DOI=10.1111/j.0013-9580.2004.33203.x;
RA   Annesi G., Sofia V., Gambardella A., Ciro Candiano I.C., Spadafora P.,
RA   Annesi F., Cutuli N., De Marco E.V., Civitelli D., Carrideo S.,
RA   Tarantino P., Barone R., Zappia M., Quattrone A.;
RT   "A novel exon 1 mutation in a patient with atypical Lafora progressive
RT   myoclonus epilepsy seen as childhood-onset cognitive deficit.";
RL   Epilepsia 45:294-295(2004).
RN   [40]
RP   VARIANTS MELF1 PRO-91; HIS-171 AND SER-279, CATALYTIC ACTIVITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=14722920; DOI=10.1002/humu.10306;
RA   Ianzano L., Young E.J., Zhao X.C., Chan E.M., Rodriguez M.T., Torrado M.V.,
RA   Scherer S.W., Minassian B.A.;
RT   "Loss of function of the cytoplasmic isoform of the protein laforin (EPM2A)
RT   causes Lafora progressive myoclonus epilepsy.";
RL   Hum. Mutat. 23:170-176(2004).
RN   [41]
RP   VARIANT PRO-46.
RX   PubMed=16021330; DOI=10.1007/s10038-005-0263-7;
RA   Singh S., Suzuki T., Uchiyama A., Kumada S., Moriyama N., Hirose S.,
RA   Takahashi Y., Sugie H., Mizoguchi K., Inoue Y., Kimura K., Sawaishi Y.,
RA   Yamakawa K., Ganesh S.;
RT   "Mutations in the NHLRC1 gene are the common cause for Lafora disease in
RT   the Japanese population.";
RL   J. Hum. Genet. 50:347-352(2005).
RN   [42]
RP   VARIANTS MELF1 ASN-140; TYR-148; LYS-210 AND TRP-310, CHARACTERIZATION OF
RP   VARIANT MELF1 TRP-310, AND SUBCELLULAR LOCATION.
RX   PubMed=18311786; DOI=10.1002/humu.20737;
RA   Singh S., Satishchandra P., Shankar S.K., Ganesh S.;
RT   "Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations
RT   and their impact on subcellular localization of laforin and malin.";
RL   Hum. Mutat. 29:E1-12(2008).
CC   -!- FUNCTION: Plays an important role in preventing glycogen
CC       hyperphosphorylation and the formation of insoluble aggregates, via its
CC       activity as glycogen phosphatase, and by promoting the ubiquitination
CC       of proteins involved in glycogen metabolism via its interaction with
CC       the E3 ubiquitin ligase NHLRC1/malin. Shows strong phosphatase activity
CC       towards complex carbohydrates in vitro, avoiding glycogen
CC       hyperphosphorylation which is associated with reduced branching and
CC       formation of insoluble aggregates (PubMed:16901901, PubMed:23922729,
CC       PubMed:25538239, PubMed:25544560, PubMed:26231210). Dephosphorylates
CC       phosphotyrosine and synthetic substrates, such as para-
CC       nitrophenylphosphate (pNPP), and has low activity with phosphoserine
CC       and phosphothreonine substrates (in vitro) (PubMed:11001928,
CC       PubMed:11220751, PubMed:11739371, PubMed:14532330, PubMed:14722920,
CC       PubMed:16971387, PubMed:18617530, PubMed:22036712, PubMed:23922729).
CC       Has been shown to dephosphorylate MAPT (By similarity). Forms a complex
CC       with NHLRC1/malin and HSP70, which suppresses the cellular toxicity of
CC       misfolded proteins by promoting their degradation through the
CC       ubiquitin-proteasome system (UPS). Acts as a scaffold protein to
CC       facilitate PPP1R3C/PTG ubiquitination by NHLRC1/malin
CC       (PubMed:23922729). Also promotes proteasome-independent protein
CC       degradation through the macroautophagy pathway (PubMed:20453062).
CC       {ECO:0000250|UniProtKB:Q9WUA5, ECO:0000269|PubMed:11001928,
CC       ECO:0000269|PubMed:11220751, ECO:0000269|PubMed:11739371,
CC       ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:14722920,
CC       ECO:0000269|PubMed:16901901, ECO:0000269|PubMed:16971387,
CC       ECO:0000269|PubMed:18070875, ECO:0000269|PubMed:18617530,
CC       ECO:0000269|PubMed:19036738, ECO:0000269|PubMed:20453062,
CC       ECO:0000269|PubMed:22036712, ECO:0000269|PubMed:23624058,
CC       ECO:0000269|PubMed:23922729, ECO:0000269|PubMed:25538239,
CC       ECO:0000269|PubMed:25544560, ECO:0000269|PubMed:26231210}.
CC   -!- FUNCTION: [Isoform 2]: Does not bind to glycogen (PubMed:18617530).
CC       Lacks phosphatase activity and might function as a dominant-negative
CC       regulator for the phosphatase activity of isoform 1 and isoform 7
CC       (PubMed:18617530, PubMed:22036712). {ECO:0000269|PubMed:18617530,
CC       ECO:0000269|PubMed:22036712}.
CC   -!- FUNCTION: [Isoform 7]: Has phosphatase activity (in vitro).
CC       {ECO:0000269|PubMed:22036712}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:20101, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:61978; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044, ECO:0000269|PubMed:11001928,
CC         ECO:0000269|PubMed:11220751};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:83421; EC=3.1.3.16;
CC         Evidence={ECO:0000305|PubMed:11001928};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-
CC         COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:61977; EC=3.1.3.16;
CC         Evidence={ECO:0000305|PubMed:11001928};
CC   -!- SUBUNIT: Homodimer (PubMed:16971387, PubMed:18617530, PubMed:23922729,
CC       PubMed:25538239, PubMed:25544560). Interacts with itself
CC       (PubMed:14532330). Interacts with PPP1R3B, PPP1R3C, PPP1R3D, HIRIP5,
CC       and EPM2AIP1 (PubMed:12782127, PubMed:12915448, PubMed:14532330,
CC       PubMed:16901901, PubMed:18070875). Binds glycogen and Lafora bodies
CC       (PubMed:11739371, PubMed:14532330, PubMed:14706656, PubMed:15102711,
CC       PubMed:18617530, PubMed:22036712). Interacts with NHLRC1/malin (via the
CC       NHL repeats) (PubMed:15930137, PubMed:22036712, PubMed:23922729). Forms
CC       a complex with NHLRC1/malin and HSP70 (PubMed:19036738). Interacts with
CC       PPP1R3D; in the presence of NHLC1/malin the interaction leads to
CC       ubiquitination and autophagic degradation of PPP1R3D. Interacts (via
CC       the phosphatase domain) with MAPT/Tau; the interaction dephosphorylates
CC       MAPT (PubMed:19542233). Isoform 1 and isoform 2 interact to form a
CC       heterodimeric complex that lacks phosphatase activity (in vitro)
CC       (PubMed:18617530). Active phosphatase isoform 7 and isoform 1 interact
CC       with each other, but give rise to lower phosphatase activity than
CC       isoform 1 or isoform 7 by themselves (in vitro) (PubMed:22036712).
CC       Active phosphatase isoform 7 and inactive isoform 2 interact with each
CC       other, but give rise to lower phosphatase activity than isoform 7 by
CC       itself (in vitro) (PubMed:22036712). Interacts with PRDM8
CC       (PubMed:22961547). {ECO:0000269|PubMed:11739371,
CC       ECO:0000269|PubMed:12782127, ECO:0000269|PubMed:12915448,
CC       ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:14706656,
CC       ECO:0000269|PubMed:15102711, ECO:0000269|PubMed:15930137,
CC       ECO:0000269|PubMed:16901901, ECO:0000269|PubMed:16971387,
CC       ECO:0000269|PubMed:18070875, ECO:0000269|PubMed:18617530,
CC       ECO:0000269|PubMed:19542233, ECO:0000269|PubMed:22036712,
CC       ECO:0000269|PubMed:22961547, ECO:0000269|PubMed:23624058,
CC       ECO:0000269|PubMed:23922729, ECO:0000269|PubMed:25538239,
CC       ECO:0000269|PubMed:25544560}.
CC   -!- INTERACTION:
CC       O95278; Q6VVB1: NHLRC1; NbExp=8; IntAct=EBI-2506661, EBI-6426628;
CC       O95278; Q9UQK1: PPP1R3C; NbExp=5; IntAct=EBI-2506661, EBI-2506727;
CC       O95278-6; P06307: CCK; NbExp=3; IntAct=EBI-25836908, EBI-6624398;
CC       O95278-6; P13473-2: LAMP2; NbExp=3; IntAct=EBI-25836908, EBI-21591415;
CC       O95278-6; Q9Y371: SH3GLB1; NbExp=3; IntAct=EBI-25836908, EBI-2623095;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11001928,
CC       ECO:0000269|PubMed:11220751, ECO:0000269|PubMed:11739371,
CC       ECO:0000269|PubMed:15102711, ECO:0000269|PubMed:17908927}. Note=Under
CC       glycogenolytic conditions localizes to the nucleus.
CC       {ECO:0000269|PubMed:17908927}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cytoplasm
CC       {ECO:0000269|PubMed:11001928, ECO:0000269|PubMed:11739371,
CC       ECO:0000269|PubMed:11883934, ECO:0000269|PubMed:14532330,
CC       ECO:0000269|PubMed:18311786, ECO:0000269|PubMed:18617530,
CC       ECO:0000269|PubMed:22036712}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11001928, ECO:0000269|PubMed:14722920,
CC       ECO:0000269|PubMed:18311786}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:11001928, ECO:0000269|PubMed:18311786}; Cytoplasmic
CC       side {ECO:0000269|PubMed:11001928, ECO:0000269|PubMed:18311786}. Cell
CC       membrane {ECO:0000269|PubMed:11220751}. Note=Colocalizes with glycogen
CC       synthase in punctate structures in the cytoplasm (PubMed:11739371,
CC       PubMed:14532330). Primarily associated with polyribosomes at the rough
CC       endoplasmic reticulum, and also detected at the plasma membrane
CC       (PubMed:11001928, PubMed:11220751, PubMed:11883934, PubMed:18311786).
CC       {ECO:0000269|PubMed:11001928, ECO:0000269|PubMed:11220751,
CC       ECO:0000269|PubMed:11739371, ECO:0000269|PubMed:11883934,
CC       ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:18311786}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:18617530}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11883934}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:11883934}; Cytoplasmic side
CC       {ECO:0000269|PubMed:11883934}. Cell membrane
CC       {ECO:0000269|PubMed:11883934}. Nucleus {ECO:0000269|PubMed:11883934,
CC       ECO:0000269|PubMed:14722920, ECO:0000269|PubMed:18617530}. Note=Also
CC       found in the nucleus. {ECO:0000269|PubMed:11883934,
CC       ECO:0000269|PubMed:18617530}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm
CC       {ECO:0000269|PubMed:22036712}. Nucleus {ECO:0000269|PubMed:22036712}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Cytoplasm
CC       {ECO:0000269|PubMed:22036712}. Nucleus {ECO:0000269|PubMed:22036712}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 7]: Cytoplasm
CC       {ECO:0000269|PubMed:22036712}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=8;
CC       Name=1; Synonyms=A, LDH1 {ECO:0000303|PubMed:11883934}, Laf331
CC       {ECO:0000303|PubMed:22036712};
CC         IsoId=O95278-1; Sequence=Displayed;
CC       Name=2; Synonyms=B, C-terISO, Laf317 {ECO:0000303|PubMed:22036712};
CC         IsoId=O95278-2; Sequence=VSP_011017, VSP_011018;
CC       Name=4; Synonyms=Laf152 {ECO:0000303|PubMed:22036712};
CC         IsoId=O95278-4; Sequence=VSP_011015, VSP_011016;
CC       Name=5; Synonyms=Laf224 {ECO:0000303|PubMed:22036712};
CC         IsoId=O95278-5; Sequence=VSP_042496, VSP_042497;
CC       Name=6; Synonyms=Laf88 {ECO:0000303|PubMed:22036712};
CC         IsoId=O95278-6; Sequence=VSP_042494;
CC       Name=7; Synonyms=Laf177 {ECO:0000303|PubMed:22036712};
CC         IsoId=O95278-7; Sequence=VSP_042495;
CC       Name=8;
CC         IsoId=O95278-8; Sequence=VSP_042493;
CC       Name=9; Synonyms=POCR {ECO:0000303|PubMed:22036712};
CC         IsoId=B3EWF7-1; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Expressed in heart, skeletal muscle, kidney,
CC       pancreas and brain. Isoform 4 is also expressed in the placenta.
CC       {ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:9771710}.
CC   -!- DOMAIN: The CBM20 domain mediates binding to cytoplasmic glycogen and
CC       to Lafora polyglucosan bodies. {ECO:0000269|PubMed:11739371,
CC       ECO:0000269|PubMed:14706656}.
CC   -!- PTM: Polyubiquitinated by NHLRC1/malin. {ECO:0000269|PubMed:15930137}.
CC   -!- PTM: Phosphorylation on Ser-25 by AMPK affects the phosphatase activity
CC       of the enzyme and its ability to homodimerize and interact with NHLRC1,
CC       PPP1R3C or PRKAA2. {ECO:0000269|PubMed:21728993}.
CC   -!- DISEASE: Myoclonic epilepsy of lafora 1 (MELF1) [MIM:254780]: A form of
CC       progressive myoclonic epilepsy, a clinically and genetically
CC       heterogeneous group of disorders defined by the combination of action
CC       and reflex myoclonus, other types of epileptic seizures, and
CC       progressive neurodegeneration and neurocognitive impairment. MELF1 is
CC       an autosomal recessive, severe form characterized by onset of
CC       progressive neurodegeneration between 8 and 18 years of age. Initial
CC       features can include headache, myoclonic jerks, generalized seizures,
CC       and often visual hallucination. Typically, as seizures increase in
CC       frequency, cognitive function declines towards dementia, and affected
CC       individuals die usually within 10 years after onset. At the cellular
CC       level, MELF1 is characterized by accumulation of starch-like
CC       polyglucosans called Lafora bodies (LBs) that are most abundant in
CC       organs with the highest glucose metabolism: brain, heart, liver and
CC       skeletal muscle. {ECO:0000269|PubMed:11001928,
CC       ECO:0000269|PubMed:11175283, ECO:0000269|PubMed:11739371,
CC       ECO:0000269|PubMed:12019207, ECO:0000269|PubMed:12560877,
CC       ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:14706656,
CC       ECO:0000269|PubMed:14722920, ECO:0000269|PubMed:15009235,
CC       ECO:0000269|PubMed:18311786, ECO:0000269|PubMed:25544560,
CC       ECO:0000269|PubMed:26231210, ECO:0000269|PubMed:9771710,
CC       ECO:0000269|PubMed:9931343}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: Produced by alternative splicing.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative splicing. May be
CC       due to an intron retention. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Produced by alternative splicing.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 6]: Produced by alternative initiation at Met-
CC       244 of isoform 1. Transcript amplified but protein not detected.
CC       {ECO:0000269|PubMed:22036712}.
CC   -!- MISCELLANEOUS: [Isoform 7]: Produced by alternative splicing. Active
CC       phosphatase. {ECO:0000269|PubMed:22036712}.
CC   -!- MISCELLANEOUS: [Isoform 8]: Produced by alternative splicing.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO15523.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC       Sequence=BAG51107.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=The Lafora progressive myoclonus epilepsy mutation
CC       and polymorphism database;
CC       URL="http://projects.tcag.ca/lafora/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF084535; AAC83347.2; -; mRNA.
DR   EMBL; AF284580; AAG18377.1; -; mRNA.
DR   EMBL; AF454491; AAO15523.1; ALT_SEQ; mRNA.
DR   EMBL; AF454492; AAO15524.1; -; mRNA.
DR   EMBL; AF454493; AAO15525.1; -; mRNA.
DR   EMBL; AF454494; AAO15526.1; -; mRNA.
DR   EMBL; AK022721; BAG51107.1; ALT_FRAME; mRNA.
DR   EMBL; AK299497; BAG61454.1; -; mRNA.
DR   EMBL; AL023806; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365193; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW47844.1; -; Genomic_DNA.
DR   EMBL; BC005286; AAH05286.1; -; mRNA.
DR   EMBL; BC070047; AAH70047.1; -; mRNA.
DR   EMBL; AJ130763; CAA10199.1; -; mRNA.
DR   EMBL; AJ130764; CAA10200.1; -; mRNA.
DR   CCDS; CCDS5206.1; -. [O95278-1]
DR   CCDS; CCDS87452.1; -. [O95278-8]
DR   CCDS; CCDS87453.1; -. [O95278-5]
DR   CCDS; CCDS87454.1; -. [O95278-2]
DR   RefSeq; NP_001018051.1; NM_001018041.2. [O95278-2]
DR   RefSeq; NP_001346986.1; NM_001360057.2. [O95278-5]
DR   RefSeq; NP_001346993.1; NM_001360064.2. [O95278-8]
DR   RefSeq; NP_001347000.1; NM_001360071.2. [O95278-8]
DR   RefSeq; NP_001355058.1; NM_001368129.2. [O95278-7]
DR   RefSeq; NP_001355060.1; NM_001368131.1. [O95278-8]
DR   RefSeq; NP_001355061.1; NM_001368132.1. [O95278-7]
DR   RefSeq; NP_005661.1; NM_005670.4. [O95278-1]
DR   RefSeq; XP_006715627.1; XM_006715564.3.
DR   RefSeq; XP_011534418.1; XM_011536116.2. [O95278-8]
DR   RefSeq; XP_016866789.1; XM_017011300.1.
DR   RefSeq; XP_016866790.1; XM_017011301.1.
DR   RefSeq; XP_016866791.1; XM_017011302.2. [O95278-7]
DR   RefSeq; XP_024302319.1; XM_024446551.2. [O95278-8]
DR   RefSeq; XP_047275320.1; XM_047419364.1. [O95278-7]
DR   RefSeq; XP_054212398.1; XM_054356423.1. [O95278-1]
DR   RefSeq; XP_054212402.1; XM_054356427.1. [O95278-8]
DR   RefSeq; XP_054212403.1; XM_054356428.1. [O95278-8]
DR   RefSeq; XP_054212404.1; XM_054356429.1. [O95278-7]
DR   RefSeq; XP_054212405.1; XM_054356430.1. [O95278-7]
DR   PDB; 4R30; X-ray; 2.30 A; A/B/C/D=148-331.
DR   PDB; 4RKK; X-ray; 2.40 A; A/C=1-329.
DR   PDBsum; 4R30; -.
DR   PDBsum; 4RKK; -.
DR   AlphaFoldDB; O95278; -.
DR   SMR; O95278; -.
DR   BioGRID; 113679; 54.
DR   IntAct; O95278; 10.
DR   STRING; 9606.ENSP00000356489; -.
DR   BindingDB; O95278; -.
DR   ChEMBL; CHEMBL2311242; -.
DR   CAZy; CBM20; Carbohydrate-Binding Module Family 20.
DR   DEPOD; EPM2A; -.
DR   iPTMnet; O95278; -.
DR   PhosphoSitePlus; O95278; -.
DR   BioMuta; EPM2A; -.
DR   MassIVE; O95278; -.
DR   PaxDb; 9606-ENSP00000356489; -.
DR   PeptideAtlas; O95278; -.
DR   ProteomicsDB; 50779; -. [O95278-1]
DR   ProteomicsDB; 50780; -. [O95278-2]
DR   ProteomicsDB; 50782; -. [O95278-4]
DR   ProteomicsDB; 50783; -. [O95278-5]
DR   ProteomicsDB; 50784; -. [O95278-6]
DR   ProteomicsDB; 50785; -. [O95278-7]
DR   ProteomicsDB; 50786; -. [O95278-8]
DR   Pumba; O95278; -.
DR   ABCD; O95278; 1 sequenced antibody.
DR   Antibodypedia; 19839; 551 antibodies from 39 providers.
DR   DNASU; 7957; -.
DR   Ensembl; ENST00000367519.9; ENSP00000356489.3; ENSG00000112425.16. [O95278-1]
DR   Ensembl; ENST00000435470.2; ENSP00000405913.2; ENSG00000112425.16. [O95278-2]
DR   Ensembl; ENST00000611340.5; ENSP00000480268.1; ENSG00000112425.16. [O95278-8]
DR   Ensembl; ENST00000638262.1; ENSP00000492876.1; ENSG00000112425.16. [O95278-5]
DR   Ensembl; ENST00000638778.1; ENSP00000491353.1; ENSG00000112425.16. [O95278-8]
DR   Ensembl; ENST00000638783.1; ENSP00000491338.1; ENSG00000112425.16. [O95278-8]
DR   Ensembl; ENST00000639423.1; ENSP00000492701.1; ENSG00000112425.16. [O95278-8]
DR   Ensembl; ENST00000639465.1; ENSP00000491180.1; ENSG00000112425.16. [O95278-8]
DR   GeneID; 7957; -.
DR   KEGG; hsa:7957; -.
DR   MANE-Select; ENST00000367519.9; ENSP00000356489.3; NM_005670.4; NP_005661.1.
DR   UCSC; uc003qkw.4; human. [O95278-1]
DR   AGR; HGNC:3413; -.
DR   CTD; 7957; -.
DR   DisGeNET; 7957; -.
DR   GeneCards; EPM2A; -.
DR   GeneReviews; EPM2A; -.
DR   HGNC; HGNC:3413; EPM2A.
DR   HPA; ENSG00000112425; Tissue enhanced (skeletal muscle, tongue).
DR   MalaCards; EPM2A; -.
DR   MIM; 254780; phenotype.
DR   MIM; 607566; gene.
DR   neXtProt; NX_O95278; -.
DR   OpenTargets; ENSG00000112425; -.
DR   Orphanet; 501; Lafora disease.
DR   PharmGKB; PA27832; -.
DR   VEuPathDB; HostDB:ENSG00000112425; -.
DR   eggNOG; KOG1716; Eukaryota.
DR   GeneTree; ENSGT00390000010101; -.
DR   HOGENOM; CLU_076792_0_0_1; -.
DR   OMA; EMRHTTN; -.
DR   OrthoDB; 273181at2759; -.
DR   PhylomeDB; O95278; -.
DR   TreeFam; TF332841; -.
DR   BRENDA; 3.1.3.16; 2681.
DR   PathwayCommons; O95278; -.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   SignaLink; O95278; -.
DR   SIGNOR; O95278; -.
DR   BioGRID-ORCS; 7957; 10 hits in 1166 CRISPR screens.
DR   ChiTaRS; EPM2A; human.
DR   EvolutionaryTrace; O95278; -.
DR   GenomeRNAi; 7957; -.
DR   Pharos; O95278; Tbio.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112425; Expressed in skeletal muscle tissue of rectus abdominis and 204 other cell types or tissues.
DR   ExpressionAtlas; O95278; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0098556; C:cytoplasmic side of rough endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004373; F:alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity; IEA:Ensembl.
DR   GO; GO:0033192; F:calmodulin-dependent protein phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0030246; F:carbohydrate binding; IDA:UniProtKB.
DR   GO; GO:0019203; F:carbohydrate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:2001069; F:glycogen binding; IDA:UniProtKB.
DR   GO; GO:0140791; F:histone H2AXS140 phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0140793; F:histone H2AXY142 phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:1990439; F:MAP kinase serine/threonine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0017018; F:myosin phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016791; F:phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0046983; F:protein dimerization activity; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0030946; F:protein tyrosine phosphatase activity, metal-dependent; IEA:UniProtKB-EC.
DR   GO; GO:0180006; F:RNA polymerase II CTD heptapeptide repeat S2 phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0180007; F:RNA polymerase II CTD heptapeptide repeat S5 phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0180008; F:RNA polymerase II CTD heptapeptide repeat S7 phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0180005; F:RNA polymerase II CTD heptapeptide repeat T4 phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0180004; F:RNA polymerase II CTD heptapeptide repeat Y1 phosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:2001070; F:starch binding; IEA:Ensembl.
DR   GO; GO:0000045; P:autophagosome assembly; IEA:Ensembl.
DR   GO; GO:0006816; P:calcium ion transport; IEA:Ensembl.
DR   GO; GO:0046835; P:carbohydrate phosphorylation; IEA:Ensembl.
DR   GO; GO:0016311; P:dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.
DR   GO; GO:0005978; P:glycogen biosynthetic process; TAS:Reactome.
DR   GO; GO:0005977; P:glycogen metabolic process; IMP:UniProtKB.
DR   GO; GO:0046959; P:habituation; IEA:Ensembl.
DR   GO; GO:0015813; P:L-glutamate transmembrane transport; IEA:Ensembl.
DR   GO; GO:0007005; P:mitochondrion organization; IEA:Ensembl.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0035305; P:negative regulation of dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IMP:UniProtKB.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; IEA:Ensembl.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0001558; P:regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0061136; P:regulation of proteasomal protein catabolic process; IEA:Ensembl.
DR   GO; GO:0042306; P:regulation of protein import into nucleus; IEA:Ensembl.
DR   GO; GO:1903076; P:regulation of protein localization to plasma membrane; IEA:Ensembl.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:Ensembl.
DR   CDD; cd05806; CBM20_laforin; 1.
DR   CDD; cd14526; DSP_laforin-like; 1.
DR   DisProt; DP02647; -.
DR   FunFam; 2.60.40.10:FF:001039; laforin isoform X1; 1.
DR   FunFam; 3.90.190.10:FF:000054; laforin isoform X1; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   InterPro; IPR013784; Carb-bd-like_fold.
DR   InterPro; IPR002044; CBM20.
DR   InterPro; IPR034831; CBM20_laforin.
DR   InterPro; IPR045204; DSP_laforin-like.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR042942; Laforin.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   PANTHER; PTHR46864; LAFORIN; 1.
DR   PANTHER; PTHR46864:SF1; LAFORIN; 1.
DR   Pfam; PF00686; CBM_20; 1.
DR   Pfam; PF00782; DSPc; 1.
DR   SMART; SM01065; CBM_2; 1.
DR   SMART; SM00195; DSPc; 1.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   SUPFAM; SSF49452; Starch-binding domain-like; 1.
DR   PROSITE; PS51166; CBM20; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing; Autophagy;
KW   Carbohydrate metabolism; Cell membrane; Cytoplasm; Disease variant;
KW   Endoplasmic reticulum; Epilepsy; Glycogen metabolism;
KW   Glycogen storage disease; Hydrolase; Membrane; Neurodegeneration; Nucleus;
KW   Phosphoprotein; Protein phosphatase; Proteomics identification;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..331
FT                   /note="Laforin"
FT                   /id="PRO_0000094838"
FT   DOMAIN          1..124
FT                   /note="CBM20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00594"
FT   DOMAIN          156..323
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   MOTIF           266..272
FT                   /note="Glucan phosphatase signature motif CXAGXGR"
FT                   /evidence="ECO:0000305|PubMed:25544560,
FT                   ECO:0000305|PubMed:26231210"
FT   ACT_SITE        266
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000305|PubMed:11220751, ECO:0000305|PubMed:11739371,
FT                   ECO:0000305|PubMed:14532330, ECO:0000305|PubMed:22036712,
FT                   ECO:0000305|PubMed:25538239, ECO:0000305|PubMed:25544560"
FT   BINDING         32
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   BINDING         87
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   BINDING         103..107
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   BINDING         197
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   BINDING         235
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   BINDING         241
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   BINDING         267..272
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   BINDING         304
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:25544560,
FT                   ECO:0007744|PDB:4RKK"
FT   SITE            329
FT                   /note="Required for homodimerization"
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MOD_RES         25
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:21728993"
FT   VAR_SEQ         1..243
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042494"
FT   VAR_SEQ         1..159
FT                   /note="MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGAL
FT                   ALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCT
FT                   YNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSR -> MIFNK
FT                   (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042495"
FT   VAR_SEQ         1..138
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.4"
FT                   /id="VSP_042493"
FT   VAR_SEQ         102..199
FT                   /note="NGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQ
FT                   AMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIV -> IASRRLPPA
FT                   QSGSSGPHPQPGPRPRAGPAGPGGARPGLFARVPAHSPGDLG (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_011015"
FT   VAR_SEQ         160..293
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042496"
FT   VAR_SEQ         200..331
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_011016"
FT   VAR_SEQ         294..331
FT                   /note="YFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL -> PSTDAAPGGV
FT                   PAACAAGEGTHRVRALQRWGGPLHRGCLRLAPVCDGLESEEGAVFPHGQEAGCLH (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042497"
FT   VAR_SEQ         310..320
FT                   /note="LARAQEDFFQK -> ASQDTFPL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9771710,
FT                   ECO:0000303|PubMed:9931343"
FT                   /id="VSP_011017"
FT   VAR_SEQ         321..331
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9771710,
FT                   ECO:0000303|PubMed:9931343"
FT                   /id="VSP_011018"
FT   VARIANT         25
FT                   /note="S -> P (in MELF1; atypical form; does not affect
FT                   glycogen binding)"
FT                   /evidence="ECO:0000269|PubMed:12019207,
FT                   ECO:0000269|PubMed:14706656"
FT                   /id="VAR_019465"
FT   VARIANT         28
FT                   /note="E -> K (in MELF1; does not affect glycogen binding;
FT                   dbSNP:rs1776816199)"
FT                   /evidence="ECO:0000269|PubMed:14706656"
FT                   /id="VAR_019466"
FT   VARIANT         32
FT                   /note="W -> G (in MELF1; impairs protein stability; affects
FT                   phosphatase activity; abolishes glycogen binding; abolishes
FT                   phosphatase activity with insoluble glucan; disrupts the
FT                   interaction with PPP1R3C; dbSNP:rs104893955)"
FT                   /evidence="ECO:0000269|PubMed:11739371,
FT                   ECO:0000269|PubMed:12019207, ECO:0000269|PubMed:14532330,
FT                   ECO:0000269|PubMed:14706656, ECO:0000269|PubMed:25544560,
FT                   ECO:0000269|PubMed:26231210"
FT                   /id="VAR_019467"
FT   VARIANT         46
FT                   /note="A -> P (does not affect glycogen binding;
FT                   dbSNP:rs374338349)"
FT                   /evidence="ECO:0000269|PubMed:11735300,
FT                   ECO:0000269|PubMed:14706656, ECO:0000269|PubMed:16021330"
FT                   /id="VAR_019468"
FT   VARIANT         84
FT                   /note="F -> L (in MELF1; affects phosphatase activity and
FT                   glycogen binding; disrupts the interaction with PPP1R3C;
FT                   dbSNP:rs1362231306)"
FT                   /evidence="ECO:0000269|PubMed:11175283,
FT                   ECO:0000269|PubMed:14532330"
FT                   /id="VAR_019469"
FT   VARIANT         88
FT                   /note="F -> L (in MELF1; does not affect glycogen binding;
FT                   dbSNP:rs1034706422 and dbSNP:rs1463000703)"
FT                   /evidence="ECO:0000269|PubMed:14706656"
FT                   /id="VAR_019470"
FT   VARIANT         91
FT                   /note="R -> P (in MELF1; atypical form; learning
FT                   difficuties with childhood-onset)"
FT                   /evidence="ECO:0000269|PubMed:14722920,
FT                   ECO:0000269|PubMed:15009235"
FT                   /id="VAR_019471"
FT   VARIANT         108
FT                   /note="R -> C (in MELF1; loss of phosphatase activity;
FT                   reduced self-interaction capacity; disrupts the interaction
FT                   with PPP1R3C; dbSNP:rs137852915)"
FT                   /evidence="ECO:0000269|PubMed:12019207,
FT                   ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:9771710"
FT                   /id="VAR_019472"
FT   VARIANT         114
FT                   /note="E -> D"
FT                   /evidence="ECO:0000269|PubMed:9771710"
FT                   /id="VAR_019473"
FT   VARIANT         140
FT                   /note="K -> N (in MELF1)"
FT                   /evidence="ECO:0000269|PubMed:18311786"
FT                   /id="VAR_046383"
FT   VARIANT         148
FT                   /note="N -> Y (in MELF1)"
FT                   /evidence="ECO:0000269|PubMed:18311786"
FT                   /id="VAR_046384"
FT   VARIANT         171
FT                   /note="R -> H (in MELF1; results in ubiquitin-positive
FT                   perinuclear aggregates; no effect on glycogen binding;
FT                   abolishes phosphatase activity; may affect proper folding;
FT                   dbSNP:rs137852916)"
FT                   /evidence="ECO:0000269|PubMed:11001928,
FT                   ECO:0000269|PubMed:12019207, ECO:0000269|PubMed:14722920,
FT                   ECO:0000269|PubMed:25544560, ECO:0000269|PubMed:9931343"
FT                   /id="VAR_019474"
FT   VARIANT         187
FT                   /note="T -> A (in MELF1; abolishes interaction with
FT                   NHLRC1)"
FT                   /evidence="ECO:0000269|PubMed:12560877"
FT                   /id="VAR_019475"
FT   VARIANT         194
FT                   /note="T -> I (in MELF1; results in ubiquitin-positive
FT                   perinuclear aggregates; loss of phosphatase activity;
FT                   affects glycogen binding; reduced self-interaction
FT                   capacity; abolishes interaction with NHLRC1, PPP1R3C and
FT                   PRKAA2; no effect on phosphorylation of protein;
FT                   dbSNP:rs375544596)"
FT                   /evidence="ECO:0000269|PubMed:12019207,
FT                   ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:9931343"
FT                   /id="VAR_019476"
FT   VARIANT         210
FT                   /note="E -> K (in MELF1)"
FT                   /evidence="ECO:0000269|PubMed:18311786"
FT                   /id="VAR_046385"
FT   VARIANT         240
FT                   /note="G -> S (in MELF1; impaired phosphatase activity;
FT                   does not affect glycogen binding; disrupts the interaction
FT                   with PPP1R3C)"
FT                   /evidence="ECO:0000269|PubMed:11175283,
FT                   ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:25544560"
FT                   /id="VAR_019477"
FT   VARIANT         279
FT                   /note="G -> S (in MELF1; results in ubiquitin-positive
FT                   perinuclear aggregates; loss of phosphatase activity;
FT                   affects glycogen binding; disrupts the interaction with
FT                   PPP1R3C; dbSNP:rs137852917)"
FT                   /evidence="ECO:0000269|PubMed:12019207,
FT                   ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:14722920,
FT                   ECO:0000269|PubMed:9771710, ECO:0000269|PubMed:9931343"
FT                   /id="VAR_019478"
FT   VARIANT         293
FT                   /note="Q -> L (in MELF1; results in ubiquitin-positive
FT                   perinuclear aggregates; may affect proper folding; loss of
FT                   phosphatase activity; affects glycogen binding; disrupts
FT                   the interaction with PPP1R3C; dbSNP:rs796052427)"
FT                   /evidence="ECO:0000269|PubMed:11001928,
FT                   ECO:0000269|PubMed:12019207, ECO:0000269|PubMed:14532330,
FT                   ECO:0000269|PubMed:9771710"
FT                   /id="VAR_019479"
FT   VARIANT         294
FT                   /note="Y -> N (in MELF1; results in ubiquitin-positive
FT                   perinuclear aggregates; impairs phosphatase activity;
FT                   affects glycogen binding; disrupts the interaction with
FT                   PPP1R3C)"
FT                   /evidence="ECO:0000269|PubMed:12019207,
FT                   ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:25544560,
FT                   ECO:0000269|PubMed:9931343"
FT                   /id="VAR_019480"
FT   VARIANT         301
FT                   /note="P -> L (in MELF1; impairs protein stability; impairs
FT                   phosphatase activity; affects glycogen binding; disrupts
FT                   the interaction with PPP1R3C; dbSNP:rs796052428)"
FT                   /evidence="ECO:0000269|PubMed:11175283,
FT                   ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:25544560"
FT                   /id="VAR_019481"
FT   VARIANT         310
FT                   /note="L -> W (in MELF1; causes location of isoform 1 at
FT                   cytoplasmic punctae; does not affect homodimerization of
FT                   isoform 1 but prevents heterodimerization of isoform 1 and
FT                   isoform 2)"
FT                   /evidence="ECO:0000269|PubMed:18311786"
FT                   /id="VAR_046386"
FT   MUTAGEN         8
FT                   /note="V->A: Loss of phosphatase activity. No effect on
FT                   glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25544560"
FT   MUTAGEN         25
FT                   /note="S->A: Partial loss of phosphatase activity.
FT                   Abolishes homodimerization. Abolishes interaction with
FT                   NHLRC1, PPP1R3C and PRKAA2. Does not affect glycogen
FT                   binding. Reduces stability of the protein."
FT                   /evidence="ECO:0000269|PubMed:21728993"
FT   MUTAGEN         25
FT                   /note="S->D: Partial loss of phosphatase activity.
FT                   Increases interaction with NHLRC1. Does not affect
FT                   interaction with NHLRC1, PPP1R3C or PRKAA2. Does not affect
FT                   binding to carbohydrate. Does not affect homodimerization."
FT                   /evidence="ECO:0000269|PubMed:21728993"
FT   MUTAGEN         87
FT                   /note="K->A: Loss of phosphatase activity. Abolishes
FT                   glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:11739371,
FT                   ECO:0000269|PubMed:25544560"
FT   MUTAGEN         99
FT                   /note="W->A: Strongly reduces phosphatase activity.
FT                   Strongly reduces glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25544560"
FT   MUTAGEN         109..110
FT                   /note="CC->SS: No effect on homodimerization or
FT                   carbohydrate binding. Decreased phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MUTAGEN         123
FT                   /note="C->S: No effect on homodimerization or carbohydrate
FT                   binding. Decreased phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MUTAGEN         126
FT                   /note="I->T: Strongly decreased phosphatase activity. No
FT                   effect on glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25544560"
FT   MUTAGEN         142
FT                   /note="T->A: Strongly decreased phosphatase activity. No
FT                   effect on glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25544560"
FT   MUTAGEN         168
FT                   /note="S->A,D: Abolishes interaction with NHLRC1."
FT                   /evidence="ECO:0000269|PubMed:21728993"
FT   MUTAGEN         169
FT                   /note="C->S: No effect on homodimerization or carbohydrate
FT                   binding. Decreased phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MUTAGEN         169
FT                   /note="C->S: No effect on phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:25538239"
FT   MUTAGEN         171
FT                   /note="R->A: No effect on phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:25538239"
FT   MUTAGEN         187
FT                   /note="T->D: Abolishes interaction with NHLRC1."
FT                   /evidence="ECO:0000269|PubMed:21728993"
FT   MUTAGEN         194
FT                   /note="T->D: Does not affect interaction with NHLRC1,
FT                   PPP1R3C or PRKAA2."
FT                   /evidence="ECO:0000269|PubMed:21728993"
FT   MUTAGEN         197
FT                   /note="D->A: Strongly decreased phosphatase activity. No
FT                   effect on glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25538239,
FT                   ECO:0000269|PubMed:25544560"
FT   MUTAGEN         205
FT                   /note="C->S: No effect on homodimerization or carbohydrate
FT                   binding. Decreased phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MUTAGEN         235
FT                   /note="D->A: Complete loss of phosphatase activity. Does
FT                   not affect glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:14532330,
FT                   ECO:0000269|PubMed:25538239"
FT   MUTAGEN         236
FT                   /note="M->A: Complete loss of phosphatase activity. No
FT                   effect on glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25544560"
FT   MUTAGEN         250
FT                   /note="C->S: No effect on homodimerization or carbohydrate
FT                   binding. Decreased phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MUTAGEN         251
FT                   /note="L->A: Impairs protein stability. Strongly reduces
FT                   phosphatase activity. No effect on glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25544560"
FT   MUTAGEN         266
FT                   /note="C->S: Complete loss of phosphatase activity. Does
FT                   not affect glycogen binding. Does not affect
FT                   self-interaction. Increases the interaction with PPP1R3C."
FT                   /evidence="ECO:0000269|PubMed:11220751,
FT                   ECO:0000269|PubMed:11739371, ECO:0000269|PubMed:14532330,
FT                   ECO:0000269|PubMed:22036712, ECO:0000269|PubMed:23922729,
FT                   ECO:0000269|PubMed:25538239, ECO:0000269|PubMed:25544560"
FT   MUTAGEN         272
FT                   /note="R->A: Complete loss of phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:25538239"
FT   MUTAGEN         321
FT                   /note="F->S: Impairs protein stability. Strongly reduces
FT                   phosphatase activity. No effect on glycogen binding."
FT                   /evidence="ECO:0000269|PubMed:25544560"
FT   MUTAGEN         329..331
FT                   /note="Missing: Fails to homodimerize. Does not affect
FT                   carbohydrate binding or phosphatase activity."
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MUTAGEN         329
FT                   /note="C->S: Fails to homodimerize. Does not affect
FT                   carbohydrate binding, interaction with NHLRC1, phosphatase
FT                   activity, or ubiquitination by NHLRC1."
FT                   /evidence="ECO:0000269|PubMed:23922729"
FT   MUTAGEN         329
FT                   /note="C->S: No effect on homodimerization."
FT                   /evidence="ECO:0000269|PubMed:25538239"
FT   CONFLICT        193
FT                   /note="Q -> K (in Ref. 8; AAH70047)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="A -> P (in Ref. 4; AAO15523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        258
FT                   /note="K -> E (in Ref. 5; BAG61454)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        294
FT                   /note="Y -> H (in Ref. 5; BAG61454)"
FT                   /evidence="ECO:0000305"
FT   STRAND          1..9
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   HELIX           11..14
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   STRAND          19..26
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   HELIX           27..29
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   TURN            30..32
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   HELIX           34..36
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   STRAND          58..67
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   STRAND          84..91
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   STRAND          97..103
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   STRAND          108..110
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   HELIX           114..116
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   STRAND          121..123
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   HELIX           138..151
FT                   /evidence="ECO:0007829|PDB:4RKK"
FT   STRAND          157..161
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           173..177
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           178..183
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   STRAND          188..191
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           195..201
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   STRAND          208..210
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           214..223
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           238..258
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   STRAND          262..265
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           271..283
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           289..296
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   STRAND          303..305
FT                   /evidence="ECO:0007829|PDB:4R30"
FT   HELIX           307..321
FT                   /evidence="ECO:0007829|PDB:4R30"
SQ   SEQUENCE   331 AA;  37158 MW;  DD79F917262AB458 CRC64;
     MRFRFGVVVP PAVAGARPEL LVVGSRPELG RWEPRGAVRL RPAGTAAGDG ALALQEPGLW
     LGEVELAAEE AAQDGAEPGR VDTFWYKFLK REPGGELSWE GNGPHHDRCC TYNENNLVDG
     VYCLPIGHWI EATGHTNEMK HTTDFYFNIA GHQAMHYSRI LPNIWLGSCP RQVEHVTIKL
     KHELGITAVM NFQTEWDIVQ NSSGCNRYPE PMTPDTMIKL YREEGLAYIW MPTPDMSTEG
     RVQMLPQAVC LLHALLEKGH IVYVHCNAGV GRSTAAVCGW LQYVMGWNLR KVQYFLMAKR
     PAVYIDEEAL ARAQEDFFQK FGKVRSSVCS L
//
ID   Q0VGM3_HUMAN            Unreviewed;       111 AA.
AC   Q0VGM3;
DT   05-SEP-2006, integrated into UniProtKB/TrEMBL.
DT   05-SEP-2006, sequence version 1.
DT   02-APR-2025, entry version 91.
DE   SubName: Full=TARP protein {ECO:0000313|EMBL:AAI05590.1};
GN   Name=TARP {ECO:0000313|EMBL:AAI05590.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI05590.1};
RN   [1] {ECO:0000313|EMBL:AAI05590.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate {ECO:0000313|EMBL:AAI05590.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004370}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC105589; AAI05590.1; -; mRNA.
DR   RefSeq; NP_001003806.1; NM_001003806.2.
DR   RefSeq; XP_011513709.1; XM_011515407.2.
DR   RefSeq; XP_016867716.1; XM_017012227.1.
DR   AlphaFoldDB; Q0VGM3; -.
DR   IntAct; Q0VGM3; 1.
DR   PeptideAtlas; Q0VGM3; -.
DR   DNASU; 445347; -.
DR   GeneID; 445347; -.
DR   CTD; 445347; -.
DR   DisGeNET; 445347; -.
DR   GeneCards; TARP; -.
DR   OrthoDB; 16948at9604; -.
DR   BioGRID-ORCS; 445347; 10 hits in 217 CRISPR screens.
DR   ChiTaRS; TARP; human.
DR   GO; GO:0042101; C:T cell receptor complex; IEA:UniProtKB-KW.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR051117; TRG_var/const_region.
DR   PANTHER; PTHR19256:SF65; T CELL RECEPTOR GAMMA CONSTANT 1-RELATED; 1.
DR   PANTHER; PTHR19256; T-CELL RECEPTOR GAMMA CHAIN; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
PE   2: Evidence at transcript level;
KW   Adaptive immunity {ECO:0000256|ARBA:ARBA00023130};
KW   Immunity {ECO:0000256|ARBA:ARBA00022859};
KW   Immunoglobulin domain {ECO:0000256|ARBA:ARBA00023319};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Receptor {ECO:0000256|ARBA:ARBA00023170};
KW   T cell receptor {ECO:0000256|ARBA:ARBA00043266};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        77..99
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
SQ   SEQUENCE   111 AA;  12847 MW;  696A82A5F2544362 CRC64;
     MKTNDTYMKF SWLTVPEKSL DKEHRCIVRH ENNKNGVDQE IIFPPIKTDV ITMDPKDNCS
     KDANDTLLLQ LTNTSAYYMY LLLLLKSVVY FAIITCCLLR RTAFCCNGEK S
//
ID   SUCHY_HUMAN             Reviewed;         438 AA.
AC   Q9HAC7; A4D1W5; B4DJF0; B4DR73; Q4KMW4; Q4KMW8; Q4KMZ0; Q8TE00; Q8TEY1;
DT   19-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2024, sequence version 3.
DT   09-APR-2025, entry version 171.
DE   RecName: Full=Succinyl-CoA:glutarate CoA-transferase {ECO:0000303|PubMed:38915184};
DE            EC=2.8.3.- {ECO:0000269|PubMed:23893049, ECO:0000269|PubMed:34492704, ECO:0000269|PubMed:38915184};
DE   AltName: Full=Dermal papilla-derived protein 13;
DE   AltName: Full=Dicarboxyl-CoA:dicarboxylic acid coenzyme A transferase SUGCT {ECO:0000303|PubMed:38915184};
DE   AltName: Full=Succinate--hydroxymethylglutarate CoA-transferase {ECO:0000303|PubMed:23893049};
DE            EC=2.8.3.13 {ECO:0000305|PubMed:23893049};
DE   Flags: Precursor;
GN   Name=SUGCT {ECO:0000303|PubMed:38915184, ECO:0000312|HGNC:HGNC:16001};
GN   Synonyms=C7orf10, DERP13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19880432; DOI=10.1093/dnares/dsp022;
RA   Wakamatsu A., Kimura K., Yamamoto J., Nishikawa T., Nomura N., Sugano S.,
RA   Isogai T.;
RT   "Identification and functional analyses of 11,769 full-length human cDNAs
RT   focused on alternative splicing.";
RL   DNA Res. 16:371-383(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-71, AND TISSUE SPECIFICITY.
RX   PubMed=11829489; DOI=10.1006/geno.2002.6695;
RA   Nakabayashi K., Fernandez B.A., Teshima I., Shuman C., Proud V.K.,
RA   Curry C.J., Chitayat D., Grebe T., Ming J., Oshimura M., Meguro M.,
RA   Mitsuya K., Deb-Rinker P., Herbrick J.A., Weksberg R., Scherer S.W.;
RT   "Molecular genetic studies of human chromosome 7 in Russell-Silver
RT   syndrome.";
RL   Genomics 79:186-196(2002).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-438 (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RA   Ikeda A., Yamashita M., Yoshimoto M.;
RT   "Molecular cloning of a dermal papiila derived gene.";
RL   Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND CHARACTERIZATION OF
RP   VARIANT GA3 TRP-329.
RX   PubMed=23893049; DOI=10.1007/s10545-013-9632-0;
RA   Marlaire S., Van Schaftingen E., Veiga-da-Cunha M.;
RT   "C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the
RT   enzyme that converts glutarate to glutaryl-CoA.";
RL   J. Inherit. Metab. Dis. 37:13-19(2014).
RN   [10]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=34492704; DOI=10.1182/bloodadvances.2021004750;
RA   Marcero J.R., Cox J.E., Bergonia H.A., Medlock A.E., Phillips J.D.,
RA   Dailey H.A.;
RT   "The immunometabolite itaconate inhibits heme synthesis and remodels
RT   cellular metabolism in erythroid precursors.";
RL   Blood Adv. 5:4831-4841(2021).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.08 ANGSTROMS) OF 31-438, FUNCTION, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, AND MUTAGENESIS OF ASP-205.
RX   PubMed=38915184; DOI=10.1021/acschembio.4c00204;
RA   Wu R., Khamrui S., Dodatko T., Leandro J., Sabovic A., Violante S.,
RA   Cross J.R., Marsan E., Kumar K., DeVita R.J., Lazarus M.B., Houten S.M.;
RT   "Characterization, Structure, and Inhibition of the Human Succinyl-
RT   CoA:glutarate-CoA Transferase, a Putative Genetic Modifier of Glutaric
RT   Aciduria Type 1.";
RL   ACS Chem. Biol. 19:1544-1553(2024).
RN   [12]
RP   INVOLVEMENT IN GA3, VARIANTS GA3 101-ARG--HIS-438 DEL; 172-ARG--HIS-438 DEL
RP   AND TRP-329, AND FUNCTION.
RX   PubMed=18926513; DOI=10.1016/j.ajhg.2008.09.018;
RA   Sherman E.A., Strauss K.A., Tortorelli S., Bennett M.J., Knerr I.,
RA   Morton D.H., Puffenberger E.G.;
RT   "Genetic mapping of glutaric aciduria, type 3, to chromosome 7 and
RT   identification of mutations in C7orf10.";
RL   Am. J. Hum. Genet. 83:604-609(2008).
CC   -!- FUNCTION: Coenzyme A (CoA) transferase that reversibly catalyzes the
CC       transfer of a CoA moiety from a dicarboxyl-CoA to a dicarboxylate in a
CC       metabolite recycling process. Displays preference for succinyl-CoA and
CC       glutarate-CoA as dicarboxyl-CoA donors and glutarate, succinate,
CC       adipate/hexanedioate, itaconate and 3-hydroxy-3-methylglutarate as
CC       dicarboxylate acceptors (PubMed:23893049, PubMed:34492704,
CC       PubMed:38915184). Acts on intermediates or end products of lysine and
CC       tryptophan degradation pathway, in particular catalyzes succinyl-CoA-
CC       dependent reesterification of free glutarate into glutaryl-CoA to
CC       prevent renal excretion of glutarate (PubMed:18926513, PubMed:23893049,
CC       PubMed:38915184). Upon inflammation, may convert macrophage-derived
CC       itaconate to itaconyl-CoA in erythroid precursors where it negatively
CC       regulates the TCA cycle and heme synthesis to limit erythroid
CC       differentiation in the context of stress erythropoiesis
CC       (PubMed:34492704). {ECO:0000269|PubMed:18926513,
CC       ECO:0000269|PubMed:23893049, ECO:0000269|PubMed:34492704,
CC       ECO:0000269|PubMed:38915184}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glutarate + succinyl-CoA = glutaryl-CoA + succinate;
CC         Xref=Rhea:RHEA:67900, ChEBI:CHEBI:30031, ChEBI:CHEBI:30921,
CC         ChEBI:CHEBI:57292, ChEBI:CHEBI:57378;
CC         Evidence={ECO:0000269|PubMed:23893049};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67901;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:67902;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-hydroxy-3-methylglutarate + succinyl-CoA = (3S)-3-hydroxy-3-
CC         methylglutaryl-CoA + succinate; Xref=Rhea:RHEA:12284,
CC         ChEBI:CHEBI:17325, ChEBI:CHEBI:30031, ChEBI:CHEBI:43074,
CC         ChEBI:CHEBI:57292; EC=2.8.3.13;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12285;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:12286;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-hydroxy-3-methylglutarate + glutaryl-CoA = (3S)-3-hydroxy-3-
CC         methylglutaryl-CoA + glutarate; Xref=Rhea:RHEA:81723,
CC         ChEBI:CHEBI:17325, ChEBI:CHEBI:30921, ChEBI:CHEBI:43074,
CC         ChEBI:CHEBI:57378; Evidence={ECO:0000269|PubMed:23893049,
CC         ECO:0000269|PubMed:38915184};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:81724;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:81725;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexanedioate + glutaryl-CoA = hexanedioyl-CoA + glutarate;
CC         Xref=Rhea:RHEA:81711, ChEBI:CHEBI:17128, ChEBI:CHEBI:30921,
CC         ChEBI:CHEBI:57378, ChEBI:CHEBI:76327;
CC         Evidence={ECO:0000269|PubMed:23893049};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:81712;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:81713;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=itaconate + glutaryl-CoA = itaconyl-CoA + glutarate;
CC         Xref=Rhea:RHEA:81715, ChEBI:CHEBI:17240, ChEBI:CHEBI:30921,
CC         ChEBI:CHEBI:57378, ChEBI:CHEBI:57381;
CC         Evidence={ECO:0000269|PubMed:23893049};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:81716;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:81717;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=itaconate + succinyl-CoA = itaconyl-CoA + succinate;
CC         Xref=Rhea:RHEA:38283, ChEBI:CHEBI:17240, ChEBI:CHEBI:30031,
CC         ChEBI:CHEBI:57292, ChEBI:CHEBI:57381;
CC         Evidence={ECO:0000269|PubMed:34492704};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38284;
CC         Evidence={ECO:0000305|PubMed:34492704};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:38285;
CC         Evidence={ECO:0000305|PubMed:23893049};
CC   -!- ACTIVITY REGULATION: Inhibited by valsartan and losartan carboxylate.
CC       {ECO:0000269|PubMed:38915184}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:23893049,
CC       ECO:0000269|PubMed:34492704}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9HAC7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HAC7-2; Sequence=VSP_014721, VSP_014722;
CC       Name=3;
CC         IsoId=Q9HAC7-3; Sequence=VSP_014722;
CC       Name=4;
CC         IsoId=Q9HAC7-4; Sequence=VSP_043291;
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney. Intermediate expression
CC       in liver, skeletal muscle and pancreas. Little to no expression
CC       detected in other tissues examined. {ECO:0000269|PubMed:11829489}.
CC   -!- DISEASE: Glutaric aciduria 3 (GA3) [MIM:231690]: An autosomal recessive
CC       metabolic condition characterized by urinary excretion of abnormal
CC       quantities of glutaric acid, in the presence of normal 3-
CC       hydroxyglutarate, glutarylcarnitine and glutarylglycine urinary levels.
CC       Affected individuals show no consistent clinical phenotype and many are
CC       asymptomatic. {ECO:0000269|PubMed:18926513,
CC       ECO:0000269|PubMed:23893049}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the CoA-transferase III family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH98117.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH98261.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH98310.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH98318.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB13922.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG61185.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK021870; BAB13922.1; ALT_INIT; mRNA.
DR   EMBL; AK299133; BAG61185.1; ALT_INIT; mRNA.
DR   EMBL; AK296048; BAG58812.1; -; mRNA.
DR   EMBL; AC004988; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005030; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005160; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006023; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025536; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC026866; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079149; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092030; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH236951; EAL24000.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW94136.1; -; Genomic_DNA.
DR   EMBL; AF397013; AAL76418.1; -; mRNA.
DR   EMBL; AB014767; BAB87807.1; -; mRNA.
DR   EMBL; BC098117; AAH98117.1; ALT_INIT; mRNA.
DR   EMBL; BC098261; AAH98261.1; ALT_INIT; mRNA.
DR   EMBL; BC098310; AAH98310.1; ALT_INIT; mRNA.
DR   EMBL; BC098318; AAH98318.1; ALT_INIT; mRNA.
DR   CCDS; CCDS55104.2; -. [Q9HAC7-3]
DR   CCDS; CCDS55105.2; -. [Q9HAC7-1]
DR   CCDS; CCDS55106.2; -. [Q9HAC7-4]
DR   RefSeq; NP_001180240.1; NM_001193311.1. [Q9HAC7-3]
DR   RefSeq; NP_001180240.2; NM_001193311.2. [Q9HAC7-3]
DR   RefSeq; NP_001180241.1; NM_001193312.1. [Q9HAC7-4]
DR   RefSeq; NP_001180241.2; NM_001193312.2. [Q9HAC7-4]
DR   RefSeq; NP_001180242.1; NM_001193313.1. [Q9HAC7-1]
DR   RefSeq; NP_001180242.2; NM_001193313.2. [Q9HAC7-1]
DR   RefSeq; NP_079004.1; NM_024728.2. [Q9HAC7-2]
DR   RefSeq; NP_079004.2; NM_024728.3. [Q9HAC7-2]
DR   PDB; 9BR6; X-ray; 2.40 A; A/B=31-438.
DR   PDB; 9BR7; X-ray; 2.08 A; A/B/C/D=31-438.
DR   PDBsum; 9BR6; -.
DR   PDBsum; 9BR7; -.
DR   AlphaFoldDB; Q9HAC7; -.
DR   SMR; Q9HAC7; -.
DR   BioGRID; 122883; 23.
DR   IntAct; Q9HAC7; 34.
DR   STRING; 9606.ENSP00000486291; -.
DR   GlyGen; Q9HAC7; 1 site, 1 O-linked glycan (1 site).
DR   PhosphoSitePlus; Q9HAC7; -.
DR   BioMuta; SUGCT; -.
DR   DMDM; 71152390; -.
DR   jPOST; Q9HAC7; -.
DR   MassIVE; Q9HAC7; -.
DR   PaxDb; 9606-ENSP00000338475; -.
DR   PeptideAtlas; Q9HAC7; -.
DR   ProteomicsDB; 81391; -. [Q9HAC7-1]
DR   ProteomicsDB; 81392; -. [Q9HAC7-2]
DR   ProteomicsDB; 81393; -. [Q9HAC7-3]
DR   ProteomicsDB; 81394; -. [Q9HAC7-4]
DR   Pumba; Q9HAC7; -.
DR   Antibodypedia; 49926; 158 antibodies from 20 providers.
DR   DNASU; 79783; -.
DR   Ensembl; ENST00000335693.9; ENSP00000338475.5; ENSG00000175600.16. [Q9HAC7-1]
DR   Ensembl; ENST00000401647.7; ENSP00000385222.3; ENSG00000175600.16. [Q9HAC7-4]
DR   Ensembl; ENST00000628514.3; ENSP00000486291.2; ENSG00000175600.16. [Q9HAC7-3]
DR   GeneID; 79783; -.
DR   KEGG; hsa:79783; -.
DR   MANE-Select; ENST00000335693.9; ENSP00000338475.5; NM_001193313.2; NP_001180242.2.
DR   UCSC; uc003thn.3; human. [Q9HAC7-1]
DR   AGR; HGNC:16001; -.
DR   CTD; 79783; -.
DR   DisGeNET; 79783; -.
DR   GeneCards; SUGCT; -.
DR   HGNC; HGNC:16001; SUGCT.
DR   HPA; ENSG00000175600; Tissue enhanced (kidney, liver).
DR   MalaCards; SUGCT; -.
DR   MIM; 231690; phenotype.
DR   MIM; 609187; gene.
DR   neXtProt; NX_Q9HAC7; -.
DR   OpenTargets; ENSG00000175600; -.
DR   Orphanet; 35706; Glutaric acidemia type 3.
DR   PharmGKB; PA25942; -.
DR   VEuPathDB; HostDB:ENSG00000175600; -.
DR   eggNOG; KOG3957; Eukaryota.
DR   GeneTree; ENSGT00940000157866; -.
DR   HOGENOM; CLU_033975_0_2_1; -.
DR   InParanoid; Q9HAC7; -.
DR   OMA; RVAMYDV; -.
DR   OrthoDB; 5863171at2759; -.
DR   PhylomeDB; Q9HAC7; -.
DR   TreeFam; TF314188; -.
DR   BioCyc; MetaCyc:ENSG00000175600-MONOMER; -.
DR   BRENDA; 2.8.3.13; 2681.
DR   PathwayCommons; Q9HAC7; -.
DR   SignaLink; Q9HAC7; -.
DR   BioGRID-ORCS; 79783; 11 hits in 1143 CRISPR screens.
DR   ChiTaRS; SUGCT; human.
DR   GenomeRNAi; 79783; -.
DR   Pharos; Q9HAC7; Tbio.
DR   PRO; PR:Q9HAC7; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9HAC7; protein.
DR   Bgee; ENSG00000175600; Expressed in right adrenal gland cortex and 122 other cell types or tissues.
DR   ExpressionAtlas; Q9HAC7; baseline and differential.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0047369; F:succinate-hydroxymethylglutarate CoA-transferase activity; IDA:UniProtKB.
DR   FunFam; 3.40.50.10540:FF:000005; succinate--hydroxymethylglutarate CoA-transferase isoform X1; 1.
DR   FunFam; 3.30.1540.10:FF:000005; succinate--hydroxymethylglutarate CoA-transferase isoform X4; 1.
DR   Gene3D; 3.40.50.10540; Crotonobetainyl-coa:carnitine coa-transferase, domain 1; 1.
DR   Gene3D; 3.30.1540.10; formyl-coa transferase, domain 3; 1.
DR   InterPro; IPR050483; CoA-transferase_III_domain.
DR   InterPro; IPR003673; CoA-Trfase_fam_III.
DR   InterPro; IPR044855; CoA-Trfase_III_dom3_sf.
DR   InterPro; IPR023606; CoA-Trfase_III_dom_1_sf.
DR   PANTHER; PTHR48207; SUCCINATE--HYDROXYMETHYLGLUTARATE COA-TRANSFERASE; 1.
DR   PANTHER; PTHR48207:SF3; SUCCINATE--HYDROXYMETHYLGLUTARATE COA-TRANSFERASE; 1.
DR   Pfam; PF02515; CoA_transf_3; 1.
DR   SUPFAM; SSF89796; CoA-transferase family III (CaiB/BaiF); 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Disease variant;
KW   Glutaricaciduria; Mitochondrion; Proteomics identification;
KW   Reference proteome; Transferase; Transit peptide.
FT   TRANSIT         1..31
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..438
FT                   /note="Succinyl-CoA:glutarate CoA-transferase"
FT                   /id="PRO_0000194726"
FT   ACT_SITE        205
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         394
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TNE1"
FT   VAR_SEQ         119..155
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014721"
FT   VAR_SEQ         193..240
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043291"
FT   VAR_SEQ         363
FT                   /note="Q -> QNAVSGFQSLLHSLAHGPFLHLQGSAR (in isoform 2 and
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014722"
FT   VARIANT         101..438
FT                   /note="Missing (in GA3; dbSNP:rs137852862)"
FT                   /evidence="ECO:0000269|PubMed:18926513"
FT                   /id="VAR_090006"
FT   VARIANT         172..438
FT                   /note="Missing (in GA3; dbSNP:rs137852861)"
FT                   /evidence="ECO:0000269|PubMed:18926513"
FT                   /id="VAR_090007"
FT   VARIANT         329
FT                   /note="R -> W (in GA3; severely decreased protein stability
FT                   and processing; dbSNP:rs137852860)"
FT                   /evidence="ECO:0000269|PubMed:18926513,
FT                   ECO:0000269|PubMed:23893049"
FT                   /id="VAR_054852"
FT   MUTAGEN         205
FT                   /note="D->A: Loss of CoA transferase activity toward
FT                   glutaryl-CoA and 3-hydroxy-3-methylglutarate substrates."
FT                   /evidence="ECO:0000269|PubMed:38915184"
FT   CONFLICT        92
FT                   /note="E -> G (in Ref. 7; BAB87807)"
FT                   /evidence="ECO:0000305"
FT   TURN            40..43
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          45..48
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           54..64
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          68..73
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   TURN            75..77
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           80..83
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          86..89
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           94..99
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          110..112
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           113..125
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          127..131
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           137..140
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           145..151
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          156..163
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          165..167
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   TURN            168..171
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           176..182
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   TURN            183..188
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           203..226
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          231..235
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           236..254
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          269..275
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          277..284
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           288..297
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           302..305
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           307..309
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           312..317
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           319..331
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           335..341
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   TURN            342..344
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          349..351
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           355..360
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           362..366
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          370..375
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   TURN            376..378
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          379..384
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          389..392
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   TURN            404..407
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           408..414
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   HELIX           420..429
FT                   /evidence="ECO:0007829|PDB:9BR6"
FT   STRAND          431..433
FT                   /evidence="ECO:0007829|PDB:9BR6"
SQ   SEQUENCE   438 AA;  47708 MW;  7C22CEFA4A0FFB9E CRC64;
     MLATLARVAA LRRTCLFSGR GGGRGLWTGR PQSDMNNIKP LEGVKILDLT RVLAGPFATM
     NLGDLGAEVI KVERPGAGDD TRTWGPPFVG TESTYYLSVN RNKKSIAVNI KDPKGVKIIK
     ELAAVCDVFV ENYVPGKLSA MGLGYEDIDE IAPHIIYCSI TGYGQTGPIS QRAGYDAVAS
     AVSGLMHITG PENGDPVRPG VAMTDLATGL YAYGAIMAGL IQKYKTGKGL FIDCNLLSSQ
     VACLSHIAAN YLIGQKEAKR WGTAHGSIVP YQAFKTKDGY IVVGAGNNQQ FATVCKILDL
     PELIDNSKYK TNHLRVHNRK ELIKILSERF EEELTSKWLY LFEGSGVPYG PINNMKNVFA
     EPQVLHNGLV MEMEHPTVGK ISVPGPAVRY SKFKMSEARP PPLLGQHTTH ILKEVLRYDD
     RAIGELLSAG VVDQHETH
//
ID   SEM1_HUMAN              Reviewed;          70 AA.
AC   P60896; Q13437; Q61067;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 1.
DT   09-APR-2025, entry version 173.
DE   RecName: Full=26S proteasome complex subunit SEM1;
DE   AltName: Full=26S proteasome complex subunit DSS1;
DE   AltName: Full=Deleted in split hand/split foot protein 1;
DE   AltName: Full=Split hand/foot deleted protein 1;
DE   AltName: Full=Split hand/foot malformation type 1 protein;
GN   Name=SEM1 {ECO:0000312|HGNC:HGNC:10845};
GN   Synonyms=C7orf76, DSS1, SHFDG1, SHFM1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8733122; DOI=10.1093/hmg/5.5.571;
RA   Crackower M.A., Scherer S.W., Rommens J.M., Hui C.-C., Poorkaj P.,
RA   Soder S., Cobben J.M., Hudgins L., Evans J.P., Tsui L.-C.;
RT   "Characterization of the split hand/split foot malformation locus SHFM1 at
RT   7q21.3-q22.1 and analysis of a candidate gene for its expression during
RT   limb development.";
RL   Hum. Mol. Genet. 5:571-579(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION.
RX   PubMed=1317798; DOI=10.1111/j.1432-1033.1992.tb16961.x;
RA   Kanayama H.O., Tamura T., Ugai S., Kagawa S., Tanahashi N., Yoshimura T.,
RA   Tanaka K., Ichihara A.;
RT   "Demonstration that a human 26S proteolytic complex consists of a
RT   proteasome and multiple associated protein components and hydrolyzes ATP
RT   and ubiquitin-ligated proteins by closely linked mechanisms.";
RL   Eur. J. Biochem. 206:567-578(1992).
RN   [5]
RP   INTERACTION WITH BRCA2.
RX   PubMed=10373512; DOI=10.1128/mcb.19.7.4633;
RA   Marston N.J., Richards W.J., Hughes D., Bertwistle D., Marshall C.J.,
RA   Ashworth A.;
RT   "Interaction between the product of the breast cancer susceptibility gene
RT   BRCA2 and DSS1, a protein functionally conserved from yeast to mammals.";
RL   Mol. Cell. Biol. 19:4633-4642(1999).
RN   [6]
RP   FUNCTION.
RX   PubMed=15117943; DOI=10.1074/jbc.m403165200;
RA   Sone T., Saeki Y., Toh-e A., Yokosawa H.;
RT   "Sem1p is a novel subunit of the 26S proteasome from Saccharomyces
RT   cerevisiae.";
RL   J. Biol. Chem. 279:28807-28816(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17323924; DOI=10.1021/bi061994u;
RA   Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
RT   "Mass spectrometric characterization of the affinity-purified human 26S
RT   proteasome complex.";
RL   Biochemistry 46:3553-3565(2007).
RN   [8]
RP   INTERACTION WITH BRCA2.
RX   PubMed=21719596; DOI=10.1182/blood-2010-12-324541;
RA   Biswas K., Das R., Alter B.P., Kuznetsov S.G., Stauffer S., North S.L.,
RA   Burkett S., Brody L.C., Meyer S., Byrd R.A., Sharan S.K.;
RT   "A comprehensive functional characterization of BRCA2 variants associated
RT   with Fanconi anemia using mouse ES cell-based assay.";
RL   Blood 118:2430-2442(2011).
RN   [9]
RP   INTERACTION WITH TREX-2 COMPLEX.
RX   PubMed=22307388; DOI=10.1093/nar/gks059;
RA   Jani D., Lutz S., Hurt E., Laskey R.A., Stewart M., Wickramasinghe V.O.;
RT   "Functional and structural characterization of the mammalian TREX-2 complex
RT   that links transcription with nuclear messenger RNA export.";
RL   Nucleic Acids Res. 40:4562-4573(2012).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   FUNCTION.
RX   PubMed=24896180; DOI=10.1038/nature13374;
RA   Bhatia V., Barroso S.I., Garcia-Rubio M.L., Tumini E., Herrera-Moyano E.,
RA   Aguilera A.;
RT   "BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export
RT   factor PCID2.";
RL   Nature 511:362-365(2014).
RN   [12]
RP   IDENTIFICATION IN THE HR COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=26833090; DOI=10.1016/j.molcel.2015.12.026;
RA   Trego K.S., Groesser T., Davalos A.R., Parplys A.C., Zhao W., Nelson M.R.,
RA   Hlaing A., Shih B., Rydberg B., Pluth J.M., Tsai M.S., Hoeijmakers J.H.J.,
RA   Sung P., Wiese C., Campisi J., Cooper P.K.;
RT   "Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous
RT   Recombination and Genome Stability.";
RL   Mol. Cell 61:535-546(2016).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.4 ANGSTROMS) IN COMPLEX WITH BRCA2.
RX   PubMed=12228710; DOI=10.1126/science.297.5588.1837;
RA   Yang H., Jeffrey P.D., Miller J., Kinnucan E., Sun Y., Thoma N.H.,
RA   Zheng N., Chen P.L., Lee W.H., Pavletich N.P.;
RT   "BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA
RT   structure.";
RL   Science 297:1837-1848(2002).
RN   [14]
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.50 ANGSTROMS) OF 1-389, AND SUBUNIT.
RX   PubMed=27428775; DOI=10.1038/nsmb.3273;
RA   Huang X., Luan B., Wu J., Shi Y.;
RT   "An atomic structure of the human 26S proteasome.";
RL   Nat. Struct. Mol. Biol. 23:778-785(2016).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (4.50 ANGSTROMS) OF 1-389, AND SUBUNIT.
RX   PubMed=27342858; DOI=10.1073/pnas.1608050113;
RA   Schweitzer A., Aufderheide A., Rudack T., Beck F., Pfeifer G.,
RA   Plitzko J.M., Sakata E., Schulten K., Foerster F., Baumeister W.;
RT   "Structure of the human 26S proteasome at a resolution of 3.9 Aa.";
RL   Proc. Natl. Acad. Sci. U.S.A. 113:7816-7821(2016).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated proteins.
CC       This complex plays a key role in the maintenance of protein homeostasis
CC       by removing misfolded or damaged proteins, which could impair cellular
CC       functions, and by removing proteins whose functions are no longer
CC       required. Therefore, the proteasome participates in numerous cellular
CC       processes, including cell cycle progression, apoptosis, or DNA damage
CC       repair (PubMed:15117943). Component of the TREX-2 complex
CC       (transcription and export complex 2), composed of at least ENY2, GANP,
CC       PCID2, SEM1, and either centrin CETN2 or CETN3 (PubMed:22307388). The
CC       TREX-2 complex functions in docking export-competent ribonucleoprotein
CC       particles (mRNPs) to the nuclear entrance of the nuclear pore complex
CC       (nuclear basket). TREX-2 participates in mRNA export and accurate
CC       chromatin positioning in the nucleus by tethering genes to the nuclear
CC       periphery. Binds and stabilizes BRCA2 and is thus involved in the
CC       control of R-loop-associated DNA damage and thus transcription-
CC       associated genomic instability. R-loop accumulation increases in SEM1-
CC       depleted cells. {ECO:0000269|PubMed:1317798,
CC       ECO:0000269|PubMed:15117943, ECO:0000269|PubMed:22307388,
CC       ECO:0000269|PubMed:24896180}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle complex.
CC       The 26S proteasome consists of a 20S core particle (CP) and two 19S
CC       regulatory subunits (RP). The regulatory particle is made of a lid
CC       composed of 9 subunits including SEM1, a base containing 6 ATPases and
CC       few additional components (PubMed:27342858, PubMed:27428775). Belongs
CC       to the TREX-2 complex (transcription and export complex 2), composed of
CC       at least ENY2, GANP, PCID2, SEM1, and either centrin CETN2 or CETN3
CC       (PubMed:22307388). Component of the homologous recombination repair
CC       (HR) complex composed of ERCC5/XPG, BRCA2, PALB2, DSS1 and RAD51
CC       (PubMed:26833090). Interacts with the C-terminal of BRCA2
CC       (PubMed:10373512, PubMed:21719596). {ECO:0000269|PubMed:10373512,
CC       ECO:0000269|PubMed:12228710, ECO:0000269|PubMed:21719596,
CC       ECO:0000269|PubMed:22307388, ECO:0000269|PubMed:26833090,
CC       ECO:0000269|PubMed:27342858, ECO:0000269|PubMed:27428775}.
CC   -!- INTERACTION:
CC       P60896; P51587: BRCA2; NbExp=10; IntAct=EBI-79819, EBI-79792;
CC       P60896; Q01658: DR1; NbExp=3; IntAct=EBI-79819, EBI-750300;
CC       P60896; P35637: FUS; NbExp=3; IntAct=EBI-79819, EBI-400434;
CC       P60896; P28799: GRN; NbExp=3; IntAct=EBI-79819, EBI-747754;
CC       P60896; Q00403: GTF2B; NbExp=3; IntAct=EBI-79819, EBI-389564;
CC       P60896; Q9Y5Q9: GTF3C3; NbExp=3; IntAct=EBI-79819, EBI-1054873;
CC       P60896; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-79819, EBI-1055254;
CC       P60896; Q5S007: LRRK2; NbExp=3; IntAct=EBI-79819, EBI-5323863;
CC       P60896; P35240-4: NF2; NbExp=3; IntAct=EBI-79819, EBI-1014514;
CC       P60896; Q5JVF3: PCID2; NbExp=4; IntAct=EBI-79819, EBI-1051701;
CC       P60896; Q5JVF3-1: PCID2; NbExp=3; IntAct=EBI-79819, EBI-15970419;
CC       P60896; O43242: PSMD3; NbExp=4; IntAct=EBI-79819, EBI-357622;
CC       P60896; P00441: SOD1; NbExp=3; IntAct=EBI-79819, EBI-990792;
CC       P60896; Q6NUL7: SPTLC1; NbExp=3; IntAct=EBI-79819, EBI-25912847;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:26833090}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage; Named isoforms=2;
CC       Name=1;
CC         IsoId=P60896-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ZVN7-1; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Expressed in limb bud, craniofacial primordia and
CC       skin.
CC   -!- SIMILARITY: Belongs to the DSS1/SEM1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U41515; AAA91179.1; -; mRNA.
DR   EMBL; AC073230; AAQ93368.1; -; Genomic_DNA.
DR   EMBL; BC032782; AAH32782.1; -; mRNA.
DR   CCDS; CCDS5646.1; -. [P60896-1]
DR   PIR; G02284; G02284.
DR   RefSeq; NP_006295.1; NM_006304.2. [P60896-1]
DR   PDB; 1IYJ; X-ray; 3.40 A; A/C=1-70.
DR   PDB; 1MIU; X-ray; 3.10 A; B=1-70.
DR   PDB; 1MJE; X-ray; 3.50 A; B=1-70.
DR   PDB; 3T5X; X-ray; 2.12 A; B=1-70.
DR   PDB; 5GJQ; EM; 4.50 A; Y=1-70.
DR   PDB; 5GJR; EM; 3.50 A; AB/Y=1-70.
DR   PDB; 5L4K; EM; 4.50 A; Y=1-70.
DR   PDB; 5LN3; EM; 6.80 A; Y=1-70.
DR   PDB; 5M32; EM; 3.80 A; s=1-70.
DR   PDB; 5T0C; EM; 3.80 A; Ae/Be=1-70.
DR   PDB; 5T0G; EM; 4.40 A; e=1-70.
DR   PDB; 5T0H; EM; 6.80 A; e=1-70.
DR   PDB; 5T0I; EM; 8.00 A; e=1-70.
DR   PDB; 5T0J; EM; 8.00 A; e=1-70.
DR   PDB; 5VFR; EM; 4.90 A; e=1-70.
DR   PDB; 5VFT; EM; 7.00 A; e=1-70.
DR   PDB; 5VGZ; EM; 3.70 A; e=1-70.
DR   PDB; 5VHF; EM; 5.70 A; e=1-70.
DR   PDB; 5VHH; EM; 6.10 A; e=1-70.
DR   PDB; 5VHI; EM; 6.80 A; e=1-70.
DR   PDB; 5VHS; EM; 8.80 A; e=38-70.
DR   PDB; 6MSB; EM; 3.00 A; e=1-70.
DR   PDB; 6MSD; EM; 3.20 A; e=1-70.
DR   PDB; 6MSG; EM; 3.50 A; e=1-70.
DR   PDB; 6MSH; EM; 3.60 A; e=1-70.
DR   PDB; 6MSJ; EM; 3.30 A; e=1-70.
DR   PDB; 6MSK; EM; 3.20 A; e=1-70.
DR   PDB; 6WJD; EM; 4.80 A; e=1-70.
DR   PDB; 6WJN; EM; 5.70 A; e=1-70.
DR   PDB; 7QXN; EM; 3.70 A; e=1-70.
DR   PDB; 7QXP; EM; 3.60 A; e=1-70.
DR   PDB; 7QXU; EM; 4.30 A; e=1-70.
DR   PDB; 7QXW; EM; 4.10 A; e=1-70.
DR   PDB; 7QXX; EM; 4.40 A; e=1-70.
DR   PDB; 7QY7; EM; 4.70 A; e=1-70.
DR   PDB; 7QYA; EM; 4.80 A; e=1-70.
DR   PDB; 7QYB; EM; 4.10 A; e=1-70.
DR   PDB; 7W37; EM; 3.00 A; e=1-70.
DR   PDB; 7W38; EM; 3.10 A; e=1-70.
DR   PDB; 7W39; EM; 3.20 A; e=1-70.
DR   PDB; 7W3A; EM; 3.50 A; e=1-70.
DR   PDB; 7W3B; EM; 3.60 A; e=1-70.
DR   PDB; 7W3C; EM; 3.40 A; e=1-70.
DR   PDB; 7W3F; EM; 3.30 A; e=1-70.
DR   PDB; 7W3G; EM; 3.20 A; e=1-70.
DR   PDB; 7W3H; EM; 3.20 A; e=1-70.
DR   PDB; 7W3I; EM; 3.50 A; e=1-70.
DR   PDB; 7W3J; EM; 3.50 A; e=1-70.
DR   PDB; 7W3K; EM; 3.60 A; e=1-70.
DR   PDB; 7W3M; EM; 3.50 A; e=1-70.
DR   PDB; 8CVT; EM; 3.00 A; e=1-70.
DR   PDB; 8JRI; EM; 3.40 A; e=1-70.
DR   PDB; 8JRT; EM; 3.60 A; e=1-70.
DR   PDB; 8JTI; EM; 3.80 A; e=1-70.
DR   PDB; 8USB; EM; 2.73 A; e=1-70.
DR   PDB; 8USC; EM; 3.10 A; e=1-70.
DR   PDB; 9E8G; EM; 3.01 A; e=1-70.
DR   PDB; 9E8H; EM; 2.90 A; e=1-65.
DR   PDB; 9E8I; EM; 2.87 A; e=1-70.
DR   PDB; 9E8J; EM; 3.47 A; e=1-70.
DR   PDB; 9E8K; EM; 4.08 A; e=1-70.
DR   PDB; 9E8L; EM; 3.59 A; e=1-70.
DR   PDB; 9E8N; EM; 3.62 A; e=1-70.
DR   PDB; 9E8O; EM; 3.10 A; e=1-70.
DR   PDB; 9E8Q; EM; 3.16 A; e=1-70.
DR   PDBsum; 1IYJ; -.
DR   PDBsum; 1MIU; -.
DR   PDBsum; 1MJE; -.
DR   PDBsum; 3T5X; -.
DR   PDBsum; 5GJQ; -.
DR   PDBsum; 5GJR; -.
DR   PDBsum; 5L4K; -.
DR   PDBsum; 5LN3; -.
DR   PDBsum; 5M32; -.
DR   PDBsum; 5T0C; -.
DR   PDBsum; 5T0G; -.
DR   PDBsum; 5T0H; -.
DR   PDBsum; 5T0I; -.
DR   PDBsum; 5T0J; -.
DR   PDBsum; 5VFR; -.
DR   PDBsum; 5VFT; -.
DR   PDBsum; 5VGZ; -.
DR   PDBsum; 5VHF; -.
DR   PDBsum; 5VHH; -.
DR   PDBsum; 5VHI; -.
DR   PDBsum; 5VHS; -.
DR   PDBsum; 6MSB; -.
DR   PDBsum; 6MSD; -.
DR   PDBsum; 6MSG; -.
DR   PDBsum; 6MSH; -.
DR   PDBsum; 6MSJ; -.
DR   PDBsum; 6MSK; -.
DR   PDBsum; 6WJD; -.
DR   PDBsum; 6WJN; -.
DR   PDBsum; 7QXN; -.
DR   PDBsum; 7QXP; -.
DR   PDBsum; 7QXU; -.
DR   PDBsum; 7QXW; -.
DR   PDBsum; 7QXX; -.
DR   PDBsum; 7QY7; -.
DR   PDBsum; 7QYA; -.
DR   PDBsum; 7QYB; -.
DR   PDBsum; 7W37; -.
DR   PDBsum; 7W38; -.
DR   PDBsum; 7W39; -.
DR   PDBsum; 7W3A; -.
DR   PDBsum; 7W3B; -.
DR   PDBsum; 7W3C; -.
DR   PDBsum; 7W3F; -.
DR   PDBsum; 7W3G; -.
DR   PDBsum; 7W3H; -.
DR   PDBsum; 7W3I; -.
DR   PDBsum; 7W3J; -.
DR   PDBsum; 7W3K; -.
DR   PDBsum; 7W3M; -.
DR   PDBsum; 8CVT; -.
DR   PDBsum; 8JRI; -.
DR   PDBsum; 8JRT; -.
DR   PDBsum; 8JTI; -.
DR   PDBsum; 8USB; -.
DR   PDBsum; 8USC; -.
DR   PDBsum; 9E8G; -.
DR   PDBsum; 9E8H; -.
DR   PDBsum; 9E8I; -.
DR   PDBsum; 9E8J; -.
DR   PDBsum; 9E8K; -.
DR   PDBsum; 9E8L; -.
DR   PDBsum; 9E8N; -.
DR   PDBsum; 9E8O; -.
DR   PDBsum; 9E8Q; -.
DR   AlphaFoldDB; P60896; -.
DR   EMDB; EMD-14201; -.
DR   EMDB; EMD-14202; -.
DR   EMDB; EMD-14203; -.
DR   EMDB; EMD-14204; -.
DR   EMDB; EMD-14205; -.
DR   EMDB; EMD-14209; -.
DR   EMDB; EMD-14210; -.
DR   EMDB; EMD-14211; -.
DR   EMDB; EMD-21691; -.
DR   EMDB; EMD-21696; -.
DR   EMDB; EMD-27018; -.
DR   EMDB; EMD-32272; -.
DR   EMDB; EMD-32273; -.
DR   EMDB; EMD-32274; -.
DR   EMDB; EMD-32275; -.
DR   EMDB; EMD-32276; -.
DR   EMDB; EMD-32277; -.
DR   EMDB; EMD-32278; -.
DR   EMDB; EMD-32279; -.
DR   EMDB; EMD-32280; -.
DR   EMDB; EMD-32281; -.
DR   EMDB; EMD-32282; -.
DR   EMDB; EMD-32283; -.
DR   EMDB; EMD-32284; -.
DR   EMDB; EMD-36598; -.
DR   EMDB; EMD-36605; -.
DR   EMDB; EMD-4089; -.
DR   EMDB; EMD-4146; -.
DR   EMDB; EMD-42506; -.
DR   EMDB; EMD-42507; -.
DR   EMDB; EMD-47719; -.
DR   EMDB; EMD-47720; -.
DR   EMDB; EMD-47721; -.
DR   EMDB; EMD-47722; -.
DR   EMDB; EMD-47723; -.
DR   EMDB; EMD-47724; -.
DR   EMDB; EMD-47725; -.
DR   EMDB; EMD-47726; -.
DR   EMDB; EMD-47727; -.
DR   EMDB; EMD-8664; -.
DR   EMDB; EMD-8665; -.
DR   EMDB; EMD-8666; -.
DR   EMDB; EMD-8667; -.
DR   EMDB; EMD-8668; -.
DR   EMDB; EMD-8672; -.
DR   EMDB; EMD-8674; -.
DR   EMDB; EMD-8675; -.
DR   EMDB; EMD-8676; -.
DR   EMDB; EMD-8684; -.
DR   EMDB; EMD-9216; -.
DR   EMDB; EMD-9217; -.
DR   EMDB; EMD-9218; -.
DR   EMDB; EMD-9219; -.
DR   EMDB; EMD-9220; -.
DR   EMDB; EMD-9221; -.
DR   EMDB; EMD-9222; -.
DR   EMDB; EMD-9511; -.
DR   EMDB; EMD-9512; -.
DR   SMR; P60896; -.
DR   BioGRID; 113692; 143.
DR   ComplexPortal; CPX-2477; TREX-2 transcription-export complex, CETN2 variant.
DR   ComplexPortal; CPX-5993; 26S proteasome complex.
DR   ComplexPortal; CPX-7281; TREX-2 transcription-export complex, CETN3 variant.
DR   ComplexPortal; CPX-8964; 19S proteasome regulatory complex.
DR   ComplexPortal; CPX-9082; 19S-20S-PA28-alphabeta hybrid proteasome complex.
DR   ComplexPortal; CPX-9085; 19S-20S-PA28-gamma hybrid proteasome complex.
DR   ComplexPortal; CPX-9086; 30S proteasome complex.
DR   CORUM; P60896; -.
DR   DIP; DIP-31023N; -.
DR   IntAct; P60896; 127.
DR   MINT; P60896; -.
DR   ChEMBL; CHEMBL2364701; -.
DR   iPTMnet; P60896; -.
DR   PhosphoSitePlus; P60896; -.
DR   BioMuta; SEM1; -.
DR   jPOST; P60896; -.
DR   MassIVE; P60896; -.
DR   PeptideAtlas; P60896; -.
DR   ProteomicsDB; 57235; -.
DR   Antibodypedia; 30181; 191 antibodies from 28 providers.
DR   DNASU; 7979; -.
DR   Ensembl; ENST00000248566.4; ENSP00000248566.2; ENSG00000127922.10. [P60896-1]
DR   GeneID; 7979; -.
DR   KEGG; hsa:7979; -.
DR   MANE-Select; ENST00000248566.4; ENSP00000248566.2; NM_006304.2; NP_006295.1.
DR   AGR; HGNC:10845; -.
DR   CTD; 7979; -.
DR   DisGeNET; 7979; -.
DR   GeneCards; SEM1; -.
DR   HGNC; HGNC:10845; SEM1.
DR   HPA; ENSG00000127922; Low tissue specificity.
DR   MalaCards; SEM1; -.
DR   MIM; 601285; gene.
DR   neXtProt; NX_P60896; -.
DR   OpenTargets; ENSG00000127922; -.
DR   Orphanet; 2440; Isolated split hand-split foot malformation.
DR   PharmGKB; PA35749; -.
DR   VEuPathDB; HostDB:ENSG00000127922; -.
DR   GeneTree; ENSGT00940000162732; -.
DR   OMA; TLWENNW; -.
DR   OrthoDB; 9527655at2759; -.
DR   PhylomeDB; P60896; -.
DR   TreeFam; TF314699; -.
DR   PathwayCommons; P60896; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-HSA-1236974; ER-Phagosome pathway.
DR   Reactome; R-HSA-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-HSA-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-HSA-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-HSA-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-HSA-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-HSA-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-HSA-180534; Vpu mediated degradation of CD4.
DR   Reactome; R-HSA-180585; Vif-mediated degradation of APOBEC3G.
DR   Reactome; R-HSA-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-HSA-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-211733; Regulation of activated PAK-2p34 by proteasome mediated degradation.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-HSA-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-HSA-382556; ABC-family proteins mediated transport.
DR   Reactome; R-HSA-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-HSA-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-HSA-4641257; Degradation of AXIN.
DR   Reactome; R-HSA-4641258; Degradation of DVL.
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362768; Hh mutants are degraded by ERAD.
DR   Reactome; R-HSA-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-HSA-5610783; Degradation of GLI2 by the proteasome.
DR   Reactome; R-HSA-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-HSA-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-HSA-5678895; Defective CFTR causes cystic fibrosis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-68867; Assembly of the pre-replicative complex.
DR   Reactome; R-HSA-68949; Orc1 removal from chromatin.
DR   Reactome; R-HSA-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-HSA-69481; G2/M Checkpoints.
DR   Reactome; R-HSA-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-HSA-75815; Ubiquitin-dependent degradation of Cyclin D.
DR   Reactome; R-HSA-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-HSA-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   Reactome; R-HSA-9604323; Negative regulation of NOTCH4 signaling.
DR   Reactome; R-HSA-9701192; Defective homologous recombination repair (HRR) due to BRCA1 loss of function.
DR   Reactome; R-HSA-9704331; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function.
DR   Reactome; R-HSA-9704646; Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function.
DR   Reactome; R-HSA-9709275; Impaired BRCA2 translocation to the nucleus.
DR   Reactome; R-HSA-9709570; Impaired BRCA2 binding to RAD51.
DR   Reactome; R-HSA-9755511; KEAP1-NFE2L2 pathway.
DR   Reactome; R-HSA-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2.
DR   Reactome; R-HSA-9763198; Impaired BRCA2 binding to SEM1 (DSS1).
DR   Reactome; R-HSA-9824272; Somitogenesis.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   Reactome; R-HSA-9907900; Proteasome assembly.
DR   SignaLink; P60896; -.
DR   SIGNOR; P60896; -.
DR   BioGRID-ORCS; 7979; 692 hits in 1156 CRISPR screens.
DR   ChiTaRS; SHFM1; human.
DR   EvolutionaryTrace; P60896; -.
DR   GeneWiki; SHFM1; -.
DR   GenomeRNAi; 7979; -.
DR   Pharos; P60896; Tbio.
DR   PRO; PR:P60896; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000127922; Expressed in calcaneal tendon and 204 other cell types or tissues.
DR   ExpressionAtlas; P60896; baseline and differential.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0032039; C:integrator complex; IDA:HGNC-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000502; C:proteasome complex; IDA:UniProtKB.
DR   GO; GO:0008541; C:proteasome regulatory particle, lid subcomplex; IEA:InterPro.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:Ensembl.
DR   GO; GO:0006406; P:mRNA export from nucleus; IEA:InterPro.
DR   GO; GO:0043248; P:proteasome assembly; IEA:InterPro.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; NAS:ComplexPortal.
DR   CDD; cd13768; DSS1_Sem1; 1.
DR   DisProt; DP00617; -.
DR   InterPro; IPR007834; DSS1_SEM1.
DR   PANTHER; PTHR16771; 26 PROTEASOME COMPLEX SUBUNIT DSS1; 1.
DR   PANTHER; PTHR16771:SF0; 26S PROTEASOME COMPLEX SUBUNIT SEM1; 1.
DR   Pfam; PF05160; DSS1_SEM1; 1.
DR   SMART; SM01385; DSS1_SEM1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Nucleus; Proteasome;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..70
FT                   /note="26S proteasome complex subunit SEM1"
FT                   /id="PRO_0000122961"
FT   VARIANT         17
FT                   /note="D -> G (in dbSNP:rs1802882)"
FT                   /id="VAR_012003"
FT   HELIX           10..12
FT                   /evidence="ECO:0007829|PDB:1MIU"
FT   STRAND          21..23
FT                   /evidence="ECO:0007829|PDB:1MJE"
FT   HELIX           42..44
FT                   /evidence="ECO:0007829|PDB:3T5X"
FT   HELIX           51..62
FT                   /evidence="ECO:0007829|PDB:3T5X"
SQ   SEQUENCE   70 AA;  8278 MW;  0E0F58D2F3D9F723 CRC64;
     MSEKKQPVDL GLLEEDDEFE EFPAEDWAGL DEDEDAHVWE DNWDDDNVED DFSNQLRAEL
     EKHGYKMETS
//
ID   E9PQ42_HUMAN            Unreviewed;       246 AA.
AC   E9PQ42;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   02-APR-2025, entry version 79.
DE   SubName: Full=TMEM276-ZFTRAF1 readthrough {ECO:0000313|Ensembl:ENSP00000434470.1};
DE   Flags: Fragment;
GN   Name=TMEM276-ZFTRAF1 {ECO:0000313|Ensembl:ENSP00000434470.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000434470.1, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000434470.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000434470.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000434470.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L.III.,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4] {ECO:0000313|Ensembl:ENSP00000434470.1}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC084125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; E9PQ42; -.
DR   MassIVE; E9PQ42; -.
DR   PeptideAtlas; E9PQ42; -.
DR   ProteomicsDB; 22907; -.
DR   Antibodypedia; 52728; 26 antibodies from 11 providers.
DR   Ensembl; ENST00000526887.5; ENSP00000434470.1; ENSG00000291316.1.
DR   UCSC; uc064rne.1; human.
DR   GeneCards; TMEM276-ZFTRAF1; -.
DR   HGNC; HGNC:56752; TMEM276-ZFTRAF1.
DR   MalaCards; TMEM276-ZFTRAF1; -.
DR   VEuPathDB; HostDB:ENSG00000187954; -.
DR   GeneTree; ENSGT00390000018258; -.
DR   HOGENOM; CLU_035849_0_0_1; -.
DR   ChiTaRS; CYHR1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000187954; Expressed in right hemisphere of cerebellum and 179 other cell types or tissues.
DR   ExpressionAtlas; E9PQ42; baseline and differential.
DR   GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR039338; ZFTRAF1.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001293; Znf_TRAF.
DR   PANTHER; PTHR23059:SF5; CYSTEINE AND HISTIDINE RICH 1; 1.
DR   PANTHER; PTHR23059; CYSTEINE AND HISTIDINE-RICH PROTEIN 1; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF49599; TRAF domain-like; 1.
DR   PROSITE; PS50145; ZF_TRAF; 1.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00207};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00207};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00207}.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           31..246
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5003244177"
FT   DOMAIN          64..122
FT                   /note="TRAF-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50145"
FT   ZN_FING         64..122
FT                   /note="TRAF-type"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00207"
FT   NON_TER         246
FT                   /evidence="ECO:0000313|Ensembl:ENSP00000434470.1"
SQ   SEQUENCE   246 AA;  27969 MW;  39E244D0183407E2 CRC64;
     MAPKPGAEWS TALSHLVLGV VSLHAAVSTA ECTNGHLMCA GCFIHLLADA RLKEEQATCP
     NCRCEISKSL CCRNLAVEKA VSELPSECGF CLRQFPRSLL ERHQKEECQD RVTQCKYKRI
     GCPWHGPFHE LTVHEAACAH PTKTGSELME ILDGMDQSHR KEMQLYNSIF SLLSFEKIGY
     TEVQFRPYRT DDFITRLYYE TPRFTVLNQT WVLKARVNDS ERNPNLSCKR TLSFQLLLKS
     KVTAPL
//
ID   KIFC2_HUMAN             Reviewed;         838 AA.
AC   Q96AC6; E9PHB2; Q96NN6;
DT   15-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   09-APR-2025, entry version 166.
DE   RecName: Full=Kinesin-like protein KIFC2;
GN   Name=KIFC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: May play a role in microtubule-dependent retrograde axonal
CC       transport. May function as the motor for the transport of
CC       multivesicular body (MVB)-like organelles in dendrites (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96AC6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96AC6-2; Sequence=VSP_056102, VSP_056103, VSP_056104;
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK055045; BAB70844.1; -; mRNA.
DR   EMBL; AC084125; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471162; EAW82085.1; -; Genomic_DNA.
DR   EMBL; BC017311; AAH17311.1; -; mRNA.
DR   CCDS; CCDS6427.1; -. [Q96AC6-1]
DR   RefSeq; NP_665697.1; NM_145754.5. [Q96AC6-1]
DR   AlphaFoldDB; Q96AC6; -.
DR   SMR; Q96AC6; -.
DR   BioGRID; 124785; 6.
DR   IntAct; Q96AC6; 10.
DR   MINT; Q96AC6; -.
DR   STRING; 9606.ENSP00000301332; -.
DR   iPTMnet; Q96AC6; -.
DR   PhosphoSitePlus; Q96AC6; -.
DR   BioMuta; KIFC2; -.
DR   DMDM; 34098674; -.
DR   jPOST; Q96AC6; -.
DR   MassIVE; Q96AC6; -.
DR   PaxDb; 9606-ENSP00000301332; -.
DR   PeptideAtlas; Q96AC6; -.
DR   ProteomicsDB; 75953; -. [Q96AC6-1]
DR   ProteomicsDB; 77539; -.
DR   Antibodypedia; 14932; 104 antibodies from 20 providers.
DR   DNASU; 90990; -.
DR   Ensembl; ENST00000301332.3; ENSP00000301332.2; ENSG00000167702.13. [Q96AC6-1]
DR   GeneID; 90990; -.
DR   KEGG; hsa:90990; -.
DR   UCSC; uc003zcz.4; human. [Q96AC6-1]
DR   AGR; HGNC:29530; -.
DR   CTD; 90990; -.
DR   DisGeNET; 90990; -.
DR   GeneCards; KIFC2; -.
DR   HGNC; HGNC:29530; KIFC2.
DR   HPA; ENSG00000167702; Tissue enhanced (brain).
DR   MIM; 615216; gene.
DR   neXtProt; NX_Q96AC6; -.
DR   OpenTargets; ENSG00000167702; -.
DR   PharmGKB; PA134874212; -.
DR   VEuPathDB; HostDB:ENSG00000167702; -.
DR   eggNOG; KOG0239; Eukaryota.
DR   GeneTree; ENSGT00940000154022; -.
DR   HOGENOM; CLU_001485_12_6_1; -.
DR   InParanoid; Q96AC6; -.
DR   OrthoDB; 3176171at2759; -.
DR   PhylomeDB; Q96AC6; -.
DR   TreeFam; TF105238; -.
DR   PathwayCommons; Q96AC6; -.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SignaLink; Q96AC6; -.
DR   BioGRID-ORCS; 90990; 124 hits in 1159 CRISPR screens.
DR   ChiTaRS; KIFC2; human.
DR   GenomeRNAi; 90990; -.
DR   Pharos; Q96AC6; Tbio.
DR   PRO; PR:Q96AC6; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q96AC6; protein.
DR   Bgee; ENSG00000167702; Expressed in right hemisphere of cerebellum and 163 other cell types or tissues.
DR   ExpressionAtlas; Q96AC6; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0032839; C:dendrite cytoplasm; IEA:GOC.
DR   GO; GO:0005871; C:kinesin complex; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0008574; F:plus-end-directed microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0098971; P:anterograde dendritic transport of neurotransmitter receptor complex; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0048489; P:synaptic vesicle transport; IBA:GO_Central.
DR   FunFam; 3.40.850.10:FF:000066; Kinesin-like protein; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR47972:SF5; KINESIN-LIKE PROTEIN KIFC3; 1.
DR   PANTHER; PTHR47972; KINESIN-LIKE PROTEIN KLP-3; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Microtubule; Motor protein; Nucleotide-binding; Proteomics identification;
KW   Reference proteome.
FT   CHAIN           1..838
FT                   /note="Kinesin-like protein KIFC2"
FT                   /id="PRO_0000125429"
FT   DOMAIN          409..740
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   REGION          23..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          140..185
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          718..792
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          186..351
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        23..32
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        156..167
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         484..491
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   VAR_SEQ         1..252
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056102"
FT   VAR_SEQ         523..551
FT                   /note="VTLSMVEIYNEAVRDLLAPGPPERLAVRQ -> RYHGRCLSPAESPEHPRPG
FT                   LPPCRARSPL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056103"
FT   VAR_SEQ         552..838
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056104"
FT   VARIANT         67
FT                   /note="G -> E (in dbSNP:rs35817880)"
FT                   /id="VAR_049684"
FT   VARIANT         166
FT                   /note="S -> F (in dbSNP:rs12675537)"
FT                   /id="VAR_049685"
SQ   SEQUENCE   838 AA;  90147 MW;  5C692E0B67A0BE77 CRC64;
     MYAFYSLLIY IFYSLFRRDG GAAAAAEPGD PAQRARKPRG RRRPDLPAPE LWTELTGLAA
     SSEPEDGSEG AAEGRAAAVS LEEALLRLAE FLSVQLGAEE SCGGPADLGQ SGEVPSLLTV
     TSQLLALLAW LRSPRGRQAL LQGTQPAPRV RPPSPDGSTS QEESPSHFTA VPGEPLGDET
     QGQQPLQLEE DQRAWQRLEQ LILGQLEELK QQLEQQEEEL GRLRLGVGAT DSEKRVQHLT
     LENEALKQSL SLMRDLLLHW GPGPPIRAPQ EEAEALLELQ GRLQEAQDTT EALRAQLGVQ
     EVQLQGLQGA LQQLQQETEQ NCRRELQQMH GQLAGLRARM ASLRQGCGDL RGLVSTFTQS
     CQGSLSEARG QVSWALGALS SGGPGTQLPE GQQGPPAGCP GRLPELKGNI RVLCRLRPGT
     SSSLVSVEPG PGGTVTTCYR GRHRRFRLDW VFPPDASQEE VFRELEPAVL SCLRGYSVCI
     FTYGQTGTGK TYSMEGPPED PGIVPRALQS LFREMGAGRQ HRVTLSMVEI YNEAVRDLLA
     PGPPERLAVR QGPEGQGGIQ VAGLTHWDVP NLETLHQMLK LGRSNRATAA TAMNQRSSRS
     HALVTLTLRA ASPPRAPGTA GTLHLVDLAG SERARKAGAA GPPRGDPDGA RRLREAQTIN
     RSLLALGGVM AALRAHRPHV PFRDSQLTRL LQPALGPGTT AVLLLQVGAG AGQVCACRSP
     PTRARPPAPL ARRSPRGRRI SGRQSAPSSS PTEWVKWSWG QPGAAGSRAP PGRLLPSAPT
     LRSPGPPAPL RRPLAVLHAP VPTTARARLS RPQRACPSSP GSRPCPWGLR PGLCWQRR
//
ID   A0A1B0GTE1_HUMAN        Unreviewed;       492 AA.
AC   A0A1B0GTE1;
DT   05-OCT-2016, integrated into UniProtKB/TrEMBL.
DT   05-OCT-2016, sequence version 1.
DT   02-APR-2025, entry version 45.
DE   SubName: Full=Contactin associated protein family member 3C {ECO:0000313|Ensembl:ENSP00000489658.1};
DE   Flags: Fragment;
GN   Name=CNTNAP3C {ECO:0000313|Ensembl:ENSP00000489658.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000489658.1, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000489658.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000489658.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000489658.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000489658.1}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004479}; Single-
CC       pass type I membrane protein {ECO:0000256|ARBA:ARBA00004479}.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00122}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX088645; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FP700059; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; A0A1B0GTE1; -.
DR   SMR; A0A1B0GTE1; -.
DR   BioMuta; ENSG00000283378; -.
DR   MassIVE; A0A1B0GTE1; -.
DR   PeptideAtlas; A0A1B0GTE1; -.
DR   Ensembl; ENST00000636699.1; ENSP00000489658.1; ENSG00000283378.1.
DR   AGR; HGNC:53878; -.
DR   GeneCards; CNTNAP3C; -.
DR   HGNC; HGNC:53878; CNTNAP3C.
DR   VEuPathDB; HostDB:ENSG00000283378; -.
DR   GeneTree; ENSGT00940000160228; -.
DR   InParanoid; A0A1B0GTE1; -.
DR   OMA; HISDRSG; -.
DR   OrthoDB; 26719at2759; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; A0A1B0GTE1; protein.
DR   Bgee; ENSG00000283378; Expressed in primordial germ cell in gonad and 74 other cell types or tissues.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   CDD; cd00057; FA58C; 1.
DR   CDD; cd00110; LamG; 2.
DR   FunFam; 2.60.120.260:FF:000016; Contactin-associated protein-like 4 isoform 1; 1.
DR   Gene3D; 2.60.120.200; -; 2.
DR   Gene3D; 2.60.120.260; Galactose-binding domain-like; 1.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000421; FA58C.
DR   InterPro; IPR008979; Galactose-bd-like_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR050372; Neurexin-related_CASP.
DR   PANTHER; PTHR15036:SF36; CONTACTIN-ASSOCIATED PROTEIN-LIKE 3-RELATED; 1.
DR   PANTHER; PTHR15036; PIKACHURIN-LIKE PROTEIN; 1.
DR   Pfam; PF00754; F5_F8_type_C; 1.
DR   Pfam; PF02210; Laminin_G_2; 2.
DR   SMART; SM00231; FA58C; 1.
DR   SMART; SM00282; LamG; 2.
DR   SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 2.
DR   SUPFAM; SSF49785; Galactose-binding domain-like; 1.
DR   PROSITE; PS01285; FA58C_1; 1.
DR   PROSITE; PS01286; FA58C_2; 1.
DR   PROSITE; PS50022; FA58C_3; 1.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 2.
PE   4: Predicted;
KW   EGF-like domain {ECO:0000256|ARBA:ARBA00022536};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|ARBA:ARBA00022737};
KW   Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           26..492
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5008408603"
FT   DOMAIN          31..177
FT                   /note="F5/8 type C"
FT                   /evidence="ECO:0000259|PROSITE:PS50022"
FT   DOMAIN          183..364
FT                   /note="Laminin G"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   DOMAIN          370..492
FT                   /note="Laminin G"
FT                   /evidence="ECO:0000259|PROSITE:PS50025"
FT   NON_TER         492
FT                   /evidence="ECO:0000313|Ensembl:ENSP00000489658.1"
SQ   SEQUENCE   492 AA;  54649 MW;  8E2E2A55FF8F1B0F CRC64;
     MASVAWAVLK VLLLLPTQTW SPVGAGNPPD CDAPLASALP RSSFSSSSEL SSSHGPGFSR
     LNRRDGAGGW TPLVSNKYQW LQIDLGERME VTAVATQGGY GSSDWVTSYL LMFSDGGRNW
     KQYRREESIW GFPGNTNADS VVHYRLQPPF EARFLRFLPL AWNPRGRIGM RIEVYGCAYK
     SEVVYFDGQS ALLYRLDKKP LKPIRDVISL KFKAMQSNGI LLHREGQHGN HITLELIKGK
     LVFFLNSGNA KLPSTIAPVT LTLGSLLDDQ HWHSVLIELL DTQVNFTVDK HTHHFQAKGD
     SSYLDLNFEI SFGGIPTPGR SRAFRRKSFH GCLENLYYNG VDVTELAKKH KPQILMMGNV
     SFSCPQPQTV PVTFLSSRSY LALPGNSGED KVSVTFQFRT WNRAGHLLFG ELRRGSGSFV
     LFLKDGKLKL SLFQPGQSPR NVTAGAGLND GQWHSVSFSA KWSHMNVVVD DDTAVQPLVA
     VLIDSGDTYY FG
//
ID   UBTD1_HUMAN             Reviewed;         227 AA.
AC   Q9HAC8; D3DR57; Q53HI3;
DT   27-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   09-APR-2025, entry version 171.
DE   RecName: Full=Ubiquitin domain-containing protein 1;
GN   Name=UBTD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Coronary artery;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH UBE2D3.
RX   PubMed=24211586; DOI=10.1016/j.bbrc.2013.10.137;
RA   Uhler J.P., Spaahr H., Farge G., Clavel S., Larsson N.G., Falkenberg M.,
RA   Samuelsson T., Gustafsson C.M.;
RT   "The UbL protein UBTD1 stably interacts with the UBE2D family of E2
RT   ubiquitin conjugating enzymes.";
RL   Biochem. Biophys. Res. Commun. 443:7-12(2014).
RN   [7]
RP   FUNCTION, AND INDUCTION BY CYTOTOXIC AGENTS.
RX   PubMed=25382750; DOI=10.1002/path.4478;
RA   Zhang X.W., Wang X.F., Ni S.J., Qin W., Zhao L.Q., Hua R.X., Lu Y.W.,
RA   Li J., Dimri G.P., Guo W.J.;
RT   "UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive
RT   feedback loop.";
RL   J. Pathol. 235:656-667(2015).
CC   -!- FUNCTION: May be involved in the regulation of cellular senescence
CC       through a positive feedback loop with TP53. Is a TP53 downstream target
CC       gene that increases the stability of TP53 protein by promoting the
CC       ubiquitination and degradation of MDM2. {ECO:0000269|PubMed:25382750}.
CC   -!- SUBUNIT: Interacts with UBTD1. {ECO:0000269|PubMed:24211586}.
CC   -!- INTERACTION:
CC       Q9HAC8; O15344: MID1; NbExp=6; IntAct=EBI-745871, EBI-2340316;
CC       Q9HAC8; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-745871, EBI-10172526;
CC       Q9HAC8; Q9Y605: MRFAP1; NbExp=5; IntAct=EBI-745871, EBI-995714;
CC       Q9HAC8; Q96HT8: MRFAP1L1; NbExp=8; IntAct=EBI-745871, EBI-748896;
CC       Q9HAC8; Q99942: RNF5; NbExp=5; IntAct=EBI-745871, EBI-348482;
CC       Q9HAC8; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-745871, EBI-11952721;
CC       Q9HAC8; Q9Y4K3: TRAF6; NbExp=3; IntAct=EBI-745871, EBI-359276;
CC       Q9HAC8; Q9HCM9: TRIM39; NbExp=4; IntAct=EBI-745871, EBI-739510;
CC       Q9HAC8; Q9HCM9-2: TRIM39; NbExp=5; IntAct=EBI-745871, EBI-11523450;
CC       Q9HAC8; Q86XT4: TRIM50; NbExp=3; IntAct=EBI-745871, EBI-9867283;
CC       Q9HAC8; P51668: UBE2D1; NbExp=3; IntAct=EBI-745871, EBI-743540;
CC       Q9HAC8; P62837: UBE2D2; NbExp=8; IntAct=EBI-745871, EBI-347677;
CC       Q9HAC8; P61077: UBE2D3; NbExp=6; IntAct=EBI-745871, EBI-348268;
CC       Q9HAC8; Q9Y2X8: UBE2D4; NbExp=9; IntAct=EBI-745871, EBI-745527;
CC       Q9HAC8; O00308: WWP2; NbExp=3; IntAct=EBI-745871, EBI-743923;
CC   -!- INDUCTION: Induced by cytotoxic agents, it is also increased during
CC       premature senescence. the induction seems to be mediated by TP53.
CC       {ECO:0000269|PubMed:24211586}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK021869; BAB13921.1; -; mRNA.
DR   EMBL; AK222597; BAD96317.1; -; mRNA.
DR   EMBL; AL359388; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49918.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49919.1; -; Genomic_DNA.
DR   EMBL; BC007331; AAH07331.1; -; mRNA.
DR   CCDS; CCDS7465.1; -.
DR   RefSeq; NP_079230.1; NM_024954.5.
DR   AlphaFoldDB; Q9HAC8; -.
DR   SMR; Q9HAC8; -.
DR   BioGRID; 123073; 43.
DR   IntAct; Q9HAC8; 26.
DR   STRING; 9606.ENSP00000359698; -.
DR   iPTMnet; Q9HAC8; -.
DR   PhosphoSitePlus; Q9HAC8; -.
DR   SwissPalm; Q9HAC8; -.
DR   BioMuta; UBTD1; -.
DR   DMDM; 74752759; -.
DR   jPOST; Q9HAC8; -.
DR   MassIVE; Q9HAC8; -.
DR   PaxDb; 9606-ENSP00000359698; -.
DR   PeptideAtlas; Q9HAC8; -.
DR   ProteomicsDB; 81395; -.
DR   Pumba; Q9HAC8; -.
DR   Antibodypedia; 30969; 361 antibodies from 28 providers.
DR   DNASU; 80019; -.
DR   Ensembl; ENST00000370664.4; ENSP00000359698.3; ENSG00000165886.5.
DR   GeneID; 80019; -.
DR   KEGG; hsa:80019; -.
DR   MANE-Select; ENST00000370664.4; ENSP00000359698.3; NM_024954.5; NP_079230.1.
DR   UCSC; uc001knv.2; human.
DR   AGR; HGNC:25683; -.
DR   CTD; 80019; -.
DR   DisGeNET; 80019; -.
DR   GeneCards; UBTD1; -.
DR   HGNC; HGNC:25683; UBTD1.
DR   HPA; ENSG00000165886; Low tissue specificity.
DR   MIM; 616388; gene.
DR   neXtProt; NX_Q9HAC8; -.
DR   OpenTargets; ENSG00000165886; -.
DR   PharmGKB; PA134976337; -.
DR   VEuPathDB; HostDB:ENSG00000165886; -.
DR   eggNOG; KOG0013; Eukaryota.
DR   GeneTree; ENSGT00940000158630; -.
DR   HOGENOM; CLU_070348_0_0_1; -.
DR   InParanoid; Q9HAC8; -.
DR   OMA; GCMGRYL; -.
DR   OrthoDB; 1640476at2759; -.
DR   PhylomeDB; Q9HAC8; -.
DR   TreeFam; TF323925; -.
DR   PathwayCommons; Q9HAC8; -.
DR   SignaLink; Q9HAC8; -.
DR   BioGRID-ORCS; 80019; 11 hits in 1152 CRISPR screens.
DR   ChiTaRS; UBTD1; human.
DR   GenomeRNAi; 80019; -.
DR   Pharos; Q9HAC8; Tdark.
DR   PRO; PR:Q9HAC8; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q9HAC8; protein.
DR   Bgee; ENSG00000165886; Expressed in left testis and 137 other cell types or tissues.
DR   CDD; cd17120; Ubl_UBTD1; 1.
DR   Gene3D; 3.10.20.90; Phosphatidylinositol 3-kinase Catalytic Subunit, Chain A, domain 1; 1.
DR   Gene3D; 1.20.225.20; Ub domain-containing protein, DC-UbP/UBTD2, N-terminal domain; 1.
DR   InterPro; IPR032752; DC-UbP/UBTD2_N.
DR   InterPro; IPR038169; DC-UbP/UBTD2_N_sf.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR019956; Ubiquitin_dom.
DR   InterPro; IPR039869; UBTD1/2.
DR   PANTHER; PTHR13609; UBIQUITIN DOMAIN CONTAINING 1 PROTEIN-RELATED; 1.
DR   Pfam; PF16455; UBD; 1.
DR   Pfam; PF00240; ubiquitin; 1.
DR   PRINTS; PR00348; UBIQUITIN.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..227
FT                   /note="Ubiquitin domain-containing protein 1"
FT                   /id="PRO_0000242674"
FT   DOMAIN          149..224
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   REGION          1..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        24..35
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CONFLICT        133
FT                   /note="E -> G (in Ref. 2; BAD96317)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        173
FT                   /note="Q -> L (in Ref. 2; BAD96317)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   227 AA;  25938 MW;  7D34DB6027797255 CRC64;
     MGNCVGRQRR ERPAAPGHPR KRAGRNEPLK KERLKWKSDY PMTDGQLRSK RDEFWDTAPA
     FEGRKEIWDA LKAAAYAAEA NDHELAQAIL DGASITLPHG TLCECYDELG NRYQLPIYCL
     SPPVNLLLEH TEEESLEPPE PPPSVRREFP LKVRLSTGKD VRLSASLPDT VGQLKRQLHA
     QEGIEPSWQR WFFSGKLLTD RTRLQETKIQ KDFVIQVIIN QPPPPQD
//
ID   APDD1_HUMAN             Reviewed;         171 AA.
AC   C0HMD6;
DT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.
DT   09-APR-2025, sequence version 1.
DT   09-APR-2025, entry version 1.
DE   RecName: Full=PIDD1 alternative open reading frame protein {ECO:0000305};
DE   AltName: Full=altPIDD1 {ECO:0000303|PubMed:39532532};
GN   Name=PIDD1 {ECO:0000312|HGNC:HGNC:16491};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000305}
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH CAPN2, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF ASP-11.
RX   PubMed=39532532; DOI=10.26508/lsa.202402910;
RA   Comtois F., Jacques J.F., Metayer L., Ouedraogo W.Y.D., Ouangraoua A.,
RA   Denault J.B., Roucou X.;
RT   "Noncanonical altPIDD1 protein: unveiling the true major translational
RT   output of the PIDD1 gene.";
RL   Life. Sci Alliance 8:0-0(2025).
CC   -!- SUBUNIT: Interacts with calpain-2 catalytic subunit CAPN2.
CC       {ECO:0000269|PubMed:39532532}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:39532532}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:39532532}. Note=Localizes
CC       to actin-containing cytoskeletal structures.
CC       {ECO:0000269|PubMed:39532532}.
CC   -!- PTM: Cleaved in vitro following UV irradiation to induce caspase-
CC       mediated apoptosis and this cleavage is inhibited by a broad-spectrum
CC       caspase inhibitor. {ECO:0000269|PubMed:39532532}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP006621; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   HGNC; HGNC:16491; PIDD1.
DR   Proteomes; UP000005640; Unplaced.
PE   1: Evidence at protein level;
KW   Cytoplasm; Cytoskeleton; Reference proteome.
FT   CHAIN           1..171
FT                   /note="PIDD1 alternative open reading frame protein"
FT                   /id="PRO_0000462034"
FT   MUTAGEN         11
FT                   /note="D->A: Abolishes cleavage after UV irradiation."
FT                   /evidence="ECO:0000269|PubMed:39532532"
SQ   SEQUENCE   171 AA;  16643 MW;  8F21ACD1008CF04A CRC64;
     MSGLQGPSVG DGCNGGGARA GGSCCRRRCF RGFGRRVQGA AFPGRQPAEL GPVPRGLPAA
     AAPVCPAASA AAAGGILASE HSRGPSAAGG HPGPAASEPV LPPLPGPQRR ATPGHTGCLS
     PGCPDQPARW SEWPGPSGPP GPELQQPGDT AGLCPADARS GCALAVSQLP L
//
ID   1A1L2_HUMAN             Reviewed;         568 AA.
AC   Q4AC99;
DT   20-MAY-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   05-FEB-2025, entry version 132.
DE   RecName: Full=Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2;
DE            Short=ACC synthase-like protein 2;
GN   Name=ACCSL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-529.
RA   Totoki Y., Yada T., Sakaki Y., Takeda T.;
RT   "Identification of novel human genes predicted by combining multiple gene-
RT   finders.";
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -!- CAUTION: While belonging to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family, it lacks a number of residues which are
CC       necessary for activity thus suggesting that it lacks enzymatic
CC       activity. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB231734; BAE17132.1; -; mRNA.
DR   EMBL; AC134775; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS41636.1; -.
DR   RefSeq; NP_001027025.2; NM_001031854.2.
DR   AlphaFoldDB; Q4AC99; -.
DR   SMR; Q4AC99; -.
DR   BioGRID; 133403; 1.
DR   STRING; 9606.ENSP00000368109; -.
DR   iPTMnet; Q4AC99; -.
DR   PhosphoSitePlus; Q4AC99; -.
DR   BioMuta; ACCSL; -.
DR   DMDM; 296439453; -.
DR   jPOST; Q4AC99; -.
DR   MassIVE; Q4AC99; -.
DR   PaxDb; 9606-ENSP00000368109; -.
DR   PeptideAtlas; Q4AC99; -.
DR   Antibodypedia; 26088; 49 antibodies from 17 providers.
DR   DNASU; 390110; -.
DR   Ensembl; ENST00000378832.1; ENSP00000368109.1; ENSG00000205126.2.
DR   GeneID; 390110; -.
DR   KEGG; hsa:390110; -.
DR   MANE-Select; ENST00000378832.1; ENSP00000368109.1; NM_001031854.2; NP_001027025.2.
DR   UCSC; uc001mxw.1; human.
DR   AGR; HGNC:34391; -.
DR   CTD; 390110; -.
DR   DisGeNET; 390110; -.
DR   GeneCards; ACCSL; -.
DR   HGNC; HGNC:34391; ACCSL.
DR   HPA; ENSG00000205126; Not detected.
DR   neXtProt; NX_Q4AC99; -.
DR   PharmGKB; PA164714805; -.
DR   VEuPathDB; HostDB:ENSG00000205126; -.
DR   eggNOG; KOG0256; Eukaryota.
DR   GeneTree; ENSGT00940000162841; -.
DR   HOGENOM; CLU_017584_1_3_1; -.
DR   InParanoid; Q4AC99; -.
DR   OMA; HIAQKCL; -.
DR   OrthoDB; 691673at2759; -.
DR   PhylomeDB; Q4AC99; -.
DR   TreeFam; TF354218; -.
DR   PathwayCommons; Q4AC99; -.
DR   SignaLink; Q4AC99; -.
DR   BioGRID-ORCS; 390110; 9 hits in 1135 CRISPR screens.
DR   ChiTaRS; ACCSL; human.
DR   GenomeRNAi; 390110; -.
DR   Pharos; Q4AC99; Tdark.
DR   PRO; PR:Q4AC99; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q4AC99; protein.
DR   Bgee; ENSG00000205126; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 12 other cell types or tissues.
DR   ExpressionAtlas; Q4AC99; baseline and differential.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008483; F:transaminase activity; IBA:GO_Central.
DR   GO; GO:0006520; P:amino acid metabolic process; IBA:GO_Central.
DR   GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR   CDD; cd00609; AAT_like; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR004839; Aminotransferase_I/II_large.
DR   InterPro; IPR050478; Ethylene_sulfur-biosynth.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR43795; BIFUNCTIONAL ASPARTATE AMINOTRANSFERASE AND GLUTAMATE/ASPARTATE-PREPHENATE AMINOTRANSFERASE-RELATED; 1.
DR   PANTHER; PTHR43795:SF1; INACTIVE 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE-LIKE PROTEIN 2-RELATED; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   PRINTS; PR00753; ACCSYNTHASE.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification; Pyridoxal phosphate; Reference proteome.
FT   CHAIN           1..568
FT                   /note="Probable inactive 1-aminocyclopropane-1-carboxylate
FT                   synthase-like protein 2"
FT                   /id="PRO_0000337057"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         395
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250"
FT   VARIANT         529
FT                   /note="C -> R (in dbSNP:rs2074051)"
FT                   /evidence="ECO:0000269|Ref.1"
FT                   /id="VAR_060626"
FT   CONFLICT        192
FT                   /note="S -> R (in Ref. 1; BAE17132)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        272
FT                   /note="F -> S (in Ref. 1; BAE17132)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        276
FT                   /note="L -> P (in Ref. 1; BAE17132)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        311
FT                   /note="L -> P (in Ref. 1; BAE17132)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        434
FT                   /note="K -> E (in Ref. 1; BAE17132)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        454
FT                   /note="C -> R (in Ref. 1; BAE17132)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   568 AA;  65249 MW;  233FC638E76AC393 CRC64;
     MSHRSDTLPV PSGQRRGRVP RDHSIYTQLL EITLHLQQAM TEHFVQLTSR QGLSLEERRH
     TEAICEHEAL LSRLICRMIN LLQSGAASGL ELQVPLPSED SRGDVRYGQR AQLSGQPDPV
     PQLSDCEAAF VNRDLSIRGI DISVFYQSSF QDYNAYQKDK YHKDKNTLGF INLGTSENKL
     CMDLMTERLQ ESDMNCIEDT LLQYPDWRGQ PFLREEVARF LTYYCRAPTR LDPENVVVLN
     GCCSVFCALA MVLCDPGEAF LVPAPFYGGF AFSSRLYAKV ELIPVHLESE VTVTNTHPFQ
     LTVDKLEEAL LEARLEGKKV RGLVLINPQN PLGDIYSPDS LMKYLEFAKR YNLHVIIDEI
     YMLSVFDESI TFHSILSMKS LPDSNRTHVI WGTSKDFGIS GFRFGALYTH NKEVASAVSA
     FGYLHSISGI TQHKLCQLLQ NTEWIDKVYL PTNCYRLREA HKYITAELKA LEIPFHNRSS
     GLYVWINLKK YLDPCTFEEE RLLYCRFLDN KLLLSRGKTY MCKEPGWFCL IFADELPRLK
     LAMRRFCDVL QEQKEALIVK QLEDAMRE
//
ID   C2CD3_HUMAN             Reviewed;        2353 AA.
AC   Q4AC94; C9JR55; E2QRD1; Q2NLE1; Q3C1U9; Q6ZU92; Q8IYM4; Q8NB87; Q8NDH7;
AC   Q9Y4M2;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 4.
DT   09-APR-2025, entry version 141.
DE   RecName: Full=C2 domain-containing protein 3;
GN   Name=C2CD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLN-1219.
RA   Totoki Y., Yada T., Sakaki Y., Takeda T.;
RT   "Identification of novel human genes predicted by combining multiple gene-
RT   finders.";
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 705-2352 (ISOFORM 1), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1067-2352 (ISOFORM 2), AND VARIANT GLN-1219.
RC   TISSUE=Brain, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 716-2353 (ISOFORM 1), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1245-2353 (ISOFORM 4), AND VARIANT GLN-997.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1193-2353 (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1999-2353 (ISOFORM 5), AND VARIANT GLN-1219.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2114, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23769972; DOI=10.1016/j.devcel.2013.05.016;
RA   Balestra F.R., Strnad P., Fluckiger I., Gonczy P.;
RT   "Discovering regulators of centriole biogenesis through siRNA-based
RT   functional genomics in human cells.";
RL   Dev. Cell 25:555-571(2013).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-728; SER-1891; SER-2114 AND
RP   SER-2132, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   INVOLVEMENT IN OFD14, VARIANT OFD14 GLY-1029, FUNCTION, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH OFD1.
RX   PubMed=24997988; DOI=10.1038/ng.3031;
RA   Thauvin-Robinet C., Lee J.S., Lopez E., Herranz-Perez V., Shida T.,
RA   Franco B., Jego L., Ye F., Pasquier L., Loget P., Gigot N., Aral B.,
RA   Lopes C.A., St-Onge J., Bruel A.L., Thevenon J., Gonzalez-Granero S.,
RA   Alby C., Munnich A., Vekemans M., Huet F., Fry A.M., Saunier S.,
RA   Riviere J.B., Attie-Bitach T., Garcia-Verdugo J.M., Faivre L.,
RA   Megarbane A., Nachury M.V.;
RT   "The oral-facial-digital syndrome gene C2CD3 encodes a positive regulator
RT   of centriole elongation.";
RL   Nat. Genet. 46:905-911(2014).
RN   [10]
RP   VARIANT CYS-1743.
RX   PubMed=26477546; DOI=10.1016/j.ajhg.2015.09.009;
RG   Care4Rare Canada Consortium;
RA   Srour M., Hamdan F.F., McKnight D., Davis E., Mandel H.,
RA   Schwartzentruber J., Martin B., Patry L., Nassif C., Dionne-Laporte A.,
RA   Ospina L.H., Lemyre E., Massicotte C., Laframboise R., Maranda B.,
RA   Labuda D., Decarie J.C., Rypens F., Goldsher D., Fallet-Bianco C.,
RA   Soucy J.F., Laberge A.M., Maftei C., Boycott K., Brais B., Boucher R.M.,
RA   Rouleau G.A., Katsanis N., Majewski J., Elpeleg O., Kukolich M.K.,
RA   Shalev S., Michaud J.L.;
RT   "Joubert Syndrome in French Canadians and Identification of Mutations in
RT   CEP104.";
RL   Am. J. Hum. Genet. 97:744-753(2015).
CC   -!- FUNCTION: Component of the centrioles that acts as a positive regulator
CC       of centriole elongation (PubMed:24997988). Promotes assembly of
CC       centriolar distal appendage, a structure at the distal end of the
CC       mother centriole that acts as an anchor of the cilium, and is required
CC       for recruitment of centriolar distal appendages proteins CEP83, SCLT1,
CC       CEP89, FBF1 and CEP164. Not required for centriolar satellite integrity
CC       or RAB8 activation. Required for primary cilium formation
CC       (PubMed:23769972). Required for sonic hedgehog/SHH signaling and for
CC       proteolytic processing of GLI3. {ECO:0000269|PubMed:23769972,
CC       ECO:0000269|PubMed:24997988}.
CC   -!- SUBUNIT: Interacts with IFT88, BBS4 and PCM1 (By similarity). Interacts
CC       with OFD1; OFD1 may act as a negative regulator of C2CD3. Associates
CC       with the BBSome complex. {ECO:0000250, ECO:0000269|PubMed:24997988}.
CC   -!- INTERACTION:
CC       Q4AC94; O75665: OFD1; NbExp=3; IntAct=EBI-10897521, EBI-716327;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, cilium basal body
CC       {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome, centriole {ECO:0000269|PubMed:23769972,
CC       ECO:0000269|PubMed:24997988}. Note=Localizes to centrioles and
CC       procentrioles both in interphase and mitosis. Localizes to centriolar
CC       satellites, localization is dependent on PCM1 and dynein-mediated
CC       retrograde transport. Also localizes to the distal ends of the mother
CC       and daughter centrioles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=5;
CC         IsoId=Q4AC94-5; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q4AC94-1; Sequence=VSP_034677, VSP_034678;
CC       Name=2;
CC         IsoId=Q4AC94-2; Sequence=VSP_029444, VSP_029445, VSP_029447;
CC       Name=3;
CC         IsoId=Q4AC94-3; Sequence=VSP_029448, VSP_034679;
CC       Name=4;
CC         IsoId=Q4AC94-4; Sequence=VSP_029446, VSP_034676;
CC   -!- DISEASE: Orofaciodigital syndrome 14 (OFD14) [MIM:615948]: A form of
CC       orofaciodigital syndrome, a group of heterogeneous disorders
CC       characterized by malformations of the oral cavity, face and digits, and
CC       associated phenotypic abnormalities that lead to the delineation of
CC       various subtypes. OFD14 patients show severe microcephaly, cerebral
CC       malformations the molar tooth sign, and intellectual disability in
CC       addition to canonical OFDS features. {ECO:0000269|PubMed:24997988}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03654.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC86334.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB231763; BAE46898.1; -; mRNA.
DR   EMBL; AB231764; BAE17137.1; -; mRNA.
DR   EMBL; AP000577; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP002392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003717; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK091397; BAC03654.1; ALT_INIT; mRNA.
DR   EMBL; AK125894; BAC86334.1; ALT_INIT; mRNA.
DR   EMBL; BC035599; AAH35599.1; -; mRNA.
DR   EMBL; BC110508; AAI10509.1; -; mRNA.
DR   EMBL; AL080220; CAB45779.1; -; mRNA.
DR   EMBL; AL833903; CAD38759.1; -; mRNA.
DR   CCDS; CCDS31636.1; -. [Q4AC94-1]
DR   CCDS; CCDS66167.1; -. [Q4AC94-5]
DR   PIR; T12555; T12555.
DR   RefSeq; NP_001273506.1; NM_001286577.2. [Q4AC94-5]
DR   RefSeq; NP_056346.3; NM_015531.6. [Q4AC94-1]
DR   AlphaFoldDB; Q4AC94; -.
DR   BioGRID; 117480; 39.
DR   IntAct; Q4AC94; 29.
DR   MINT; Q4AC94; -.
DR   STRING; 9606.ENSP00000334379; -.
DR   GlyGen; Q4AC94; 4 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (3 sites).
DR   iPTMnet; Q4AC94; -.
DR   PhosphoSitePlus; Q4AC94; -.
DR   BioMuta; C2CD3; -.
DR   DMDM; 313104297; -.
DR   jPOST; Q4AC94; -.
DR   MassIVE; Q4AC94; -.
DR   PaxDb; 9606-ENSP00000334379; -.
DR   PeptideAtlas; Q4AC94; -.
DR   ProteomicsDB; 62084; -. [Q4AC94-5]
DR   ProteomicsDB; 62085; -. [Q4AC94-1]
DR   ProteomicsDB; 62086; -. [Q4AC94-2]
DR   ProteomicsDB; 62087; -. [Q4AC94-3]
DR   ProteomicsDB; 62088; -. [Q4AC94-4]
DR   Pumba; Q4AC94; -.
DR   Antibodypedia; 48039; 147 antibodies from 19 providers.
DR   DNASU; 26005; -.
DR   Ensembl; ENST00000313663.11; ENSP00000323339.7; ENSG00000168014.18. [Q4AC94-1]
DR   Ensembl; ENST00000334126.12; ENSP00000334379.7; ENSG00000168014.18. [Q4AC94-5]
DR   Ensembl; ENST00000442398.7; ENSP00000404577.3; ENSG00000168014.18. [Q4AC94-4]
DR   GeneID; 26005; -.
DR   KEGG; hsa:26005; -.
DR   MANE-Select; ENST00000334126.12; ENSP00000334379.7; NM_001286577.2; NP_001273506.1.
DR   UCSC; uc001ouu.4; human. [Q4AC94-5]
DR   AGR; HGNC:24564; -.
DR   CTD; 26005; -.
DR   DisGeNET; 26005; -.
DR   GeneCards; C2CD3; -.
DR   GeneReviews; C2CD3; -.
DR   HGNC; HGNC:24564; C2CD3.
DR   HPA; ENSG00000168014; Low tissue specificity.
DR   MalaCards; C2CD3; -.
DR   MIM; 615944; gene.
DR   MIM; 615948; phenotype.
DR   neXtProt; NX_Q4AC94; -.
DR   OpenTargets; ENSG00000168014; -.
DR   Orphanet; 434179; Orofaciodigital syndrome type 14.
DR   PharmGKB; PA162379082; -.
DR   VEuPathDB; HostDB:ENSG00000168014; -.
DR   eggNOG; ENOG502QRQ8; Eukaryota.
DR   GeneTree; ENSGT00510000048072; -.
DR   HOGENOM; CLU_000804_0_0_1; -.
DR   InParanoid; Q4AC94; -.
DR   OMA; CYMPVVD; -.
DR   OrthoDB; 79771at2759; -.
DR   PhylomeDB; Q4AC94; -.
DR   TreeFam; TF323591; -.
DR   PathwayCommons; Q4AC94; -.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   SignaLink; Q4AC94; -.
DR   BioGRID-ORCS; 26005; 14 hits in 1151 CRISPR screens.
DR   CD-CODE; DEE660B4; Stress granule.
DR   ChiTaRS; C2CD3; human.
DR   GenomeRNAi; 26005; -.
DR   Pharos; Q4AC94; Tbio.
DR   PRO; PR:Q4AC94; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q4AC94; protein.
DR   Bgee; ENSG00000168014; Expressed in sural nerve and 195 other cell types or tissues.
DR   ExpressionAtlas; Q4AC94; baseline and differential.
DR   GO; GO:0034451; C:centriolar satellite; IDA:UniProtKB.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0036064; C:ciliary basal body; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005815; C:microtubule organizing center; IBA:GO_Central.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0061511; P:centriole elongation; IDA:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0021997; P:neural plate axis specification; IEA:Ensembl.
DR   GO; GO:0021915; P:neural tube development; IEA:Ensembl.
DR   GO; GO:1905515; P:non-motile cilium assembly; IMP:UniProtKB.
DR   GO; GO:0071539; P:protein localization to centrosome; IDA:UniProtKB.
DR   GO; GO:0016485; P:protein processing; IEA:Ensembl.
DR   GO; GO:0030162; P:regulation of proteolysis; IEA:Ensembl.
DR   GO; GO:0008589; P:regulation of smoothened signaling pathway; IEA:Ensembl.
DR   CDD; cd00030; C2; 1.
DR   CDD; cd08683; C2_C2cd3; 1.
DR   FunFam; 2.60.40.150:FF:000175; C2 calcium dependent domain containing 3; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   InterPro; IPR037775; C2_C2CD3.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   PANTHER; PTHR21254; C2 DOMAIN-CONTAINING PROTEIN 3; 1.
DR   PANTHER; PTHR21254:SF1; C2 DOMAIN-CONTAINING PROTEIN 3; 1.
DR   Pfam; PF00168; C2; 2.
DR   SMART; SM00239; C2; 5.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 3.
DR   PROSITE; PS50004; C2; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell projection; Ciliopathy;
KW   Cilium biogenesis/degradation; Cytoplasm; Cytoskeleton; Disease variant;
KW   Intellectual disability; Phosphoprotein; Proteomics identification;
KW   Reference proteome; Repeat.
FT   CHAIN           1..2353
FT                   /note="C2 domain-containing protein 3"
FT                   /id="PRO_0000311239"
FT   DOMAIN          521..678
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          787..919
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          985..1147
FT                   /note="C2 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1171..1339
FT                   /note="C2 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1403..1533
FT                   /note="C2 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          1617..1745
FT                   /note="C2 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          1..27
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          488..508
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          549..568
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1569..1591
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1822..1846
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1972..2032
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2084..2118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2130..2269
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2301..2334
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        496..507
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1830..1839
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2007..2016
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2084..2098
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2181..2198
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2236..2253
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2254..2267
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         466
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q52KB6"
FT   MOD_RES         728
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1891
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         2114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         2132
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1364..1382
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029444"
FT   VAR_SEQ         1881..1908
FT                   /note="SILTSLRKNLSELDQIQRYFRQKLTKPF -> PEAWRRGDCLMWYRGSWRAS
FT                   GFGKKKT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029445"
FT   VAR_SEQ         1888..1921
FT                   /note="KNLSELDQIQRYFRQKLTKPFLPLSPQTQTAISQ -> SSPSLSYPSALRLK
FT                   RPSHSTRRAVGTILGQVPAA (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029446"
FT   VAR_SEQ         1909..2353
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029447"
FT   VAR_SEQ         1922..2353
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034676"
FT   VAR_SEQ         1961..1968
FT                   /note="DLQTITRD -> LPAPNDS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_029448"
FT   VAR_SEQ         1961..1963
FT                   /note="DLQ -> GSY (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1"
FT                   /id="VSP_034677"
FT   VAR_SEQ         1964..2353
FT                   /note="Missing (in isoform 1)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.1"
FT                   /id="VSP_034678"
FT   VAR_SEQ         1969..2353
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_034679"
FT   VARIANT         773
FT                   /note="P -> R (in dbSNP:rs34050666)"
FT                   /id="VAR_037181"
FT   VARIANT         997
FT                   /note="R -> Q (in dbSNP:rs11235995)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_037182"
FT   VARIANT         1029
FT                   /note="C -> G (in OFD14; dbSNP:rs587777654)"
FT                   /evidence="ECO:0000269|PubMed:24997988"
FT                   /id="VAR_071196"
FT   VARIANT         1219
FT                   /note="R -> Q (in dbSNP:rs826058)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17974005, ECO:0000269|Ref.1"
FT                   /id="VAR_037183"
FT   VARIANT         1297
FT                   /note="Y -> C (in dbSNP:rs1095423)"
FT                   /id="VAR_037184"
FT   VARIANT         1663
FT                   /note="S -> N (in dbSNP:rs12419308)"
FT                   /id="VAR_037185"
FT   VARIANT         1743
FT                   /note="G -> C (in dbSNP:rs1064793399)"
FT                   /evidence="ECO:0000269|PubMed:26477546"
FT                   /id="VAR_075697"
FT   VARIANT         1831
FT                   /note="G -> W (in dbSNP:rs1632245)"
FT                   /id="VAR_037186"
FT   VARIANT         1832
FT                   /note="R -> G (in dbSNP:rs1632242)"
FT                   /id="VAR_037187"
FT   CONFLICT        143
FT                   /note="I -> T (in Ref. 1; BAE17137)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        740
FT                   /note="M -> V (in Ref. 1; BAE17137)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        846
FT                   /note="V -> A (in Ref. 4; AAI10509)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1141
FT                   /note="T -> A (in Ref. 1; BAE17137)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1351
FT                   /note="H -> R (in Ref. 1; BAE17137)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1417
FT                   /note="P -> S (in Ref. 1; BAE17137)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1625
FT                   /note="Q -> R (in Ref. 1; BAC86334)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1777
FT                   /note="A -> E (in Ref. 1; BAC86334)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2353 AA;  260389 MW;  D559291AEB1B0DA1 CRC64;
     MKQRKGQGSG GSRGRKKRGL SDISPSTSLP PLVEGQLRCF LKLTVNRVIW KIAKPPTCVL
     VRVRWWGETS DGTLFCPRDA LQTEPKAVRT TTRYAIRCGP KQFTSYLTDM AVLVLEVITK
     LDGLPIGRVQ INGLAQLSPT HQINGFFTIV SSTSKKLGEL QVSLALEPLS ETYDSYHPLP
     TTDMTENVLL SKQGFRENTE PSSTQFQVPS RPRDIHTIKI DGKELAANSS RSTTPRGKDH
     VCFAENPDTI KDSSFGLQHS LNSGQSLESV TLKGRAPRKQ MSLLNSSEFQ PQIRTVAKSH
     SDSCILSSNN LPTKDLLSAL LEQGNKLRNA MVISAMKSSP ETSMLLDQVH PPINEDSLRA
     STQIRAFSRN RFKDHIEDHL LPSTENTFWR HDTKADTRAI QLLLGSAELS QGNFWDGLGS
     PPDSPSPGSD VYCISELNDP QYDQSLLENL FYTAPKSDTS ISDFLSEEDD IVPSKKISQS
     TALARSSKVL ESSDHKLKKR SAGKRNRNLV EQQMLSETPE DAQTMTLSVD RLALLGRTHS
     VRIIIETMGV PPDSPQMTPG KKSYAGPPPK VTTAKKRTFF VEYHFPVGFS ESGLGKTALI
     TEVVRLASSK ITDGKVKFQQ RFVFPVQFGG PMIEHWWNSN LTFQIYVKKT PQKKPEVIGS
     VSLSLRAVIQ SELLSFSDQL PVQQENGQSP FGPLKVTMEL ITDNKDFTGI NTKLSGNTHY
     TPLCAPTSPN KALPELNQDM TCTKNPQNLN QIHEETAKKA QNLVLPNRKS PSPVAPHPST
     FVATPASHNL VNQTNGTTKE SALLLHVLLM VPDGKDFISG ESEKQSPCNV YLNCKLFSTE
     EVTRSVIAWG TTQPVFNFSQ VIPVSLSSKY LERLKNNVMV IETWNKVRSP GQDKLLGLVK
     LPLHQFYMSF KDAKISRLLL DAQYPVVAVD SYMPVIDVFS GHQNGSLRVF LAMGSSNQIM
     ALQRLKNEEG TLPPFSPRPA HFLDQPTAAS VAMAEDRGNG LMEHCFEIHI EMVKGLAPLQ
     ATVWGEADCY VQYYFPVQHS QSSVLKGPEF LENGITLKPF RTATTLCVPD PIFNSEHHHS
     LLLPAEVPVQ RLLLSAFSAQ GLVPGGGVQF EIWCRYYYPN VRDQKVAKGT LPLSRICAMV
     TTQHREDVGI QTFNLPLTPR IENRKELRNQ SSGLLDVGLR YRRSPRTAEG VLAARTVSIS
     VQIIRACGLQ AAAKALAERE PALQFSATVG VNASVTTHLS FLPQGEQRRT HPVACSFCPE
     FSHHVEFTCN LVTQHCSGEA CFLAELLEFA EVIFAVYHEN TKSASDIISI ESCKEYLLGV
     VKVPTKELLI KRSGITGWYP IILPEDGGLP HGLELMQKIV GGLELSISFT HRGDRERVLE
     AAEHLGWSFE NSLKDFVRMD EGEPATVTIS TPRLWLPIHC VLLAGHNHIH KNTYCYLRYK
     FYDHEAFWTP LKKPKESVNK KQIMVTFKAS KRAEVTRGPS LLWYFREERL EIQVWRAYGN
     DSVERPHQTD SWIGSAYVDL ARLGERSART LTVSGVYPLF GRNASNLSGA ALRVHVVLSS
     LSSHLEPTHE LDSMDCSSHS ESEQLPRRND EVQLSPPEVI SCHQKSPAST QVPCSSTTAE
     VRLTQEGPAD LDGTFAVSIL VERAMHLSLK GSPLTERKVS IPSCCVSFAT ADESSPVYTQ
     VVENTDSPIW NFQQQSRLSK ELLLDPQQTL VFKVWHKGDE ERVIGFASVD LSPLLSGFQF
     VCGWYNITDF SGECQGQIKV AVSPLESLIH FKEERQARRG VETSKSLIPI YSPFSFPASD
     TYAAFSSHMA RQTLDQLAHA SSKELDFSSP GRSDTTRSQA SRHEEHVQNI RRFHESLHLQ
     GEAPLPCDDK LTTSPLSSQT SILTSLRKNL SELDQIQRYF RQKLTKPFLP LSPQTQTAIS
     QHQESCRDHL GPGASSLDPG SQCILEKSSN LVLQVSSLIT DLQTITRDSQ AALSSHRARS
     RSNKATTLPD AQDTEALQER CTMPDEPLVR APDKGTDSPS PPPLEETSNG GRMLHESLRH
     AVPITRMQSS EDTEAGPAYS DEDYEEDIIE PRTLNEITTV TDKTSPWSSV ISDTSEVISP
     QPDEVQREGP SCPSPGPFCR EELMVKSSFL SSPERAVNPH LPRQGSPSQS LVACECEASK
     ARVGGESASA NPQPIPCPTL SGAQQSSTFV GWSSPQTDQN KEPKSEAPAE NEAATSELGD
     SADSFKKLPL NLASQSRREN HKGPPIDSSD IRQRQVTTGS ETSTKQSLLL PGPIVVPNFF
     LPPQQLEASL RMLSLSATLP PAATTDQDKS EATRGALSQR PCRPRPNSLP LNLPEEETLR
     IARIFSSQYS QKD
//
ID   FERM2_HUMAN             Reviewed;         680 AA.
AC   Q96AC1; B5TJY2; Q14840; Q86TY7;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   09-APR-2025, entry version 196.
DE   RecName: Full=Fermitin family homolog 2;
DE   AltName: Full=Kindlin-2;
DE   AltName: Full=Mitogen-inducible gene 2 protein;
DE            Short=MIG-2;
DE   AltName: Full=Pleckstrin homology domain-containing family C member 1;
DE            Short=PH domain-containing family C member 1;
GN   Name=FERMT2; Synonyms=KIND2, MIG2, PLEKHC1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RC   TISSUE=Lung fibroblast;
RX   PubMed=8175911; DOI=10.1242/jcs.107.1.227;
RA   Wick M., Buerger C., Bruesselbach S., Lucibello F.C., Mueller R.;
RT   "Identification of serum-inducible genes: different patterns of gene
RT   regulation during G0->S and G1->S progression.";
RL   J. Cell Sci. 107:227-239(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND GENOMIC ORGANIZATION.
RC   TISSUE=Colon tumor;
RX   PubMed=12697302; DOI=10.1016/s0925-4439(03)00035-8;
RA   Weinstein E.J., Bourner M., Head R., Zakeri H., Bauer C., Mazzarella R.;
RT   "URP1: a member of a novel family of PH and FERM domain-containing
RT   membrane-associated proteins is significantly over-expressed in lung and
RT   colon carcinomas.";
RL   Biochim. Biophys. Acta 1637:207-216(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION
RP   WITH FBLIM1.
RC   TISSUE=Lung;
RX   PubMed=12679033; DOI=10.1016/s0092-8674(03)00163-6;
RA   Tu Y., Wu S., Shi X., Chen K., Wu C.;
RT   "Migfilin and Mig-2 link focal adhesions to filamin and the actin
RT   cytoskeleton and function in cell shape modulation.";
RL   Cell 113:37-47(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Tan S.-M., Li Y.-F.;
RL   Submitted (AUG-2008) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Choriocarcinoma, Lung carcinoma, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, INTERACTION WITH ITGB3, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   614-GLN-TRP-615.
RX   PubMed=18458155; DOI=10.1083/jcb.200710196;
RA   Ma Y.Q., Qin J., Wu C., Plow E.F.;
RT   "Kindlin-2 (Mig-2): a co-activator of beta3 integrins.";
RL   J. Cell Biol. 181:439-446(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159; SER-181 AND SER-666, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159; SER-339; SER-351 AND
RP   SER-666, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH ITGB1.
RX   PubMed=21768292; DOI=10.1083/jcb.201007108;
RA   Brunner M., Millon-Fremillon A., Chevalier G., Nakchbandi I.A., Mosher D.,
RA   Block M.R., Albiges-Rizo C., Bouvard D.;
RT   "Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent
RT   fibronectin deposition.";
RL   J. Cell Biol. 194:307-322(2011).
RN   [16]
RP   FUNCTION, INTERACTION WITH ITGB1 AND ITGB3, LIPID-BINDING, MUTAGENESIS OF
RP   LYS-390, AND SUBCELLULAR LOCATION.
RX   PubMed=21325030; DOI=10.1242/jcs.076976;
RA   Qu H., Tu Y., Shi X., Larjava H., Saleem M.A., Shattil S.J., Fukuda K.,
RA   Qin J., Kretzler M., Wu C.;
RT   "Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition
RT   through interactions with phosphoinositides and integrins.";
RL   J. Cell Sci. 124:879-891(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159; SER-351 AND SER-666, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   FUNCTION, INTERACTION WITH CTNNB1, IDENTIFICATION IN A COMPLEX WITH CTNNB1
RP   AND TCF7L2, AND SUBCELLULAR LOCATION.
RX   PubMed=22699938; DOI=10.1038/embor.2012.88;
RA   Yu Y., Wu J., Wang Y., Zhao T., Ma B., Liu Y., Fang W., Zhu W.G., Zhang H.;
RT   "Kindlin 2 forms a transcriptional complex with beta-catenin and TCF4 to
RT   enhance Wnt signalling.";
RL   EMBO Rep. 13:750-758(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-666, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159 AND SER-351, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   STRUCTURE BY NMR OF 367-500 IN COMPLEX WITH
RP   PHOSPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE, FUNCTION, DOMAIN, MUTAGENESIS OF
RP   LYS-383; LYS-385 AND LYS-393, AND LIPID-BINDING.
RX   PubMed=22030399; DOI=10.1074/jbc.m111.295352;
RA   Liu J., Fukuda K., Xu Z., Ma Y.Q., Hirbawi J., Mao X., Wu C., Plow E.F.,
RA   Qin J.;
RT   "Structural basis of phosphoinositide binding to kindlin-2 protein
RT   pleckstrin homology domain in regulating integrin activation.";
RL   J. Biol. Chem. 286:43334-43342(2011).
RN   [22]
RP   STRUCTURE BY NMR OF 1-105, FUNCTION, DOMAIN, SUBCELLULAR LOCATION,
RP   MUTAGENESIS OF HIS-40 AND 74-LYS--LYS-81, AND LIPID-BINDING.
RX   PubMed=22078565; DOI=10.1016/j.str.2011.08.012;
RA   Perera H.D., Ma Y.Q., Yang J., Hirbawi J., Plow E.F., Qin J.;
RT   "Membrane binding of the N-terminal ubiquitin-like domain of kindlin-2 is
RT   crucial for its regulation of integrin activation.";
RL   Structure 19:1664-1671(2011).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 328-499.
RX   PubMed=22653426; DOI=10.1007/s13238-012-2046-1;
RA   Liu Y., Zhu Y., Ye S., Zhang R.;
RT   "Crystal structure of kindlin-2 PH domain reveals a conformational
RT   transition for its membrane anchoring and regulation of integrin
RT   activation.";
RL   Protein Cell 3:434-440(2012).
CC   -!- FUNCTION: Scaffolding protein that enhances integrin activation
CC       mediated by TLN1 and/or TLN2, but activates integrins only weakly by
CC       itself. Binds to membranes enriched in phosphoinositides. Enhances
CC       integrin-mediated cell adhesion onto the extracellular matrix and cell
CC       spreading; this requires both its ability to interact with integrins
CC       and with phospholipid membranes. Required for the assembly of focal
CC       adhesions. Participates in the connection between extracellular matrix
CC       adhesion sites and the actin cytoskeleton and also in the orchestration
CC       of actin assembly and cell shape modulation. Recruits FBLIM1 to focal
CC       adhesions. Plays a role in the TGFB1 and integrin signaling pathways.
CC       Stabilizes active CTNNB1 and plays a role in the regulation of
CC       transcription mediated by CTNNB1 and TCF7L2/TCF4 and in Wnt signaling.
CC       {ECO:0000269|PubMed:12679033, ECO:0000269|PubMed:18458155,
CC       ECO:0000269|PubMed:21325030, ECO:0000269|PubMed:22030399,
CC       ECO:0000269|PubMed:22078565, ECO:0000269|PubMed:22699938}.
CC   -!- SUBUNIT: Interacts with ILK (By similarity). Interacts with FBLIM1.
CC       Interacts with ITGB1 and ITGB3. Interacts with active, unphosphorylated
CC       CTNNB1. Identified in a complex with CTNNB1 and TCF7L2/TCF4. Interacts
CC       with ITGB1; the interaction is inhibited in presence of ITGB1BP1.
CC       {ECO:0000250, ECO:0000269|PubMed:12679033, ECO:0000269|PubMed:18458155,
CC       ECO:0000269|PubMed:21325030, ECO:0000269|PubMed:21768292,
CC       ECO:0000269|PubMed:22030399, ECO:0000269|PubMed:22699938}.
CC   -!- INTERACTION:
CC       Q96AC1; P35222: CTNNB1; NbExp=13; IntAct=EBI-4399465, EBI-491549;
CC       Q96AC1; P15884: TCF4; NbExp=6; IntAct=EBI-4399465, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cell cortex. Cytoplasm,
CC       cytoskeleton. Cytoplasm, cytoskeleton, stress fiber. Cell junction,
CC       focal adhesion. Membrane; Peripheral membrane protein; Cytoplasmic
CC       side. Cell projection, lamellipodium membrane; Peripheral membrane
CC       protein; Cytoplasmic side. Nucleus. Cytoplasm, myofibril, sarcomere, I
CC       band {ECO:0000250}. Cell surface {ECO:0000250}. Note=Colocalizes with
CC       actin stress fibers at cell-ECM focal adhesion sites. Colocalizes with
CC       ITGB3 at lamellipodia at the leading edge of spreading cells. Binds to
CC       membranes that contain phosphatidylinositides.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q96AC1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96AC1-2; Sequence=VSP_008783, VSP_008784, VSP_008785;
CC       Name=3;
CC         IsoId=Q96AC1-3; Sequence=VSP_008783;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. Found in numerous tumor tissues.
CC   -!- INDUCTION: By serum in lung fetal fibroblast cultured cells.
CC       {ECO:0000269|PubMed:8175911}.
CC   -!- DOMAIN: The FERM domain is not correctly detected by PROSITE or Pfam
CC       techniques because it contains the insertion of a PH domain.
CC   -!- DOMAIN: The PH domain binds phospholipids. Binds preferentially
CC       phosphatidylinositol-3,4,5-trisphosphate, and has lower affinity for
CC       phosphatidylinositol-4,5-bisphosphate (PubMed:22030399).
CC       {ECO:0000269|PubMed:22030399}.
CC   -!- DOMAIN: The N-terminal region displays a ubiquitin-type fold and
CC       mediates interaction with membranes containing negatively charged
CC       phosphatidylinositol phosphate via a surface enriched in positively
CC       charged residues. {ECO:0000269|PubMed:22078565}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be due to an exon inclusion and an
CC       intron retention. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the kindlin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA80852.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=FERMT2 entry;
CC       URL="https://en.wikipedia.org/wiki/FERMT2";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z24725; CAA80852.1; ALT_INIT; mRNA.
DR   EMBL; AF443279; AAN75823.1; -; mRNA.
DR   EMBL; EU979385; ACH73257.1; -; mRNA.
DR   EMBL; BX161467; CAD61925.1; -; mRNA.
DR   EMBL; AL139317; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL352979; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC011125; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC017327; AAH17327.1; -; mRNA.
DR   CCDS; CCDS45107.1; -. [Q96AC1-3]
DR   CCDS; CCDS45108.1; -. [Q96AC1-2]
DR   CCDS; CCDS9713.1; -. [Q96AC1-1]
DR   PIR; S69890; S69890.
DR   RefSeq; NP_001128471.1; NM_001134999.2. [Q96AC1-3]
DR   RefSeq; NP_001128472.1; NM_001135000.2. [Q96AC1-2]
DR   RefSeq; NP_006823.1; NM_006832.3. [Q96AC1-1]
DR   PDB; 2LGX; NMR; -; A=1-105.
DR   PDB; 2LKO; NMR; -; A=367-500.
DR   PDB; 2MSU; NMR; -; A=339-358.
DR   PDB; 4F7H; X-ray; 1.90 A; A=328-499.
DR   PDB; 6U4N; NMR; -; A=1-105.
DR   PDB; 6XTJ; X-ray; 1.60 A; AAA=8-680.
DR   PDBsum; 2LGX; -.
DR   PDBsum; 2LKO; -.
DR   PDBsum; 2MSU; -.
DR   PDBsum; 4F7H; -.
DR   PDBsum; 6U4N; -.
DR   PDBsum; 6XTJ; -.
DR   AlphaFoldDB; Q96AC1; -.
DR   BMRB; Q96AC1; -.
DR   SMR; Q96AC1; -.
DR   BioGRID; 116175; 189.
DR   CORUM; Q96AC1; -.
DR   IntAct; Q96AC1; 55.
DR   MINT; Q96AC1; -.
DR   STRING; 9606.ENSP00000342858; -.
DR   ChEMBL; CHEMBL5465266; -.
DR   GlyGen; Q96AC1; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q96AC1; -.
DR   MetOSite; Q96AC1; -.
DR   PhosphoSitePlus; Q96AC1; -.
DR   SwissPalm; Q96AC1; -.
DR   BioMuta; FERMT2; -.
DR   DMDM; 38258220; -.
DR   jPOST; Q96AC1; -.
DR   MassIVE; Q96AC1; -.
DR   PaxDb; 9606-ENSP00000342858; -.
DR   PeptideAtlas; Q96AC1; -.
DR   ProteomicsDB; 75949; -. [Q96AC1-1]
DR   ProteomicsDB; 75950; -. [Q96AC1-2]
DR   ProteomicsDB; 75951; -. [Q96AC1-3]
DR   Pumba; Q96AC1; -.
DR   Antibodypedia; 23904; 381 antibodies from 32 providers.
DR   DNASU; 10979; -.
DR   Ensembl; ENST00000341590.8; ENSP00000340391.3; ENSG00000073712.15. [Q96AC1-1]
DR   Ensembl; ENST00000343279.8; ENSP00000342858.4; ENSG00000073712.15. [Q96AC1-3]
DR   Ensembl; ENST00000395631.6; ENSP00000378993.2; ENSG00000073712.15. [Q96AC1-1]
DR   Ensembl; ENST00000399304.7; ENSP00000382243.3; ENSG00000073712.15. [Q96AC1-2]
DR   Ensembl; ENST00000553373.5; ENSP00000451084.1; ENSG00000073712.15. [Q96AC1-3]
DR   GeneID; 10979; -.
DR   KEGG; hsa:10979; -.
DR   MANE-Select; ENST00000341590.8; ENSP00000340391.3; NM_006832.3; NP_006823.1.
DR   UCSC; uc001xac.4; human. [Q96AC1-1]
DR   AGR; HGNC:15767; -.
DR   CTD; 10979; -.
DR   DisGeNET; 10979; -.
DR   GeneCards; FERMT2; -.
DR   HGNC; HGNC:15767; FERMT2.
DR   HPA; ENSG00000073712; Low tissue specificity.
DR   MIM; 607746; gene.
DR   neXtProt; NX_Q96AC1; -.
DR   OpenTargets; ENSG00000073712; -.
DR   PharmGKB; PA162388349; -.
DR   VEuPathDB; HostDB:ENSG00000073712; -.
DR   eggNOG; KOG3727; Eukaryota.
DR   GeneTree; ENSGT00390000013444; -.
DR   HOGENOM; CLU_011611_0_0_1; -.
DR   InParanoid; Q96AC1; -.
DR   OMA; PEHGIHY; -.
DR   OrthoDB; 10057618at2759; -.
DR   PhylomeDB; Q96AC1; -.
DR   TreeFam; TF314677; -.
DR   PathwayCommons; Q96AC1; -.
DR   Reactome; R-HSA-446353; Cell-extracellular matrix interactions.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   SignaLink; Q96AC1; -.
DR   SIGNOR; Q96AC1; -.
DR   BioGRID-ORCS; 10979; 350 hits in 1180 CRISPR screens.
DR   ChiTaRS; FERMT2; human.
DR   EvolutionaryTrace; Q96AC1; -.
DR   GeneWiki; FERMT2; -.
DR   GenomeRNAi; 10979; -.
DR   Pharos; Q96AC1; Tbio.
DR   PRO; PR:Q96AC1; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q96AC1; protein.
DR   Bgee; ENSG00000073712; Expressed in decidua and 207 other cell types or tissues.
DR   ExpressionAtlas; Q96AC1; baseline and differential.
DR   GO; GO:0005912; C:adherens junction; IDA:ARUK-UCL.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IDA:ARUK-UCL.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:ARUK-UCL.
DR   GO; GO:0005925; C:focal adhesion; IDA:HPA.
DR   GO; GO:0031674; C:I band; IEA:UniProtKB-SubCell.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0001725; C:stress fiber; IEA:UniProtKB-SubCell.
DR   GO; GO:0003779; F:actin binding; IMP:ARUK-UCL.
DR   GO; GO:0051015; F:actin filament binding; IEA:Ensembl.
DR   GO; GO:0005178; F:integrin binding; IBA:GO_Central.
DR   GO; GO:0005547; F:phosphatidylinositol-3,4,5-trisphosphate binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; IMP:ARUK-UCL.
DR   GO; GO:0120283; F:protein serine/threonine kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0046332; F:SMAD binding; IPI:ARUK-UCL.
DR   GO; GO:0034713; F:type I transforming growth factor beta receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0034334; P:adherens junction maintenance; IMP:ARUK-UCL.
DR   GO; GO:0007155; P:cell adhesion; IMP:ARUK-UCL.
DR   GO; GO:0007160; P:cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:ARUK-UCL.
DR   GO; GO:0033622; P:integrin activation; IMP:UniProtKB.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0060173; P:limb development; IEA:Ensembl.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; IMP:ARUK-UCL.
DR   GO; GO:0043116; P:negative regulation of vascular permeability; IMP:ARUK-UCL.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:ARUK-UCL.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:ARUK-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:ARUK-UCL.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IMP:ARUK-UCL.
DR   GO; GO:0033625; P:positive regulation of integrin activation; IGI:ARUK-UCL.
DR   GO; GO:1902462; P:positive regulation of mesenchymal stem cell proliferation; IMP:ARUK-UCL.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:ARUK-UCL.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IDA:ARUK-UCL.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IDA:ARUK-UCL.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; IMP:ARUK-UCL.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IMP:ARUK-UCL.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IGI:ARUK-UCL.
DR   GO; GO:1903691; P:positive regulation of wound healing, spreading of epidermal cells; IMP:ARUK-UCL.
DR   GO; GO:1902414; P:protein localization to cell junction; IMP:ARUK-UCL.
DR   GO; GO:0072657; P:protein localization to membrane; ISS:UniProtKB.
DR   GO; GO:0022604; P:regulation of cell morphogenesis; IMP:ARUK-UCL.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IMP:UniProtKB.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   CDD; cd13205; FERM_C_fermitin; 1.
DR   CDD; cd17181; FERM_F0_KIND2; 1.
DR   CDD; cd17184; FERM_F1_KIND2; 1.
DR   CDD; cd01237; PH_fermitin; 1.
DR   DisProt; DP01613; -.
DR   FunFam; 2.30.29.30:FF:000037; Fermitin family homolog 2; 1.
DR   FunFam; 2.30.29.30:FF:000057; Fermitin family homolog 2 (Drosophila); 1.
DR   FunFam; 3.10.20.90:FF:000035; Fermitin family homolog 2 (Drosophila); 1.
DR   Gene3D; 3.10.20.90; Phosphatidylinositol 3-kinase Catalytic Subunit, Chain A, domain 1; 2.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR037843; Kindlin/fermitin.
DR   InterPro; IPR040790; Kindlin_2_N.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037837; PH_Kindlin/fermitin.
DR   PANTHER; PTHR16160; FERMITIN 2-RELATED; 1.
DR   PANTHER; PTHR16160:SF11; FERMITIN FAMILY HOMOLOG 2; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF18124; Kindlin_2_N; 1.
DR   Pfam; PF00169; PH; 1.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   SUPFAM; SSF47031; Second domain of FERM; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell junction;
KW   Cell membrane; Cell projection; Cell shape; Cytoplasm; Cytoskeleton;
KW   Lipid-binding; Membrane; Nucleus; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Wnt signaling pathway.
FT   CHAIN           1..680
FT                   /note="Fermitin family homolog 2"
FT                   /id="PRO_0000219456"
FT   DOMAIN          189..661
FT                   /note="FERM"
FT   DOMAIN          380..476
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          40..81
FT                   /note="Interaction with membranes containing
FT                   phosphatidylinositol phosphate"
FT   REGION          141..165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         383
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-3,4,5-trisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:57836"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         666
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         534
FT                   /note="Q -> QPGYIRDL (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|Ref.4, ECO:0000303|Ref.5"
FT                   /id="VSP_008783"
FT   VAR_SEQ         625..626
FT                   /note="TV -> NS (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_008784"
FT   VAR_SEQ         627..680
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_008785"
FT   MUTAGEN         40
FT                   /note="H->A: Abolishes lipid-binding via the N-terminus;
FT                   when associated with 74-A--A-81."
FT                   /evidence="ECO:0000269|PubMed:22078565"
FT   MUTAGEN         74..81
FT                   /note="KTHWTLDK->ATAATLDA: Abolishes lipid-binding via the
FT                   N-terminus; when associated with A-40."
FT                   /evidence="ECO:0000269|PubMed:22078565"
FT   MUTAGEN         383
FT                   /note="K->A: Reduces phosphatidylinositol phosphate
FT                   binding. Reduces integrin activation; when associated with
FT                   A-385."
FT                   /evidence="ECO:0000269|PubMed:22030399"
FT   MUTAGEN         385
FT                   /note="K->A: Reduces integrin activation; when associated
FT                   with A-383."
FT                   /evidence="ECO:0000269|PubMed:22030399"
FT   MUTAGEN         390
FT                   /note="K->A: Abolishes phosphatidylinositol phosphate
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:21325030"
FT   MUTAGEN         393
FT                   /note="K->A: Reduces phosphatidylinositol phosphate
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:22030399"
FT   MUTAGEN         614..615
FT                   /note="QW->AA: Impairs ITGB3 binding. Abolishes enhancement
FT                   of talin-mediated integrin activation."
FT                   /evidence="ECO:0000269|PubMed:18458155"
FT   CONFLICT        31
FT                   /note="V -> I (in Ref. 1; CAA80852)"
FT                   /evidence="ECO:0000305"
FT   TURN            9..11
FT                   /evidence="ECO:0007829|PDB:2LGX"
FT   STRAND          12..16
FT                   /evidence="ECO:0007829|PDB:2LGX"
FT   STRAND          18..23
FT                   /evidence="ECO:0007829|PDB:6U4N"
FT   TURN            25..28
FT                   /evidence="ECO:0007829|PDB:2LGX"
FT   STRAND          30..35
FT                   /evidence="ECO:0007829|PDB:6U4N"
FT   HELIX           41..51
FT                   /evidence="ECO:0007829|PDB:2LGX"
FT   STRAND          58..65
FT                   /evidence="ECO:0007829|PDB:2LGX"
FT   TURN            66..68
FT                   /evidence="ECO:0007829|PDB:2LGX"
FT   STRAND          75..77
FT                   /evidence="ECO:0007829|PDB:6U4N"
FT   HELIX           79..82
FT                   /evidence="ECO:0007829|PDB:2LGX"
FT   STRAND          90..92
FT                   /evidence="ECO:0007829|PDB:6U4N"
FT   TURN            347..353
FT                   /evidence="ECO:0007829|PDB:2MSU"
FT   HELIX           354..357
FT                   /evidence="ECO:0007829|PDB:2MSU"
FT   HELIX           369..371
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   STRAND          375..382
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   STRAND          393..400
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   STRAND          403..408
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   HELIX           410..412
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   STRAND          418..422
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   STRAND          427..433
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   TURN            434..437
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   STRAND          438..447
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   STRAND          450..460
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   HELIX           461..475
FT                   /evidence="ECO:0007829|PDB:4F7H"
FT   HELIX           484..495
FT                   /evidence="ECO:0007829|PDB:4F7H"
SQ   SEQUENCE   680 AA;  77861 MW;  BAFF5AF2CD91C43C CRC64;
     MALDGIRMPD GCYADGTWEL SVHVTDLNRD VTLRVTGEVH IGGVMLKLVE KLDVKKDWSD
     HALWWEKKRT WLLKTHWTLD KYGIQADAKL QFTPQHKLLR LQLPNMKYVK VKVNFSDRVF
     KAVSDICKTF NIRHPEELSL LKKPRDPTKK KKKKLDDQSE DEALELEGPL ITPGSGSIYS
     SPGLYSKTMT PTYDAHDGSP LSPTSAWFGD SALSEGNPGI LAVSQPITSP EILAKMFKPQ
     ALLDKAKINQ GWLDSSRSLM EQDVKENEAL LLRFKYYSFF DLNPKYDAIR INQLYEQAKW
     AILLEEIECT EEEMMMFAAL QYHINKLSIM TSENHLNNSD KEVDEVDAAL SDLEITLEGG
     KTSTILGDIT SIPELADYIK VFKPKKLTLK GYKQYWCTFK DTSISCYKSK EESSGTPAHQ
     MNLRGCEVTP DVNISGQKFN IKLLIPVAEG MNEIWLRCDN EKQYAHWMAA CRLASKGKTM
     ADSSYNLEVQ NILSFLKMQH LNPDPQLIPE QITTDITPEC LVSPRYLKKY KNKQITARIL
     EAHQNVAQMS LIEAKMRFIQ AWQSLPEFGI THFIARFQGG KKEELIGIAY NRLIRMDAST
     GDAIKTWRFS NMKQWNVNWE IKMVTVEFAD EVRLSFICTE VDCKVVHEFI GGYIFLSTRA
     KDQNESLDEE MFYKLTSGWV
//
ID   SCAM5_HUMAN             Reviewed;         235 AA.
AC   Q8TAC9; B3KPJ7; B7Z762; D3DW71; Q8N3M4;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   09-APR-2025, entry version 160.
DE   RecName: Full=Secretory carrier-associated membrane protein 5;
DE            Short=Secretory carrier membrane protein 5;
DE            Short=hSCAMP5;
GN   Name=SCAMP5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND INTERACTION WITH SYT1 AND SYT2.
RX   PubMed=19234194; DOI=10.4049/jimmunol.0802002;
RA   Han C., Chen T., Yang M., Li N., Liu H., Cao X.;
RT   "Human SCAMP5, a novel secretory carrier membrane protein, facilitates
RT   calcium-triggered cytokine secretion by interaction with SNARE machinery.";
RL   J. Immunol. 182:2986-2996(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Synovial cell, Teratocarcinoma, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SLC9A7.
RX   PubMed=15840657; DOI=10.1242/jcs.02315;
RA   Lin P.J., Williams W.P., Luu Y., Molday R.S., Orlowski J., Numata M.;
RT   "Secretory carrier membrane proteins interact and regulate trafficking of
RT   the organellar (Na+,K+)/H+ exchanger NHE7.";
RL   J. Cell Sci. 118:1885-1897(2005).
RN   [7]
RP   POSSIBLE FUNCTION, AND INDUCTION.
RX   PubMed=19240033; DOI=10.1074/jbc.m807620200;
RA   Noh J.-Y., Lee H., Song S., Kim N.S., Im W., Kim M., Seo H.-M.,
RA   Chung C.-W., Chang J.-W., Ferrante R.J., Yoo Y.-J., Ryu H., Jung Y.-K.;
RT   "SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded
RT   polyglutamine protein aggregates via endocytosis inhibition.";
RL   J. Biol. Chem. 284:11318-11325(2009).
CC   -!- FUNCTION: Required for the calcium-dependent exocytosis of signal
CC       sequence-containing cytokines such as CCL5. Probably acts in
CC       cooperation with the SNARE machinery. May play a role in accumulation
CC       of expanded polyglutamine (polyQ) protein huntingtin (HTT) in case of
CC       endoplasmic reticulum stress by inhibiting the endocytosis pathway.
CC       {ECO:0000269|PubMed:19234194}.
CC   -!- SUBUNIT: Interacts (via C-terminal part) with SYT1 and SYT2;
CC       interaction with synaptotagmins making a link with the SNARE molecules.
CC       Interacts with SLC9A7. {ECO:0000269|PubMed:15840657,
CC       ECO:0000269|PubMed:19234194}.
CC   -!- INTERACTION:
CC       Q8TAC9; Q13520: AQP6; NbExp=3; IntAct=EBI-2695784, EBI-13059134;
CC       Q8TAC9; P53365: ARFIP2; NbExp=3; IntAct=EBI-2695784, EBI-638194;
CC       Q8TAC9; Q9HA82: CERS4; NbExp=3; IntAct=EBI-2695784, EBI-2622997;
CC       Q8TAC9; Q969F0: FATE1; NbExp=3; IntAct=EBI-2695784, EBI-743099;
CC       Q8TAC9; P39905-3: GDNF; NbExp=3; IntAct=EBI-2695784, EBI-12702062;
CC       Q8TAC9; Q7Z5P4: HSD17B13; NbExp=3; IntAct=EBI-2695784, EBI-18053395;
CC       Q8TAC9; P15941-11: MUC1; NbExp=3; IntAct=EBI-2695784, EBI-17263240;
CC       Q8TAC9; P57054: PIGP; NbExp=3; IntAct=EBI-2695784, EBI-17630288;
CC       Q8TAC9; Q9UKF7-2: PITPNC1; NbExp=3; IntAct=EBI-2695784, EBI-14223623;
CC       Q8TAC9; O95470: SGPL1; NbExp=3; IntAct=EBI-2695784, EBI-1046170;
CC       Q8TAC9; Q99961: SH3GL1; NbExp=3; IntAct=EBI-2695784, EBI-697911;
CC       Q8TAC9; Q3SXP7: SHISAL1; NbExp=3; IntAct=EBI-2695784, EBI-18037857;
CC       Q8TAC9; Q3KNW5: SLC10A6; NbExp=3; IntAct=EBI-2695784, EBI-18159983;
CC       Q8TAC9; Q9NPL8: TIMMDC1; NbExp=3; IntAct=EBI-2695784, EBI-6268651;
CC       Q8TAC9; Q96MV1: TLCD4; NbExp=3; IntAct=EBI-2695784, EBI-12947623;
CC       Q8TAC9; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-2695784, EBI-8638294;
CC       Q8TAC9; Q9Y320: TMX2; NbExp=3; IntAct=EBI-2695784, EBI-6447886;
CC       Q8TAC9; P49638: TTPA; NbExp=3; IntAct=EBI-2695784, EBI-10210710;
CC       Q8TAC9; P46096: Syt1; Xeno; NbExp=2; IntAct=EBI-2695784, EBI-445340;
CC       Q8TAC9; P46097: Syt2; Xeno; NbExp=2; IntAct=EBI-2695784, EBI-457969;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. Golgi
CC       apparatus membrane; Multi-pass membrane protein. Golgi apparatus,
CC       trans-Golgi network membrane; Multi-pass membrane protein. Recycling
CC       endosome membrane; Multi-pass membrane protein. Cytoplasmic vesicle,
CC       secretory vesicle, synaptic vesicle membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Note=Mainly localizes in Golgi
CC       apparatus membrane. Upon calcium-triggered exocytosis, it translocates
CC       to the cell membrane. Highly enriched in synaptic vesicles (By
CC       similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8TAC9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TAC9-2; Sequence=VSP_010206;
CC       Name=3;
CC         IsoId=Q8TAC9-3; Sequence=VSP_036934;
CC   -!- TISSUE SPECIFICITY: Expressed both by neuronal and non-neuronal
CC       tissues. Expressed in brain, stomach, thyroid, spinal cord, lymph node,
CC       trachea, adrenal gland, bone marrow and in the different parts of
CC       brain. In thyroid tissues, it is expressed by the follicular epithelial
CC       cells. In the adrenal gland tissues it is detected in the zona
CC       fasciculata of the cortex region (at protein level).
CC       {ECO:0000269|PubMed:19234194}.
CC   -!- INDUCTION: By endoplasmic reticulum stress.
CC       {ECO:0000269|PubMed:19240033}.
CC   -!- SIMILARITY: Belongs to the SCAMP family. SCAMP5 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF495715; AAM18052.1; -; mRNA.
DR   EMBL; AK056438; BAG51709.1; -; mRNA.
DR   EMBL; AK126940; BAG54404.1; -; mRNA.
DR   EMBL; AK127480; BAG54511.1; -; mRNA.
DR   EMBL; AK301505; BAH13498.1; -; mRNA.
DR   EMBL; AL834226; CAD38904.1; -; mRNA.
DR   EMBL; CH471136; EAW99277.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99278.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99280.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99283.1; -; Genomic_DNA.
DR   EMBL; BC024700; AAH24700.1; -; mRNA.
DR   CCDS; CCDS45306.1; -. [Q8TAC9-1]
DR   RefSeq; NP_001171582.1; NM_001178111.2. [Q8TAC9-1]
DR   RefSeq; NP_001171583.1; NM_001178112.2. [Q8TAC9-1]
DR   RefSeq; NP_620417.1; NM_138967.4. [Q8TAC9-1]
DR   RefSeq; XP_006720484.1; XM_006720421.2. [Q8TAC9-1]
DR   RefSeq; XP_006720485.1; XM_006720422.3.
DR   RefSeq; XP_016877478.1; XM_017021989.1.
DR   RefSeq; XP_047288175.1; XM_047432219.1. [Q8TAC9-1]
DR   RefSeq; XP_054233415.1; XM_054377440.1. [Q8TAC9-1]
DR   RefSeq; XP_054233416.1; XM_054377441.1. [Q8TAC9-1]
DR   AlphaFoldDB; Q8TAC9; -.
DR   SMR; Q8TAC9; -.
DR   BioGRID; 128182; 23.
DR   IntAct; Q8TAC9; 32.
DR   MINT; Q8TAC9; -.
DR   STRING; 9606.ENSP00000355387; -.
DR   TCDB; 8.A.103.1.5; the secretory carrier-associated membrane protein (scamp) family.
DR   iPTMnet; Q8TAC9; -.
DR   PhosphoSitePlus; Q8TAC9; -.
DR   SwissPalm; Q8TAC9; -.
DR   BioMuta; SCAMP5; -.
DR   DMDM; 47117253; -.
DR   jPOST; Q8TAC9; -.
DR   MassIVE; Q8TAC9; -.
DR   PaxDb; 9606-ENSP00000355387; -.
DR   PeptideAtlas; Q8TAC9; -.
DR   ProteomicsDB; 73856; -. [Q8TAC9-1]
DR   ProteomicsDB; 73857; -. [Q8TAC9-2]
DR   ProteomicsDB; 73858; -. [Q8TAC9-3]
DR   Antibodypedia; 27182; 89 antibodies from 16 providers.
DR   DNASU; 192683; -.
DR   Ensembl; ENST00000361900.10; ENSP00000355387.6; ENSG00000198794.12. [Q8TAC9-1]
DR   Ensembl; ENST00000425597.8; ENSP00000406547.3; ENSG00000198794.12. [Q8TAC9-1]
DR   Ensembl; ENST00000562212.5; ENSP00000455313.1; ENSG00000198794.12. [Q8TAC9-2]
DR   GeneID; 192683; -.
DR   KEGG; hsa:192683; -.
DR   MANE-Select; ENST00000425597.8; ENSP00000406547.3; NM_138967.4; NP_620417.1.
DR   UCSC; uc002azk.3; human. [Q8TAC9-1]
DR   AGR; HGNC:30386; -.
DR   CTD; 192683; -.
DR   DisGeNET; 192683; -.
DR   GeneCards; SCAMP5; -.
DR   HGNC; HGNC:30386; SCAMP5.
DR   HPA; ENSG00000198794; Tissue enhanced (brain, retina).
DR   MIM; 613766; gene.
DR   neXtProt; NX_Q8TAC9; -.
DR   OpenTargets; ENSG00000198794; -.
DR   PharmGKB; PA134962580; -.
DR   VEuPathDB; HostDB:ENSG00000198794; -.
DR   eggNOG; KOG3088; Eukaryota.
DR   GeneTree; ENSGT00940000157577; -.
DR   InParanoid; Q8TAC9; -.
DR   OMA; TWPVGWI; -.
DR   OrthoDB; 242866at2759; -.
DR   PhylomeDB; Q8TAC9; -.
DR   TreeFam; TF313797; -.
DR   PathwayCommons; Q8TAC9; -.
DR   SignaLink; Q8TAC9; -.
DR   BioGRID-ORCS; 192683; 18 hits in 1148 CRISPR screens.
DR   ChiTaRS; SCAMP5; human.
DR   GeneWiki; SCAMP5; -.
DR   GenomeRNAi; 192683; -.
DR   Pharos; Q8TAC9; Tbio.
DR   PRO; PR:Q8TAC9; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q8TAC9; protein.
DR   Bgee; ENSG00000198794; Expressed in right hemisphere of cerebellum and 139 other cell types or tissues.
DR   ExpressionAtlas; Q8TAC9; baseline and differential.
DR   GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032588; C:trans-Golgi network membrane; IDA:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0045806; P:negative regulation of endocytosis; IDA:UniProtKB.
DR   GO; GO:0045956; P:positive regulation of calcium ion-dependent exocytosis; IDA:UniProtKB.
DR   GO; GO:0001819; P:positive regulation of cytokine production; IDA:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IBA:GO_Central.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   InterPro; IPR007273; SCAMP.
DR   PANTHER; PTHR10687:SF5; SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN 5; 1.
DR   PANTHER; PTHR10687; SECRETORY CARRIER-ASSOCIATED MEMBRANE PROTEIN SCAMP; 1.
DR   Pfam; PF04144; SCAMP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasmic vesicle; Endosome;
KW   Exocytosis; Golgi apparatus; Membrane; Protein transport;
KW   Proteomics identification; Reference proteome; Synapse; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..235
FT                   /note="Secretory carrier-associated membrane protein 5"
FT                   /id="PRO_0000191262"
FT   TOPO_DOM        1..39
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        40..60
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        61..67
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        68..88
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        89..102
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..125
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        126..148
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        149..169
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        170..235
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..98
FT                   /note="MAEKVNNFPPLPKFIPLKPCFYQDFEADIPPQHVSMTKRLYYLWMLNSVTLA
FT                   VNLVGCLAWLIGGGGATNFGLAFLWLILFTPCSYVCWFRPIYKAFK -> MFLPRLRGR
FT                   YSSPACQHDQAPLLPLDV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036934"
FT   VAR_SEQ         132
FT                   /note="C -> CPTLASSCS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_010206"
SQ   SEQUENCE   235 AA;  26104 MW;  D3CFF3C9EF2FC6FF CRC64;
     MAEKVNNFPP LPKFIPLKPC FYQDFEADIP PQHVSMTKRL YYLWMLNSVT LAVNLVGCLA
     WLIGGGGATN FGLAFLWLIL FTPCSYVCWF RPIYKAFKTD SSFSFMAFFF TFMAQLVISI
     IQAVGIPGWG VCGWIATISF FGTNIGSAVV MLIPTVMFTV MAVFSFIALS MVHKFYRGSG
     GSFSKAQEEW TTGAWKNPHV QQAAQNAAMG AAQGAMNQPQ TQYSATPNYT YSNEM
//
ID   A0A8Q3SIG1_HUMAN        Unreviewed;      3320 AA.
AC   A0A8Q3SIG1;
DT   12-OCT-2022, integrated into UniProtKB/TrEMBL.
DT   12-OCT-2022, sequence version 1.
DT   02-APR-2025, entry version 15.
DE   RecName: Full=Vitellogenin domain-containing protein {ECO:0008006|Google:ProtNLM};
GN   Name=LOC400499 {ECO:0000313|Ensembl:ENSP00000512464.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000512464.1, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000512464.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000512464.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000512464.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.R., Wu K., Yang J.,
RA   Dejong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000512464.1}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00557}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC009121; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC099489; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF573656; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001357633.1; NM_001370704.1.
DR   SMR; A0A8Q3SIG1; -.
DR   PeptideAtlas; A0A8Q3SIG1; -.
DR   Ensembl; ENST00000696174.1; ENSP00000512464.1; ENSG00000188897.10.
DR   GeneID; 400499; -.
DR   MANE-Select; ENST00000696174.1; ENSP00000512464.1; NM_001370704.1; NP_001357633.1.
DR   GeneCards; LOC400499; -.
DR   GeneTree; ENSGT00440000038757; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   GO; GO:0005319; F:lipid transporter activity; IEA:InterPro.
DR   FunFam; 1.25.10.20:FF:000005; Apolipoprotein lipid transfer particle; 1.
DR   FunFam; 2.20.50.20:FF:000010; vitellogenin-like; 1.
DR   Gene3D; 2.30.230.10; Lipovitellin, beta-sheet shell regions, chain A; 1.
DR   Gene3D; 2.20.80.10; Lipovitellin-phosvitin complex, chain A, domain 4; 1.
DR   Gene3D; 2.20.50.20; Lipovitellin. Chain A, domain 3; 1.
DR   Gene3D; 1.25.10.20; Vitellinogen, superhelical; 1.
DR   InterPro; IPR015819; Lipid_transp_b-sht_shell.
DR   InterPro; IPR011030; Lipovitellin_superhlx_dom.
DR   InterPro; IPR048484; LOC400499-like.
DR   InterPro; IPR015816; Vitellinogen_b-sht_N.
DR   InterPro; IPR015255; Vitellinogen_open_b-sht.
DR   InterPro; IPR015817; Vitellinogen_open_b-sht_sub1.
DR   InterPro; IPR001747; Vitellogenin_N.
DR   InterPro; IPR001846; VWF_type-D.
DR   PANTHER; PTHR37860; AGAP008810-PA; 1.
DR   PANTHER; PTHR37860:SF2; VITELLOGENIN DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF21013; LOC400499; 1.
DR   Pfam; PF09172; Vit_open_b-sht; 1.
DR   Pfam; PF01347; Vitellogenin_N; 1.
DR   Pfam; PF00094; VWD; 1.
DR   SMART; SM01169; DUF1943; 1.
DR   SMART; SM00638; LPD_N; 1.
DR   SUPFAM; SSF56968; Lipovitellin-phosvitin complex, beta-sheet shell regions; 2.
DR   SUPFAM; SSF48431; Lipovitellin-phosvitin complex, superhelical domain; 1.
DR   PROSITE; PS51211; VITELLOGENIN; 1.
DR   PROSITE; PS51233; VWFD; 1.
PE   4: Predicted;
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|ARBA:ARBA00022729, ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           22..3320
FT                   /note="Vitellogenin domain-containing protein"
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5035810698"
FT   DOMAIN          47..654
FT                   /note="Vitellogenin"
FT                   /evidence="ECO:0000259|PROSITE:PS51211"
FT   DOMAIN          3067..3237
FT                   /note="VWFD"
FT                   /evidence="ECO:0000259|PROSITE:PS51233"
FT   REGION          268..289
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          693..727
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        279..288
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        708..720
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   3320 AA;  363323 MW;  CCBCC7F4A5CF2F6E CRC64;
     MPAPVGLLGL VLLWPLMAVT AEKIPDSQVG QVASCMTACT GSAGPHLPVG TRYTYHFSTN
     TSTSLQDVLV EGSGLGLQGL AVLDVLGLCQ MALWLQDFQV TSILGAKVEL LKESESLSAT
     LGRNPLRFIL HSGRVAHLCP HPTEPRWVLN VKRAVLSLLQ GHPGAHSPKT FDEVDILGRC
     PTTYQHHGDW LHKTKDLARC SLRRGRSSLH SQALPGVAPG LTSRLTCVQS FRAGVLREAS
     CTELDSAGPL PAKASAVQMR TLSSLSLLHE MPQDPAGTDP DDRDDEDMTP SSLLYEWEET
     PSQAMVATAA TLVRRLCLAQ TTSLEAMDLF LTLVSQLQGL SGGELMELWQ YSSFKCRDNG
     QPLLDALPSC GTEHCVGLMK ELIASAAVEA DEVEAWLSSL AFLPQPTDAM VHMLLPLLQT
     PRASPGAFLG ISALVHNLCA SLDGPCGQLP GVGSLVRILG DALGENCTIQ EPSDDDKLQL
     VLKAVGNAGL AAMALTPTLS ACASLRSSTP EIRLGAIQAF RRVPCSADRS VLSRLYQSLE
     EDAEIRINAY LALMRCPSEE VFAQVRRTQA GELSTQVGSF VWSHILQLLE THDPLKRALR
     DTLPEDILSQ EFHPEMWKHS SYSDVTFRSV SGSLGANLEG TLLFSPASFL PRSATVNLTI
     HTMGRAFNLL ELGLRLENAE EIAHRLFGRK SFWGQEDGRE PEPEEPPGPE PGPAPQPASP
     ECPGDRDRRM RYLQQKVTRR RGARQALRCE LSVKLLGQEL SFVNCGATGS HVNHWPLNLA
     ELAIKLMKGQ EVQMNRRLSL AAQELVFPTV SGLPARLTLN ASAAISIRVR GTTDFQQRSD
     FSVNGYVKPS ALLQISAQMG TAGILGQAGL RWVTSVRSAA SLDGGIQVQK GRVLKVHLNT
     PEEAVELLSF SSQLYLITRD GVRSLRHVPG PSEVQSCTGE EVSYTWGWRL CTGVTWPVPG
     QPYLLSLPVF AAVTLQKRDP GLRQYLLEAA YTLQPQKGSW FPQEATAHVF MGTPGSEVLR
     DVGVDMSYSL PQNKFRLKLL HPKKKIELDG KMEALGSAHT GHLELVLDDR DVYYIKGWSD
     LQPAMGGEAE RFQAQLEVKL VTGGSPVVFT GNLTRQVGSK LAFSASLSHL LSDQANVTAL
     LERKEENGRR VAALGAELFV PGLVGLRALG LLQQRGQLWT NSLRIQYSLL GQAKQAAHEC
     STSQKLRADS GSDGAYRLEL RHELHCTQIL AFSHKVQLWH EEDSGHLHSQ LEVSYGKHWD
     KNSNKRHLRV SQTFKNDSGP ALSNHFMEFV LQVPERQVDC RVQLYHLSLR LPYVESSSHL
     KVQYNGRPLF VAGGQWKDTS RATLWKWEGA LNLDSPWLMV SAAHRLYWPH RAVFQAVLEL
     TLGKAWTLKD LVVSVGCRSQ GPNREGKIQV YTAATTYLRV STVTVLAQSL FHSWSELESA
     WNAAVQGEIH AENSRDRKIL NCWLKGPQQE LNLTAAYRHL EWPRKTQVSL TAVRIGAQGQ
     PRGLQLEGEL EELRQDRTLY RKRGALLLRH PLHLPIPQSL LLQETFTADR RHQRYSLETR
     VVLNGREETL QTMVLGCQAG HPYVCAGLMH PYDGKVIPRN TEGCLVTWNQ HTAKNREVEA
     TLKVHRKVVL HLKGLHHDRS QHGEIRHSLA LDLAHSYQLS FPQALSLDGG IIFRQSPQGT
     FNFGMDARAA VNHNVTSQAS VQLNGSDSDF AFFFQLRHPH GPTFPPNFQV QAAAGRYRVR
     SLNGSLSVQM SGRELVLLEV DASQDTRRSS RGWGVSVLLH QAVLSAPRAV RLQLSAKITP
     ARIWLFSKAL LDQNTAQLLL KASEEWRGGR ILTFQSQTRH TVAGWAAMPR LLTLTGRLKQ
     KETLQEGTLS VTADSAVLGF LLRDQHEKAG NGTSVRSVTC VLAQNSSQAL PGELQLKGRL
     QAQTRNLRAQ ASIRAHAASL ALGGACSWGP RHGQLAGGPT HNISTLSDAG LPSEAGMLLS
     LTHVASNCSA RLALWNAGAQ LDGAIGLEDV TPESSGLQLH ASLRHTHTMP SLKHWGLPFS
     LDGHGHFQSV GRSLAAGLTV ILDGEQLRAA LERKAEGGRQ GLVLGLHHGL SGLQGTLPSQ
     LEVNCSGDAS PTQLLGWCRG DIAGQPLEVS VDIHNGSSGF EHSGRILMGP TFLNYSVSCY
     YHDGHLELSG RSWHNSEALL WAGFPGEACL SAELQIHETQ TQARVALHGG DSGVSMDLAA
     LVARPRRGPL QLVASASHTV PALQRLGLPF TNQLVFQGLW EAEEMSSSLQ LTCDSQATLV
     LDVRGQNQAV SKELLFSGRH RLPFLLGLCP SSASASAKLH YSKGEVQSMF ALGVEERHFH
     ISTRQVAAKA GLNNFIKLEQ TFLQLSALPR ELFLQTAYER AHGTRVLRQV VLWDGQEVAL
     TGSLSGPFPK PTRNLSLQVE LTHPLPLPLP RHCSLRLSSE HLGGSHRDGL VVGWDGRDQV
     LVSSSLWLGK SELAARLALA HPFNLPWRQA EASGLAESRG GRQSRQVQLT WNRGQPATLQ
     LTWADGSLAH STAWDGCLAA SPGQLQETWG LNSLQACGAF TQTPAVFVEQ LNVSWGQHRM
     RQNLTYERHW PSQPDKIIME ATLEHVLGAS CTRQSFWGEV QTDYARWLRH SLHLGLCDLP
     RALLVVGEHT LGQGGLLLRS RCHLGLAPDP DHGLHLSLTL QNHSRPRSAD FSGALELRGS
     KAQRVGLLGR VSTSTSQSLV RLEGSVDNRE EKVRLSVFRA PSCLQASVAH EEGGREESVV
     LRACAHGRTA EAEVLFRDGR QPSQPLGRLT LQAANQSLLL AARGCQGGLL GHVESRIAAV
     GSQVQARLEE KVQGLGASVR RFQQLVQPAG TLDGVAGLLL QLSQAGREAM QASGWAVATL
     WARSQALTQH LPLYLEWLQV GLEQLREELE WPLATLKDAY LEVTLRPLEE VWRERAEEAM
     RRLQAWVPGM PGKGGPRPIR AALGAMKGAL ELAAQQMLSW AEATFSRALK RLCKPLLDLY
     SLSARNRSVV VMLPLLPAGD EPLDVARVTS YLMEEKLLRP LRELSGANVL AEYYWLRRRL
     LAGPWEYHAL VAGAQHVVTF DGRVWDLSTQ CGSILLAQDF AHNTFSLTLS RTGSGLTALF
     VELNHKTLIL YPSLQAYRLY NSSLPGDSCP DLKLHPATTR KDVSRIELAS EDGVSVSCDV
     PTGLCSLTLG LWQHGISAGL LGTNDNEAGN ELMLPDGSMA RSLEELSLAW QVGGDCRATE
     KPQQEQACPG QLPACWAFFE GPHSSLRDCF RVVDPTPFLS LCVQVPCGTQ ELQPACNLAA
     AYIHLCARGF VPLAPPPQCV
//
ID   H3BUK5_HUMAN            Unreviewed;        91 AA.
AC   H3BUK5;
DT   18-APR-2012, integrated into UniProtKB/TrEMBL.
DT   20-JUN-2018, sequence version 2.
DT   02-APR-2025, entry version 57.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000457683.2};
GN   Name=LOC112694756 {ECO:0000313|Ensembl:ENSP00000457683.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000457683.2, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000457683.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000457683.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000457683.2, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.R., Wu K., Yang J.,
RA   Dejong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [4] {ECO:0007829|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [5] {ECO:0007829|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6] {ECO:0000313|Ensembl:ENSP00000457683.2}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC093512; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001352234.1; NM_001365305.2.
DR   ProteomicsDB; 42957; -.
DR   Ensembl; ENST00000566897.6; ENSP00000455724.2; ENSG00000285043.3.
DR   Ensembl; ENST00000568435.6; ENSP00000457683.2; ENSG00000285043.3.
DR   GeneID; 112694756; -.
DR   UCSC; uc059syv.1; human.
DR   GeneCards; LOC112694756; -.
DR   MalaCards; LOC112694756; -.
DR   VEuPathDB; HostDB:ENSG00000285043; -.
DR   GeneTree; ENSGT01040000240645; -.
DR   HOGENOM; CLU_222190_0_0_1; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000285043; Expressed in hindlimb stylopod muscle and 100 other cell types or tissues.
DR   ExpressionAtlas; H3BUK5; baseline and differential.
PE   1: Evidence at protein level;
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   91 AA;  9794 MW;  9C1AE516528A9ABD CRC64;
     MDAQGCCADG SSPCRKQGSS GPPDCCWTCA EACNFPLPSP AHFLDACCPQ PTRADWAPRC
     PRCCPLCDCA CTCQLPDCQS LNCLCFEIKL R
//
ID   SEHBP_HUMAN             Reviewed;          46 AA.
AC   C0HLU2;
DT   29-SEP-2021, integrated into UniProtKB/Swiss-Prot.
DT   29-SEP-2021, sequence version 1.
DT   05-FEB-2025, entry version 8.
DE   RecName: Full=Transcriptional regulator SEHBP {ECO:0000305};
DE   AltName: Full=Short ORF-encoded histone-binding protein {ECO:0000303|PubMed:33468658};
DE   AltName: Full=ZNF689 upstream open reading frame protein {ECO:0000305};
GN   Name=ZNF689 {ECO:0000303|PubMed:33468658};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2] {ECO:0000305}
RP   IDENTIFICATION, FUNCTION, INTERACTION WITH HISTONE H2B; HMGN1 AND HMGN3,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=33468658; DOI=10.1073/pnas.2021943118;
RA   Koh M., Ahmad I., Ko Y., Zhang Y., Martinez T.F., Diedrich J.K., Chu Q.,
RA   Moresco J.J., Erb M.A., Saghatelian A., Schultz P.G., Bollong M.J.;
RT   "A short ORF-encoded transcriptional regulator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 118:0-0(2021).
CC   -!- FUNCTION: Plays a role in transcription regulation.
CC       {ECO:0000269|PubMed:33468658}.
CC   -!- SUBUNIT: Interacts with histone H2B (PubMed:33468658). Also interacts
CC       with chromatin-binding proteins HMGN1 and HMGN3 (PubMed:33468658).
CC       {ECO:0000269|PubMed:33468658}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:33468658}. Cytoplasm
CC       {ECO:0000269|PubMed:33468658}.
CC   -!- MISCELLANEOUS: Encoded in the 5'-untranslated region (5'-UTR) of
CC       ZNF689. {ECO:0000269|PubMed:33468658}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC093249; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; C0HLU2; -.
DR   AGR; HGNC:25173; -.
DR   GeneCards; ZNF689; -.
DR   HGNC; HGNC:25173; ZNF689.
DR   HPA; ENSG00000289491; Tissue enhanced (adipose tissue, choroid plexus, intestine, lymphoid tissue, skeletal muscle).
DR   neXtProt; NX_C0HLU2; -.
DR   OrthoDB; 6077919at2759; -.
DR   Proteomes; UP000005640; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   InterPro; IPR054150; SEHBP.
DR   Pfam; PF21978; SEHBP; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..46
FT                   /note="Transcriptional regulator SEHBP"
FT                   /id="PRO_0000453426"
SQ   SEQUENCE   46 AA;  5037 MW;  812C9527388F43F3 CRC64;
     MALRSIKSIA GSCLCSRQRR CGSSAAIFPE GIFRCLSPKF GQEFPE
//
ID   KIF19_HUMAN             Reviewed;         998 AA.
AC   Q2TAC6; A6NLG2; B7ZKR1; Q52M87; Q8N1X8; Q8TAB6;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   09-APR-2025, entry version 151.
DE   RecName: Full=Kinesin-like protein KIF19;
GN   Name=KIF19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT TRP-471.
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 1-829 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Plus end-directed microtubule-dependent motor protein that
CC       regulates the length of motile cilia by mediating depolymerization of
CC       microtubules at ciliary tips. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000250}. Cell
CC       projection, cilium {ECO:0000250}. Note=Localizes to cilia tips.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q2TAC6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2TAC6-2; Sequence=VSP_023208, VSP_023209;
CC       Name=3;
CC         IsoId=Q2TAC6-3; Sequence=VSP_023207, VSP_023208, VSP_023209;
CC   -!- MISCELLANEOUS: [Isoform 2]: Due to intron retention. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Due to intron retention. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Kinesin family. {ECO:0000255|PROSITE-ProRule:PRU00283}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK094619; BAC04386.1; -; mRNA.
DR   EMBL; AC055863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103809; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89153.1; -; Genomic_DNA.
DR   EMBL; BC093631; AAH93631.1; -; mRNA.
DR   EMBL; BC104852; AAI04853.1; -; mRNA.
DR   EMBL; BC110989; AAI10990.1; -; mRNA.
DR   EMBL; BC143327; AAI43328.1; -; mRNA.
DR   CCDS; CCDS32718.2; -. [Q2TAC6-1]
DR   RefSeq; NP_694941.2; NM_153209.4. [Q2TAC6-1]
DR   AlphaFoldDB; Q2TAC6; -.
DR   SMR; Q2TAC6; -.
DR   BioGRID; 125878; 7.
DR   IntAct; Q2TAC6; 1.
DR   MINT; Q2TAC6; -.
DR   STRING; 9606.ENSP00000374566; -.
DR   iPTMnet; Q2TAC6; -.
DR   PhosphoSitePlus; Q2TAC6; -.
DR   BioMuta; KIF19; -.
DR   DMDM; 126215730; -.
DR   jPOST; Q2TAC6; -.
DR   MassIVE; Q2TAC6; -.
DR   PaxDb; 9606-ENSP00000374566; -.
DR   PeptideAtlas; Q2TAC6; -.
DR   ProteomicsDB; 61459; -. [Q2TAC6-1]
DR   ProteomicsDB; 61460; -. [Q2TAC6-2]
DR   ProteomicsDB; 61461; -. [Q2TAC6-3]
DR   Antibodypedia; 31955; 123 antibodies from 20 providers.
DR   DNASU; 124602; -.
DR   Ensembl; ENST00000389916.5; ENSP00000374566.4; ENSG00000196169.15. [Q2TAC6-1]
DR   GeneID; 124602; -.
DR   KEGG; hsa:124602; -.
DR   MANE-Select; ENST00000389916.5; ENSP00000374566.4; NM_153209.4; NP_694941.2.
DR   UCSC; uc002jkm.4; human. [Q2TAC6-1]
DR   AGR; HGNC:26735; -.
DR   CTD; 124602; -.
DR   DisGeNET; 124602; -.
DR   GeneCards; KIF19; -.
DR   HGNC; HGNC:26735; KIF19.
DR   HPA; ENSG00000196169; Group enriched (brain, fallopian tube, lymphoid tissue).
DR   MalaCards; KIF19; -.
DR   MIM; 619610; gene.
DR   neXtProt; NX_Q2TAC6; -.
DR   OpenTargets; ENSG00000196169; -.
DR   PharmGKB; PA143485523; -.
DR   VEuPathDB; HostDB:ENSG00000196169; -.
DR   eggNOG; KOG0242; Eukaryota.
DR   GeneTree; ENSGT00940000160989; -.
DR   HOGENOM; CLU_001485_15_0_1; -.
DR   InParanoid; Q2TAC6; -.
DR   OMA; GEQKQLC; -.
DR   OrthoDB; 3176171at2759; -.
DR   PhylomeDB; Q2TAC6; -.
DR   TreeFam; TF331721; -.
DR   PathwayCommons; Q2TAC6; -.
DR   Reactome; R-HSA-6811434; COPI-dependent Golgi-to-ER retrograde traffic.
DR   Reactome; R-HSA-983189; Kinesins.
DR   SignaLink; Q2TAC6; -.
DR   SIGNOR; Q2TAC6; -.
DR   BioGRID-ORCS; 124602; 14 hits in 1151 CRISPR screens.
DR   ChiTaRS; KIF19; human.
DR   GenomeRNAi; 124602; -.
DR   Pharos; Q2TAC6; Tbio.
DR   PRO; PR:Q2TAC6; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q2TAC6; protein.
DR   Bgee; ENSG00000196169; Expressed in right uterine tube and 96 other cell types or tissues.
DR   ExpressionAtlas; Q2TAC6; baseline and differential.
DR   GO; GO:0005930; C:axoneme; IEA:GOC.
DR   GO; GO:0005929; C:cilium; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005871; C:kinesin complex; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IBA:GO_Central.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0003777; F:microtubule motor activity; IBA:GO_Central.
DR   GO; GO:0008574; F:plus-end-directed microtubule motor activity; ISS:UniProtKB.
DR   GO; GO:0060404; P:axonemal microtubule depolymerization; ISS:UniProtKB.
DR   GO; GO:0007018; P:microtubule-based movement; IBA:GO_Central.
DR   GO; GO:0070462; P:plus-end specific microtubule depolymerization; ISS:UniProtKB.
DR   CDD; cd01370; KISc_KIP3_like; 1.
DR   FunFam; 3.40.850.10:FF:000037; kinesin-like protein KIF19; 1.
DR   Gene3D; 3.40.850.10; Kinesin motor domain; 1.
DR   InterPro; IPR027640; Kinesin-like_fam.
DR   InterPro; IPR019821; Kinesin_motor_CS.
DR   InterPro; IPR001752; Kinesin_motor_dom.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR47968; CENTROMERE PROTEIN E; 1.
DR   PANTHER; PTHR47968:SF69; KINESIN-LIKE PROTEIN; 1.
DR   Pfam; PF00225; Kinesin; 1.
DR   PRINTS; PR00380; KINESINHEAVY.
DR   SMART; SM00129; KISc; 1.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00411; KINESIN_MOTOR_1; 1.
DR   PROSITE; PS50067; KINESIN_MOTOR_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Cilium; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Microtubule; Motor protein; Nucleotide-binding;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..998
FT                   /note="Kinesin-like protein KIF19"
FT                   /id="PRO_0000278245"
FT   DOMAIN          11..346
FT                   /note="Kinesin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   REGION          482..503
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          662..706
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          746..765
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          794..911
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          948..998
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          360..391
FT                   /evidence="ECO:0000255"
FT   COILED          424..452
FT                   /evidence="ECO:0000255"
FT   COILED          507..552
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        482..494
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        662..676
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        684..697
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        746..761
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        836..852
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        989..998
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         104..111
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00283"
FT   VAR_SEQ         152..193
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023207"
FT   VAR_SEQ         530..548
FT                   /note="LALEQRCRELRARGRRLEE -> VSRVWGDKESGFRGQGEQV (in
FT                   isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023208"
FT   VAR_SEQ         549..998
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_023209"
FT   VARIANT         471
FT                   /note="R -> W (in dbSNP:rs2382644)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_030719"
FT   VARIANT         807
FT                   /note="R -> H (in dbSNP:rs2271535)"
FT                   /id="VAR_059371"
FT   VARIANT         937
FT                   /note="L -> P (in dbSNP:rs9891620)"
FT                   /id="VAR_049703"
FT   VARIANT         974
FT                   /note="R -> Q (in dbSNP:rs9675190)"
FT                   /id="VAR_061283"
SQ   SEQUENCE   998 AA;  111332 MW;  7E42AB992F038E53 CRC64;
     MKDSGDSKDQ QLMVALRVRP ISVAELEEGA TLIAHKVDEQ MVVLMDPMED PDDILRAHRS
     REKSYLFDVA FDFTATQEMV YQATTKSLIE GVISGYNATV FAYGPTGCGK TYTMLGTDQE
     PGIYVQTLND LFRAIEETSN DMEYEVSMSY LEIYNEMIRD LLNPSLGYLE LREDSKGVIQ
     VAGITEVSTI NAKEIMQLLM KGNRQRTQEP TAANQTSSRS HAVLQVTVRQ RSRVKNILQE
     VRQGRLFMID LAGSERASQT QNRGQRMKEG AHINRSLLAL GNCINALSDK GSNKYINYRD
     SKLTRLLKDS LGGNSRTVMI AHISPASSAF EESRNTLTYA GRAKNIKTRV KQNLLNVSYH
     IAQYTSIIAD LRGEIQRLKR KIDEQTGRGQ ARGRQDRGDI RHIQAEVQLH SGQGEKAGMG
     QLREQLASAF QEQMDVRRRL LELENRAMEV QIDTSRHLLT IAGWKHEKSR RALKWREEQR
     KECYAKDDSE KDSDTGDDQP DILEPPEVAA ARESIAALVD EQKQLRKQKL ALEQRCRELR
     ARGRRLEETL PRRIGSEEQR EVLSLLCRVH ELEVENTEMQ SHALLRDGAL RHRHEAVRRL
     EQHRSLCDEI IQGQRQIIDD YNLAVPQRLE ELYEVYLREL EEGSLEQATI MDQVASRALQ
     DSSLPKITPA GTSLTPDSDL ESVKTLSSDA QHLQNSALPP LSTESEGHHV FKAGTGAWQA
     KSSSVPTPPP IQLGSLVTQE APAQDSLGSW INSSPDSSEN LSEIPLSHKE RKEILTGTKC
     IWVKAARRRS RALGTEGRHL LAPATERSSL SLHSLSEGDD ARPPGPLACK RPPSPTLQHA
     ASEDNLSSST GEAPSRAVGH HGDGPRPWLR GQKKSLGKKR EESLEAKRRK RRSRSFEVTG
     QGLSHPKTHL LGPHQAERIS DHRMPVCRHP APGIRHLGKV TLPLAKVKLP PSQNTGPGDS
     SPLAVPPNPG GGSRRATRGP RLPHGTSTHG KDGCSRHN
//
ID   CCD57_HUMAN             Reviewed;         915 AA.
AC   Q2TAC2; A6NP51; A8MQC7; Q8IWG2; Q8TER3;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   10-APR-2019, sequence version 3.
DT   09-APR-2025, entry version 142.
DE   RecName: Full=Coiled-coil domain-containing protein 57 {ECO:0000305};
GN   Name=CCDC57 {ECO:0000312|HGNC:HGNC:27564};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   MET-480.
RC   TISSUE=Brain, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 458-915 (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CEP63.
RX   PubMed=32402286; DOI=10.1016/j.celrep.2020.107630;
RA   Gurkaslar H.K., Culfa E., Arslanhan M.D., Lince-Faria M.,
RA   Firat-Karalar E.N.;
RT   "CCDC57 Cooperates with Microtubules and Microcephaly Protein CEP63 and
RT   Regulates Centriole Duplication and Mitotic Progression.";
RL   Cell Rep. 31:107630-107630(2020).
CC   -!- FUNCTION: Pleiotropic regulator of centriole duplication, mitosis, and
CC       ciliogenesis. Critical interface between centrosome and microtubule-
CC       mediated cellular processes. Centriole duplication protein required for
CC       recruitment of CEP63, CEP152, and PLK4 to the centrosome. Independent
CC       of its centrosomal targeting, localizes to and interacts with
CC       microtubules and regulates microtubule nucleation, stability, and
CC       mitotic progression. {ECO:0000269|PubMed:32402286}.
CC   -!- SUBUNIT: Interacts with CEP63; the interaction is required for their
CC       location to proximal end of centrioles (PubMed:32402286). Interacts
CC       with microtubules (PubMed:32402286). {ECO:0000269|PubMed:32402286}.
CC   -!- INTERACTION:
CC       Q2TAC2; P29972: AQP1; NbExp=3; IntAct=EBI-2808286, EBI-745213;
CC       Q2TAC2; P40617: ARL4A; NbExp=3; IntAct=EBI-2808286, EBI-2875746;
CC       Q2TAC2; Q9HC52: CBX8; NbExp=3; IntAct=EBI-2808286, EBI-712912;
CC       Q2TAC2; Q96HB5-4: CCDC120; NbExp=3; IntAct=EBI-2808286, EBI-10185348;
CC       Q2TAC2; Q86Y33: CDC20B; NbExp=3; IntAct=EBI-2808286, EBI-10260504;
CC       Q2TAC2; Q8IYX8-2: CEP57L1; NbExp=3; IntAct=EBI-2808286, EBI-10181988;
CC       Q2TAC2; Q2TBE0: CWF19L2; NbExp=3; IntAct=EBI-2808286, EBI-5453285;
CC       Q2TAC2; Q3B820: FAM161A; NbExp=3; IntAct=EBI-2808286, EBI-719941;
CC       Q2TAC2; Q9Y247: FAM50B; NbExp=3; IntAct=EBI-2808286, EBI-742802;
CC       Q2TAC2; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-2808286, EBI-6658203;
CC       Q2TAC2; Q92917: GPKOW; NbExp=3; IntAct=EBI-2808286, EBI-746309;
CC       Q2TAC2; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-2808286, EBI-2514791;
CC       Q2TAC2; P69905: HBA2; NbExp=3; IntAct=EBI-2808286, EBI-714680;
CC       Q2TAC2; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-2808286, EBI-726510;
CC       Q2TAC2; Q96FQ7: LINC00526; NbExp=3; IntAct=EBI-2808286, EBI-10286106;
CC       Q2TAC2; P55081: MFAP1; NbExp=3; IntAct=EBI-2808286, EBI-1048159;
CC       Q2TAC2; Q6XQN6-2: NAPRT; NbExp=3; IntAct=EBI-2808286, EBI-10254820;
CC       Q2TAC2; P18615: NELFE; NbExp=3; IntAct=EBI-2808286, EBI-348444;
CC       Q2TAC2; Q14980: NUMA1; NbExp=3; IntAct=EBI-2808286, EBI-521611;
CC       Q2TAC2; Q8NEY8: PPHLN1; NbExp=3; IntAct=EBI-2808286, EBI-474076;
CC       Q2TAC2; Q6NYC8: PPP1R18; NbExp=3; IntAct=EBI-2808286, EBI-2557469;
CC       Q2TAC2; Q96QH2: PRAM1; NbExp=3; IntAct=EBI-2808286, EBI-2860740;
CC       Q2TAC2; Q8WWY3: PRPF31; NbExp=3; IntAct=EBI-2808286, EBI-1567797;
CC       Q2TAC2; P79522: PRR3; NbExp=3; IntAct=EBI-2808286, EBI-2803328;
CC       Q2TAC2; P35236: PTPN7; NbExp=3; IntAct=EBI-2808286, EBI-2265723;
CC       Q2TAC2; Q8TBN0: RAB3IL1; NbExp=3; IntAct=EBI-2808286, EBI-743796;
CC       Q2TAC2; Q96HH0: ROBO3; NbExp=3; IntAct=EBI-2808286, EBI-10288358;
CC       Q2TAC2; Q9NU19: TBC1D22B; NbExp=3; IntAct=EBI-2808286, EBI-8787464;
CC       Q2TAC2; Q08117: TLE5; NbExp=3; IntAct=EBI-2808286, EBI-717810;
CC       Q2TAC2; Q9NV29: TMEM100; NbExp=3; IntAct=EBI-2808286, EBI-8644968;
CC       Q2TAC2; Q3SY00: TSGA10IP; NbExp=3; IntAct=EBI-2808286, EBI-10241197;
CC       Q2TAC2; Q9Y4E8: USP15; NbExp=3; IntAct=EBI-2808286, EBI-1043104;
CC       Q2TAC2; O75604: USP2; NbExp=3; IntAct=EBI-2808286, EBI-743272;
CC       Q2TAC2; Q08E77: UTP14C; NbExp=3; IntAct=EBI-2808286, EBI-10225961;
CC       Q2TAC2; G3V1X1: ZFC3H1; NbExp=3; IntAct=EBI-2808286, EBI-6448783;
CC       Q2TAC2; Q8N5A5: ZGPAT; NbExp=3; IntAct=EBI-2808286, EBI-3439227;
CC       Q2TAC2; Q96NC0: ZMAT2; NbExp=3; IntAct=EBI-2808286, EBI-2682299;
CC       Q2TAC2; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-2808286, EBI-740727;
CC       Q2TAC2; PRO_0000449631 [P0DTD1]: rep; Xeno; NbExp=3; IntAct=EBI-2808286, EBI-25475920;
CC       Q2TAC2-2; Q8IZP0-5: ABI1; NbExp=3; IntAct=EBI-10961624, EBI-11743294;
CC       Q2TAC2-2; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-10961624, EBI-11096309;
CC       Q2TAC2-2; O14639-4: ABLIM1; NbExp=3; IntAct=EBI-10961624, EBI-11030084;
CC       Q2TAC2-2; Q9Y2J4: AMOTL2; NbExp=3; IntAct=EBI-10961624, EBI-746752;
CC       Q2TAC2-2; Q86SG2: ANKRD23; NbExp=3; IntAct=EBI-10961624, EBI-5661893;
CC       Q2TAC2-2; Q03989: ARID5A; NbExp=3; IntAct=EBI-10961624, EBI-948603;
CC       Q2TAC2-2; A0A0S2Z4M1: AXIN1; NbExp=3; IntAct=EBI-10961624, EBI-16429430;
CC       Q2TAC2-2; O15169: AXIN1; NbExp=3; IntAct=EBI-10961624, EBI-710484;
CC       Q2TAC2-2; O75815: BCAR3; NbExp=3; IntAct=EBI-10961624, EBI-702336;
CC       Q2TAC2-2; Q9BXY8: BEX2; NbExp=3; IntAct=EBI-10961624, EBI-745073;
CC       Q2TAC2-2; Q9H6X5-2: C19orf44; NbExp=3; IntAct=EBI-10961624, EBI-12061599;
CC       Q2TAC2-2; Q53TS8: C2CD6; NbExp=3; IntAct=EBI-10961624, EBI-739879;
CC       Q2TAC2-2; Q8NA61-2: CBY2; NbExp=3; IntAct=EBI-10961624, EBI-11524851;
CC       Q2TAC2-2; Q96HB5: CCDC120; NbExp=3; IntAct=EBI-10961624, EBI-744556;
CC       Q2TAC2-2; Q96M91: CFAP53; NbExp=3; IntAct=EBI-10961624, EBI-742422;
CC       Q2TAC2-2; P38432: COIL; NbExp=3; IntAct=EBI-10961624, EBI-945751;
CC       Q2TAC2-2; Q53ET0: CRTC2; NbExp=3; IntAct=EBI-10961624, EBI-1181987;
CC       Q2TAC2-2; G5E9L9: DCLK2; NbExp=3; IntAct=EBI-10961624, EBI-12174057;
CC       Q2TAC2-2; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-10961624, EBI-11988027;
CC       Q2TAC2-2; Q86UW9: DTX2; NbExp=3; IntAct=EBI-10961624, EBI-740376;
CC       Q2TAC2-2; Q5JST6: EFHC2; NbExp=3; IntAct=EBI-10961624, EBI-2349927;
CC       Q2TAC2-2; O15371: EIF3D; NbExp=3; IntAct=EBI-10961624, EBI-353818;
CC       Q2TAC2-2; Q04637-9: EIF4G1; NbExp=3; IntAct=EBI-10961624, EBI-12012124;
CC       Q2TAC2-2; Q14241: ELOA; NbExp=3; IntAct=EBI-10961624, EBI-742350;
CC       Q2TAC2-2; Q9NT22: EMILIN3; NbExp=3; IntAct=EBI-10961624, EBI-3197883;
CC       Q2TAC2-2; Q96DF8: ESS2; NbExp=3; IntAct=EBI-10961624, EBI-3928124;
CC       Q2TAC2-2; O95990-4: FAM107A; NbExp=3; IntAct=EBI-10961624, EBI-11977223;
CC       Q2TAC2-2; Q3B820: FAM161A; NbExp=6; IntAct=EBI-10961624, EBI-719941;
CC       Q2TAC2-2; Q96MY7: FAM161B; NbExp=6; IntAct=EBI-10961624, EBI-7225287;
CC       Q2TAC2-2; Q86W67: FAM228A; NbExp=3; IntAct=EBI-10961624, EBI-12958227;
CC       Q2TAC2-2; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-10961624, EBI-6658203;
CC       Q2TAC2-2; P07954: FH; NbExp=3; IntAct=EBI-10961624, EBI-1050358;
CC       Q2TAC2-2; Q9NU39: FOXD4L1; NbExp=3; IntAct=EBI-10961624, EBI-11320806;
CC       Q2TAC2-2; Q9C0B1-2: FTO; NbExp=3; IntAct=EBI-10961624, EBI-18138793;
CC       Q2TAC2-2; P14136: GFAP; NbExp=3; IntAct=EBI-10961624, EBI-744302;
CC       Q2TAC2-2; O75420: GIGYF1; NbExp=3; IntAct=EBI-10961624, EBI-947774;
CC       Q2TAC2-2; Q86WP2: GPBP1; NbExp=3; IntAct=EBI-10961624, EBI-2349758;
CC       Q2TAC2-2; Q9HAV7: GRPEL1; NbExp=3; IntAct=EBI-10961624, EBI-1043499;
CC       Q2TAC2-2; Q7Z353: HDX; NbExp=3; IntAct=EBI-10961624, EBI-1052734;
CC       Q2TAC2-2; Q8IYA8: IHO1; NbExp=3; IntAct=EBI-10961624, EBI-8638439;
CC       Q2TAC2-2; Q9UKT9: IKZF3; NbExp=5; IntAct=EBI-10961624, EBI-747204;
CC       Q2TAC2-2; Q0VD86: INCA1; NbExp=3; IntAct=EBI-10961624, EBI-6509505;
CC       Q2TAC2-2; Q9H0H0: INTS2; NbExp=3; IntAct=EBI-10961624, EBI-8471507;
CC       Q2TAC2-2; O75564-2: JRK; NbExp=3; IntAct=EBI-10961624, EBI-17181882;
CC       Q2TAC2-2; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-10961624, EBI-2556193;
CC       Q2TAC2-2; Q6ZU52: KIAA0408; NbExp=3; IntAct=EBI-10961624, EBI-739493;
CC       Q2TAC2-2; Q13351: KLF1; NbExp=3; IntAct=EBI-10961624, EBI-8284732;
CC       Q2TAC2-2; Q9UIH9: KLF15; NbExp=3; IntAct=EBI-10961624, EBI-2796400;
CC       Q2TAC2-2; Q5T749: KPRP; NbExp=3; IntAct=EBI-10961624, EBI-10981970;
CC       Q2TAC2-2; P19013: KRT4; NbExp=3; IntAct=EBI-10961624, EBI-2371606;
CC       Q2TAC2-2; Q01546: KRT76; NbExp=3; IntAct=EBI-10961624, EBI-2952745;
CC       Q2TAC2-2; Q52LG2: KRTAP13-2; NbExp=3; IntAct=EBI-10961624, EBI-11953846;
CC       Q2TAC2-2; Q3SY46: KRTAP13-3; NbExp=3; IntAct=EBI-10961624, EBI-10241252;
CC       Q2TAC2-2; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-10961624, EBI-726510;
CC       Q2TAC2-2; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-10961624, EBI-1216080;
CC       Q2TAC2-2; Q9Y6D9: MAD1L1; NbExp=3; IntAct=EBI-10961624, EBI-742610;
CC       Q2TAC2-2; Q8TC05: MDM1; NbExp=3; IntAct=EBI-10961624, EBI-3951677;
CC       Q2TAC2-2; P04732: MT1E; NbExp=3; IntAct=EBI-10961624, EBI-12310079;
CC       Q2TAC2-2; Q8TDC0: MYOZ3; NbExp=3; IntAct=EBI-10961624, EBI-5662487;
CC       Q2TAC2-2; Q15742: NAB2; NbExp=3; IntAct=EBI-10961624, EBI-8641936;
CC       Q2TAC2-2; O00746: NME4; NbExp=5; IntAct=EBI-10961624, EBI-744871;
CC       Q2TAC2-2; Q9P286: PAK5; NbExp=3; IntAct=EBI-10961624, EBI-741896;
CC       Q2TAC2-2; Q96HA1-2: POM121; NbExp=3; IntAct=EBI-10961624, EBI-11956563;
CC       Q2TAC2-2; Q96QH2: PRAM1; NbExp=3; IntAct=EBI-10961624, EBI-2860740;
CC       Q2TAC2-2; Q9NQX0: PRDM6; NbExp=3; IntAct=EBI-10961624, EBI-11320284;
CC       Q2TAC2-2; Q2NL68: PROSER3; NbExp=3; IntAct=EBI-10961624, EBI-11336487;
CC       Q2TAC2-2; Q99633: PRPF18; NbExp=3; IntAct=EBI-10961624, EBI-2798416;
CC       Q2TAC2-2; Q8WWY3: PRPF31; NbExp=6; IntAct=EBI-10961624, EBI-1567797;
CC       Q2TAC2-2; P28070: PSMB4; NbExp=3; IntAct=EBI-10961624, EBI-603350;
CC       Q2TAC2-2; Q3KNS1: PTCHD3; NbExp=3; IntAct=EBI-10961624, EBI-2860313;
CC       Q2TAC2-2; Q9Y272: RASD1; NbExp=3; IntAct=EBI-10961624, EBI-740818;
CC       Q2TAC2-2; Q5RL73: RBM48; NbExp=3; IntAct=EBI-10961624, EBI-473821;
CC       Q2TAC2-2; Q8NG50: RDM1; NbExp=5; IntAct=EBI-10961624, EBI-10288724;
CC       Q2TAC2-2; Q6NUQ1: RINT1; NbExp=3; IntAct=EBI-10961624, EBI-726876;
CC       Q2TAC2-2; A0A0S2Z4G9: RNF6; NbExp=3; IntAct=EBI-10961624, EBI-16428950;
CC       Q2TAC2-2; Q96HH0: ROBO3; NbExp=3; IntAct=EBI-10961624, EBI-10288358;
CC       Q2TAC2-2; Q9BVN2: RUSC1; NbExp=3; IntAct=EBI-10961624, EBI-6257312;
CC       Q2TAC2-2; Q7Z5V6-2: SAXO4; NbExp=3; IntAct=EBI-10961624, EBI-12000762;
CC       Q2TAC2-2; Q96B97: SH3KBP1; NbExp=3; IntAct=EBI-10961624, EBI-346595;
CC       Q2TAC2-2; Q6ZSJ9: SHISA6; NbExp=3; IntAct=EBI-10961624, EBI-12037847;
CC       Q2TAC2-2; Q6ZT89-3: SLC25A48; NbExp=3; IntAct=EBI-10961624, EBI-12065614;
CC       Q2TAC2-2; Q9H0W8: SMG9; NbExp=3; IntAct=EBI-10961624, EBI-2872322;
CC       Q2TAC2-2; Q16560-2: SNRNP35; NbExp=3; IntAct=EBI-10961624, EBI-12938570;
CC       Q2TAC2-2; O60504: SORBS3; NbExp=3; IntAct=EBI-10961624, EBI-741237;
CC       Q2TAC2-2; Q96LM5: SPMIP2; NbExp=3; IntAct=EBI-10961624, EBI-12020542;
CC       Q2TAC2-2; Q8NCR6: SPMIP6; NbExp=3; IntAct=EBI-10961624, EBI-10269322;
CC       Q2TAC2-2; O43609: SPRY1; NbExp=3; IntAct=EBI-10961624, EBI-3866665;
CC       Q2TAC2-2; Q5T7P8-2: SYT6; NbExp=3; IntAct=EBI-10961624, EBI-10246152;
CC       Q2TAC2-2; Q8TDR4: TCP10L; NbExp=3; IntAct=EBI-10961624, EBI-3923210;
CC       Q2TAC2-2; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-10961624, EBI-1105213;
CC       Q2TAC2-2; P0C1Z6: TFPT; NbExp=3; IntAct=EBI-10961624, EBI-1245626;
CC       Q2TAC2-2; O43615: TIMM44; NbExp=3; IntAct=EBI-10961624, EBI-861737;
CC       Q2TAC2-2; Q9NV29: TMEM100; NbExp=3; IntAct=EBI-10961624, EBI-8644968;
CC       Q2TAC2-2; P19237: TNNI1; NbExp=3; IntAct=EBI-10961624, EBI-746692;
CC       Q2TAC2-2; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-10961624, EBI-11952721;
CC       Q2TAC2-2; Q14142: TRIM14; NbExp=3; IntAct=EBI-10961624, EBI-2820256;
CC       Q2TAC2-2; Q14134: TRIM29; NbExp=6; IntAct=EBI-10961624, EBI-702370;
CC       Q2TAC2-2; Q7Z6J9: TSEN54; NbExp=3; IntAct=EBI-10961624, EBI-2559824;
CC       Q2TAC2-2; Q3SY00: TSGA10IP; NbExp=3; IntAct=EBI-10961624, EBI-10241197;
CC       Q2TAC2-2; Q9NRE2: TSHZ2; NbExp=3; IntAct=EBI-10961624, EBI-10687282;
CC       Q2TAC2-2; P40222: TXLNA; NbExp=3; IntAct=EBI-10961624, EBI-359793;
CC       Q2TAC2-2; Q8N1B4: VPS52; NbExp=3; IntAct=EBI-10961624, EBI-2799833;
CC       Q2TAC2-2; Q9BW85: YJU2; NbExp=3; IntAct=EBI-10961624, EBI-10300345;
CC       Q2TAC2-2; Q9P1Z0: ZBTB4; NbExp=3; IntAct=EBI-10961624, EBI-2564133;
CC       Q2TAC2-2; Q53FD0-2: ZC2HC1C; NbExp=3; IntAct=EBI-10961624, EBI-14104088;
CC       Q2TAC2-2; Q8N5A5-2: ZGPAT; NbExp=3; IntAct=EBI-10961624, EBI-10183064;
CC       Q2TAC2-2; Q9C0F3: ZNF436; NbExp=3; IntAct=EBI-10961624, EBI-8489702;
CC       Q2TAC2-2; Q6S9Z5: ZNF474; NbExp=3; IntAct=EBI-10961624, EBI-17269964;
CC       Q2TAC2-2; Q9H707: ZNF552; NbExp=3; IntAct=EBI-10961624, EBI-2555731;
CC       Q2TAC2-2; Q5T619: ZNF648; NbExp=3; IntAct=EBI-10961624, EBI-11985915;
CC       Q2TAC2-2; Q8N720: ZNF655; NbExp=3; IntAct=EBI-10961624, EBI-625509;
CC       Q2TAC2-2; A0A0S2Z5X4: ZNF688; NbExp=3; IntAct=EBI-10961624, EBI-16429014;
CC       Q2TAC2-2; Q9Y2P0: ZNF835; NbExp=3; IntAct=EBI-10961624, EBI-5667516;
CC       Q2TAC2-2; Q96MP5: ZSWIM3; NbExp=3; IntAct=EBI-10961624, EBI-5235554;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:32402286}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome, centriolar
CC       satellite {ECO:0000269|PubMed:32402286}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome, centriole
CC       {ECO:0000269|PubMed:32402286}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:32402286}. Note=Localizes to resolvable rings at
CC       the proximal end of centrioles (PubMed:32402286). In mitotic cells,
CC       localizes to spindle microtubules during metaphase (PubMed:32402286).
CC       {ECO:0000269|PubMed:32402286}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q2TAC2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2TAC2-2; Sequence=VSP_025802, VSP_025803;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI10998.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=EAW89746.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC129510; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC132872; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135056; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471099; EAW89746.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC040264; AAH40264.1; -; mRNA.
DR   EMBL; BC110997; AAI10998.1; ALT_SEQ; mRNA.
DR   EMBL; AK074059; BAB84885.1; -; mRNA.
DR   CCDS; CCDS11803.1; -. [Q2TAC2-2]
DR   CCDS; CCDS92419.1; -. [Q2TAC2-1]
DR   RefSeq; NP_001303250.1; NM_001316321.3. [Q2TAC2-2]
DR   RefSeq; NP_932348.2; NM_198082.4. [Q2TAC2-1]
DR   AlphaFoldDB; Q2TAC2; -.
DR   SMR; Q2TAC2; -.
DR   BioGRID; 129725; 170.
DR   IntAct; Q2TAC2; 154.
DR   STRING; 9606.ENSP00000376154; -.
DR   GlyCosmos; Q2TAC2; 2 sites, 1 glycan.
DR   GlyGen; Q2TAC2; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; Q2TAC2; -.
DR   PhosphoSitePlus; Q2TAC2; -.
DR   BioMuta; CCDC57; -.
DR   DMDM; 317373337; -.
DR   jPOST; Q2TAC2; -.
DR   MassIVE; Q2TAC2; -.
DR   PaxDb; 9606-ENSP00000374292; -.
DR   PeptideAtlas; Q2TAC2; -.
DR   ProteomicsDB; 61457; -. [Q2TAC2-1]
DR   ProteomicsDB; 61458; -. [Q2TAC2-2]
DR   TopDownProteomics; Q2TAC2-1; -. [Q2TAC2-1]
DR   Antibodypedia; 19887; 60 antibodies from 11 providers.
DR   DNASU; 284001; -.
DR   Ensembl; ENST00000389641.9; ENSP00000374292.5; ENSG00000176155.21. [Q2TAC2-1]
DR   Ensembl; ENST00000392343.3; ENSP00000376154.3; ENSG00000176155.21. [Q2TAC2-2]
DR   GeneID; 284001; -.
DR   KEGG; hsa:284001; -.
DR   UCSC; uc002kdz.2; human. [Q2TAC2-1]
DR   AGR; HGNC:27564; -.
DR   CTD; 284001; -.
DR   DisGeNET; 284001; -.
DR   GeneCards; CCDC57; -.
DR   HGNC; HGNC:27564; CCDC57.
DR   HPA; ENSG00000176155; Low tissue specificity.
DR   neXtProt; NX_Q2TAC2; -.
DR   OpenTargets; ENSG00000176155; -.
DR   PharmGKB; PA142672173; -.
DR   VEuPathDB; HostDB:ENSG00000176155; -.
DR   eggNOG; ENOG502QSW3; Eukaryota.
DR   GeneTree; ENSGT00940000153251; -.
DR   HOGENOM; CLU_011424_1_0_1; -.
DR   InParanoid; Q2TAC2; -.
DR   OrthoDB; 568502at2759; -.
DR   PhylomeDB; Q2TAC2; -.
DR   TreeFam; TF333001; -.
DR   PathwayCommons; Q2TAC2; -.
DR   SignaLink; Q2TAC2; -.
DR   BioGRID-ORCS; 284001; 9 hits in 318 CRISPR screens.
DR   ChiTaRS; CCDC57; human.
DR   GeneWiki; CCDC57; -.
DR   GenomeRNAi; 284001; -.
DR   Pharos; Q2TAC2; Tdark.
DR   PRO; PR:Q2TAC2; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q2TAC2; protein.
DR   Bgee; ENSG00000176155; Expressed in right uterine tube and 130 other cell types or tissues.
DR   ExpressionAtlas; Q2TAC2; baseline and differential.
DR   GO; GO:0034451; C:centriolar satellite; IDA:UniProtKB.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0005876; C:spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0007099; P:centriole replication; IDA:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; IDA:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0007020; P:microtubule nucleation; IDA:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IDA:UniProtKB.
DR   InterPro; IPR042481; CCDC57.
DR   PANTHER; PTHR46725; COILED-COIL DOMAIN-CONTAINING PROTEIN 57; 1.
DR   PANTHER; PTHR46725:SF1; COILED-COIL DOMAIN-CONTAINING PROTEIN 57; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..915
FT                   /note="Coiled-coil domain-containing protein 57"
FT                   /id="PRO_0000288871"
FT   REGION          1..502
FT                   /note="Centrosomal targeting domain"
FT                   /evidence="ECO:0000269|PubMed:32402286"
FT   REGION          555..574
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          606..915
FT                   /note="Microtubule binding domain"
FT                   /evidence="ECO:0000269|PubMed:32402286"
FT   REGION          606..653
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          724..915
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          92..173
FT                   /evidence="ECO:0000255"
FT   COILED          214..422
FT                   /evidence="ECO:0000255"
FT   COILED          456..483
FT                   /evidence="ECO:0000255"
FT   COILED          521..548
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        613..627
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        628..652
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        745..758
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        781..794
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        819..830
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        841..852
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        879..891
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         748..751
FT                   /note="DAKS -> VGAR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12693554,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_025802"
FT   VAR_SEQ         752..915
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12693554,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_025803"
FT   VARIANT         237
FT                   /note="E -> Q (in dbSNP:rs34543170)"
FT                   /id="VAR_032516"
FT   VARIANT         321
FT                   /note="Q -> R (in dbSNP:rs7406116)"
FT                   /id="VAR_032517"
FT   VARIANT         480
FT                   /note="V -> M (in dbSNP:rs7209474)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_032518"
FT   VARIANT         774
FT                   /note="R -> G (in dbSNP:rs4625783)"
FT                   /id="VAR_032519"
FT   VARIANT         776
FT                   /note="D -> N (in dbSNP:rs7406163)"
FT                   /id="VAR_032520"
FT   VARIANT         777
FT                   /note="A -> T (in dbSNP:rs7406162)"
FT                   /id="VAR_032521"
FT   VARIANT         810
FT                   /note="Q -> K (in dbSNP:rs7213172)"
FT                   /id="VAR_032522"
FT   VARIANT         833
FT                   /note="M -> T (in dbSNP:rs11077969)"
FT                   /id="VAR_032523"
FT   CONFLICT        458
FT                   /note="Q -> K (in Ref. 4; BAB84885)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   915 AA;  103039 MW;  EACE3433538F7FC2 CRC64;
     MLPLGSEPAL NELLLRKEEE WRALQAHRTQ LQEAALQDTR SQLEEAQGKL RCLQEDFVYN
     LQVLEERDLE LERYDAAFAQ AREWEEARRA EVSELKIEAA KLRQALAREA RKVEELQQQQ
     QLAFQEHRLE LERVHSDKNG EIDHHREQYE NLKWTLERKL EELDGELALQ RQELLLEFES
     KMRKREHEFR LQADNMSNTA LSRELKVKLL HKELEALKEA GAKAAESLQR AEATNAELER
     KLQSRAGELQ DLEAMSRARV KDLEDKLHSV QLTRKKEEET FKRKHEELDR LAREKDAVLV
     AVKGAHVEQL QELQTRVLEL QAHCETLEAQ LRRAEWRQAD TAKEKDAAID QLREDASTVK
     SAWDAQIAQL SKEMVSRDLQ IQTLQEEEVK LKAQVARSQQ DIERYKQQLS LAVERERSLE
     RDQVQLGLDW QRRCDDIERD QIQKSEALIQ GLSMAKSQVA AKLQETEQAL QEQEVVLKAV
     TLERDQAVQA LRMHGLPRPG AQMLLRQHEE EISKDFPSSE IQRLREQNTS LRNAIAQMRK
     EMEALSHQIP PPIQTAAEST DANQPDPEAG GDAATPDYVL ALEAEIRTLK HKFKTLEKHL
     EDVLDPLKMS SPHAESQPSV RTSTETTGGS AQAGQAGGSV QAGQAGGSVQ AGPVSSGLAL
     RKLGDRVQLL NLLVTRLRQK VLREPLEPAA LQRELPREVD QVHLEVLELR KQVAELGKHL
     RIAQHGGAEP SGRKQPPASD AVALGREDAK SAEDEAPSRH LGKHQPRSAQ VGSRLDALQG
     PKTQHSIHTV TCKSPRQKED RSPKPPQAPQ HPEEHGRQSH SSSSFASGTL QDMWRLLDLG
     SSPSGVTSQG DSTPELPAPP AADRRPVKMQ AGIATPGMKT AAQAKAKTTG ASRSHPAKAK
     GCQRPPKIRN YNIMD
//
ID   HMSDV_HUMAN             Reviewed;          53 AA.
AC   P0C7T4;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 1.
DT   05-FEB-2025, entry version 75.
DE   RecName: Full=Minor histocompatibility protein HMSD variant form;
DE            Short=HSMD-v;
DE   Contains:
DE     RecName: Full=Minor histocompatibility antigen ACC-6;
DE              Short=mHA ACC-6;
GN   Name=HMSD; Synonyms=C18orf53;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBUNIT, TISSUE SPECIFICITY, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=17409267; DOI=10.1182/blood-2007-02-075911;
RA   Kawase T., Akatsuka Y., Torikai H., Morishima S., Oka A., Tsujimura A.,
RA   Miyazaki M., Tsujimura K., Miyamura K., Ogawa S., Inoko H., Morishima Y.,
RA   Kodera Y., Kuzushima K., Takahashi T.;
RT   "Alternative splicing due to an intronic SNP in HMSD generates a novel
RT   minor histocompatibility antigen.";
RL   Blood 110:1055-1063(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: This splice variant of HMSD is the precursor of the
CC       histocompatibility antigen ACC-6. More generally, minor
CC       histocompatibility antigens (mHags) refer to immunogenic peptide which,
CC       when complexed with MHC, can generate an immune response after
CC       recognition by specific T-cells. The peptides are derived from
CC       polymorphic intracellular proteins, which are cleaved by normal
CC       pathways of antigen processing. The binding of these peptides to MHC
CC       class I or class II molecules and its expression on the cell surface
CC       can stimulate T-cell responses and thereby trigger graft rejection or
CC       graft-versus-host disease (GVHD) after hematopoietic stem cell
CC       transplantation from HLA-identical sibling donor. GVHD is a frequent
CC       complication after bone marrow transplantation (BMT), due to mismatch
CC       of minor histocompatibility antigen in HLA-matched sibling marrow
CC       transplants. However, associated with GVHD, a favorable graft-versus-
CC       leukemia (GVL) can be induced by donor-recipient disparities in mHags.
CC       ACC-6 is presented to the cell surface by MHC HLA-B*4403. This complex
CC       specifically elicits donor-cytotoxic T-lymphocyte (CTL) reactivity
CC       against hematologic malignancies after treatment by HLA-identical
CC       allogenic BMT. It induces cell recognition and lysis by CTL.
CC       Immunogenicity of most autosomal mHags results from single-nucleotide
CC       polymorphisms that cause amino-acid substitutions within epitopes,
CC       leading to the differential recognition of peptides between donor and
CC       recipient. {ECO:0000269|PubMed:17409267}.
CC   -!- SUBUNIT: ACC-6 forms a complex with MHC HLA-B*4403.
CC       {ECO:0000269|PubMed:17409267}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2; Synonyms=HMSD-v;
CC         IsoId=P0C7T4-1; Sequence=Displayed;
CC       Name=1; Synonyms=HMSD;
CC         IsoId=A8MTL9-1; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Highly expressed in dendritic cells and primary
CC       leukemia cells, especially those of myeloid lineage. ACC-6 expression
CC       is limited to cells of the hematopoietic lineage.
CC       {ECO:0000269|PubMed:17409267}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC009802; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471096; EAW63164.1; -; Genomic_DNA.
DR   AlphaFoldDB; P0C7T4; -.
DR   SMR; P0C7T4; -.
DR   BioMuta; HMSD; -.
DR   MassIVE; P0C7T4; -.
DR   PeptideAtlas; P0C7T4; -.
DR   Ensembl; ENST00000526932.1; ENSP00000431632.1; ENSG00000221887.6. [P0C7T4-1]
DR   UCSC; uc060pwo.1; human. [P0C7T4-1]
DR   AGR; HGNC:23037; -.
DR   GeneCards; HMSD; -.
DR   HGNC; HGNC:23037; HMSD.
DR   HPA; ENSG00000221887; Tissue enriched (brain).
DR   MIM; 612086; gene.
DR   neXtProt; NX_P0C7T4; -.
DR   OpenTargets; ENSG00000221887; -.
DR   VEuPathDB; HostDB:ENSG00000221887; -.
DR   GeneTree; ENSGT00940000154519; -.
DR   HOGENOM; CLU_3067960_0_0_1; -.
DR   OrthoDB; 9681056at2759; -.
DR   SignaLink; P0C7T4; -.
DR   ChiTaRS; HMSD; human.
DR   Pharos; P0C7T4; Tbio.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000221887; Expressed in C1 segment of cervical spinal cord and 95 other cell types or tissues.
DR   ExpressionAtlas; P0C7T4; baseline and differential.
DR   GO; GO:0002253; P:activation of immune response; IMP:UniProtKB.
DR   GO; GO:0019835; P:cytolysis; IMP:UniProtKB.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; IMP:UniProtKB.
PE   1: Evidence at protein level;
KW   Alternative splicing; Reference proteome.
FT   CHAIN           1..53
FT                   /note="Minor histocompatibility protein HMSD variant form"
FT                   /id="PRO_0000343869"
FT   PEPTIDE         1..11
FT                   /note="Minor histocompatibility antigen ACC-6"
FT                   /id="PRO_0000343870"
SQ   SEQUENCE   53 AA;  6023 MW;  3B10E476A2B5AF53 CRC64;
     MEIFIEVFSH FLLQLTELTL NMCLELPTGS LEKSLMISSQ VLQIPVANST KQR
//
ID   JOS2_HUMAN              Reviewed;         188 AA.
AC   Q8TAC2; M0QX25;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   09-APR-2025, entry version 153.
DE   RecName: Full=Josephin-2;
DE            EC=3.4.19.12;
DE   AltName: Full=Josephin domain-containing protein 2;
GN   Name=JOSD2; ORFNames=SBBI54;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li N., Wan T., Zhang W., Cao X.;
RT   "Hypothetical transmembrane protein SBBI54.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Macrophage;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=17696782; DOI=10.1515/bc.2007.107;
RA   Tzvetkov N., Breuer P.;
RT   "Josephin domain-containing proteins from a variety of species are active
RT   de-ubiquitination enzymes.";
RL   Biol. Chem. 388:973-978(2007).
RN   [7]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=21118805; DOI=10.1074/jbc.m110.177360;
RA   Weeks S.D., Grasty K.C., Hernandez-Cuebas L., Loll P.J.;
RT   "Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints
RT   on ataxin-3 deubiquitinating activity.";
RL   J. Biol. Chem. 286:4555-4565(2011).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF CYS-24.
RX   PubMed=23625928; DOI=10.1074/jbc.m113.463406;
RA   Seki T., Gong L., Williams A.J., Sakai N., Todi S.V., Paulson H.L.;
RT   "JosD1, a membrane-targeted deubiquitinating enzyme, is activated by
RT   ubiquitination and regulates membrane dynamics, cell motility, and
RT   endocytosis.";
RL   J. Biol. Chem. 288:17145-17155(2013).
RN   [9]
RP   3D-STRUCTURE MODELING.
RX   PubMed=12486728; DOI=10.1002/prot.10280;
RA   Albrecht M., Hoffmann D., Evert B.O., Schmitt I., Wuellner U., Lengauer T.;
RT   "Structural modeling of ataxin-3 reveals distant homology to adaptins.";
RL   Proteins 50:355-370(2003).
CC   -!- FUNCTION: Cleaves 'Lys-63'-linked poly-ubiquitin chains, and with
CC       lesser efficiency 'Lys-48'-linked poly-ubiquitin chains (in vitro). May
CC       act as a deubiquitinating enzyme. {ECO:0000269|PubMed:17696782,
CC       ECO:0000269|PubMed:21118805, ECO:0000269|PubMed:23625928}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:17696782,
CC         ECO:0000269|PubMed:21118805};
CC   -!- INTERACTION:
CC       Q8TAC2; O43865: AHCYL1; NbExp=5; IntAct=EBI-12205593, EBI-2371423;
CC       Q8TAC2; Q96DZ9-2: CMTM5; NbExp=3; IntAct=EBI-12205593, EBI-11522780;
CC       Q8TAC2; Q8NI60: COQ8A; NbExp=3; IntAct=EBI-12205593, EBI-745535;
CC       Q8TAC2; Q9Y680: FKBP7; NbExp=3; IntAct=EBI-12205593, EBI-3918971;
CC       Q8TAC2; Q8IX19: MCEMP1; NbExp=2; IntAct=EBI-12205593, EBI-2816356;
CC       Q8TAC2; P21741: MDK; NbExp=3; IntAct=EBI-12205593, EBI-722444;
CC       Q8TAC2; Q9UBC9: SPRR3; NbExp=2; IntAct=EBI-12205593, EBI-355179;
CC       Q8TAC2; P08247: SYP; NbExp=3; IntAct=EBI-12205593, EBI-9071725;
CC       Q8TAC2; P0DI81-3: TRAPPC2; NbExp=3; IntAct=EBI-12205593, EBI-11961968;
CC       Q8TAC2; P49638: TTPA; NbExp=3; IntAct=EBI-12205593, EBI-10210710;
CC       Q8TAC2; O95070: YIF1A; NbExp=3; IntAct=EBI-12205593, EBI-2799703;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:23625928}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TAC2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TAC2-2; Sequence=VSP_047537;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF247787; AAL95692.1; -; mRNA.
DR   EMBL; AK131052; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC008743; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471135; EAW71877.1; -; Genomic_DNA.
DR   EMBL; BC062416; AAH62416.1; -; mRNA.
DR   CCDS; CCDS12797.1; -. [Q8TAC2-1]
DR   CCDS; CCDS59413.1; -. [Q8TAC2-2]
DR   RefSeq; NP_001257568.1; NM_001270639.2. [Q8TAC2-1]
DR   RefSeq; NP_001257569.1; NM_001270640.2. [Q8TAC2-1]
DR   RefSeq; NP_001257570.1; NM_001270641.2. [Q8TAC2-2]
DR   RefSeq; NP_001257615.1; NM_001270686.2. [Q8TAC2-1]
DR   RefSeq; NP_612207.1; NM_138334.4. [Q8TAC2-1]
DR   RefSeq; XP_011524736.1; XM_011526434.2.
DR   PDB; 6PGV; X-ray; 2.30 A; A=1-188.
DR   PDBsum; 6PGV; -.
DR   AlphaFoldDB; Q8TAC2; -.
DR   SMR; Q8TAC2; -.
DR   BioGRID; 125956; 39.
DR   IntAct; Q8TAC2; 22.
DR   STRING; 9606.ENSP00000468956; -.
DR   BindingDB; Q8TAC2; -.
DR   ChEMBL; CHEMBL4630845; -.
DR   MEROPS; C86.005; -.
DR   GlyGen; Q8TAC2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8TAC2; -.
DR   PhosphoSitePlus; Q8TAC2; -.
DR   BioMuta; JOSD2; -.
DR   DMDM; 29840785; -.
DR   jPOST; Q8TAC2; -.
DR   MassIVE; Q8TAC2; -.
DR   PaxDb; 9606-ENSP00000468956; -.
DR   PeptideAtlas; Q8TAC2; -.
DR   ProteomicsDB; 73855; -. [Q8TAC2-1]
DR   Pumba; Q8TAC2; -.
DR   TopDownProteomics; Q8TAC2-1; -. [Q8TAC2-1]
DR   Antibodypedia; 53685; 113 antibodies from 19 providers.
DR   DNASU; 126119; -.
DR   Ensembl; ENST00000595669.5; ENSP00000468860.1; ENSG00000161677.12. [Q8TAC2-2]
DR   Ensembl; ENST00000598418.6; ENSP00000468956.2; ENSG00000161677.12. [Q8TAC2-1]
DR   Ensembl; ENST00000601423.5; ENSP00000472116.1; ENSG00000161677.12. [Q8TAC2-1]
DR   GeneID; 126119; -.
DR   KEGG; hsa:126119; -.
DR   MANE-Select; ENST00000598418.6; ENSP00000468956.2; NM_001270639.2; NP_001257568.1.
DR   UCSC; uc002pso.3; human. [Q8TAC2-1]
DR   AGR; HGNC:28853; -.
DR   CTD; 126119; -.
DR   DisGeNET; 126119; -.
DR   GeneCards; JOSD2; -.
DR   HGNC; HGNC:28853; JOSD2.
DR   HPA; ENSG00000161677; Low tissue specificity.
DR   MIM; 615324; gene.
DR   neXtProt; NX_Q8TAC2; -.
DR   OpenTargets; ENSG00000161677; -.
DR   PharmGKB; PA142671645; -.
DR   VEuPathDB; HostDB:ENSG00000161677; -.
DR   eggNOG; KOG2934; Eukaryota.
DR   GeneTree; ENSGT00390000009228; -.
DR   HOGENOM; CLU_103892_2_0_1; -.
DR   InParanoid; Q8TAC2; -.
DR   OMA; QRNCEAV; -.
DR   OrthoDB; 422700at2759; -.
DR   PhylomeDB; Q8TAC2; -.
DR   TreeFam; TF313660; -.
DR   PathwayCommons; Q8TAC2; -.
DR   Reactome; R-HSA-5689877; Josephin domain DUBs.
DR   SignaLink; Q8TAC2; -.
DR   BioGRID-ORCS; 126119; 17 hits in 1190 CRISPR screens.
DR   ChiTaRS; JOSD2; human.
DR   GenomeRNAi; 126119; -.
DR   Pharos; Q8TAC2; Tbio.
DR   PRO; PR:Q8TAC2; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8TAC2; protein.
DR   Bgee; ENSG00000161677; Expressed in C1 segment of cervical spinal cord and 159 other cell types or tissues.
DR   ExpressionAtlas; Q8TAC2; baseline and differential.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004843; F:cysteine-type deubiquitinase activity; IDA:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   FunFam; 3.90.70.40:FF:000003; josephin-2 isoform X1; 1.
DR   Gene3D; 3.90.70.40; -; 1.
DR   InterPro; IPR040053; JOSD1/2.
DR   InterPro; IPR006155; Josephin.
DR   PANTHER; PTHR13291; JOSEPHIN 1, 2; 1.
DR   PANTHER; PTHR13291:SF2; JOSEPHIN-2; 1.
DR   Pfam; PF02099; Josephin; 1.
DR   PRINTS; PR01233; JOSEPHIN.
DR   SMART; SM01246; Josephin; 1.
DR   PROSITE; PS50957; JOSEPHIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytoplasm; Hydrolase; Protease;
KW   Proteomics identification; Reference proteome; Ubl conjugation pathway.
FT   CHAIN           1..188
FT                   /note="Josephin-2"
FT                   /id="PRO_0000053843"
FT   DOMAIN          11..188
FT                   /note="Josephin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00331"
FT   ACT_SITE        24
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00331"
FT   ACT_SITE        125
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00331"
FT   VAR_SEQ         49..90
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047537"
FT   MUTAGEN         24
FT                   /note="C->A: Loss of deubiquitination activity, no change
FT                   in subcellular location."
FT                   /evidence="ECO:0000269|PubMed:23625928"
FT   HELIX           24..33
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   HELIX           40..49
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   HELIX           70..78
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   TURN            79..81
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   STRAND          82..86
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   HELIX           93..95
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   HELIX           98..100
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   STRAND          102..109
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   STRAND          124..132
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   STRAND          135..138
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   STRAND          147..151
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   HELIX           152..165
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   STRAND          169..175
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   HELIX           176..181
FT                   /evidence="ECO:0007829|PDB:6PGV"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:6PGV"
SQ   SEQUENCE   188 AA;  20756 MW;  A2832B4D9BD675E9 CRC64;
     MSQAPGAQPS PPTVYHERQR LELCAVHALN NVLQQQLFSQ EAADEICKRL APDSRLNPHR
     SLLGTGNYDV NVIMAALQGL GLAAVWWDRR RPLSQLALPQ VLGLILNLPS PVSLGLLSLP
     LRRRHWVALR QVDGVYYNLD SKLRAPEALG DEDGVRAFLA AALAQGLCEV LLVVTKEVEE
     KGSWLRTD
//
ID   A0A0U1RQV1_HUMAN        Unreviewed;       116 AA.
AC   A0A0U1RQV1;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   02-APR-2025, entry version 34.
DE   SubName: Full=Endogenous retrovirus group K3 member 1 {ECO:0000313|Ensembl:ENSP00000489180.1};
DE   Flags: Fragment;
GN   Name=ERVK3-1 {ECO:0000313|Ensembl:ENSP00000489180.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000489180.1, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000489180.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000489180.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A., Terry A., Schmutz J., Lamerdin J.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3] {ECO:0000313|Ensembl:ENSP00000489180.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000489180.1}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC010642; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020915; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; A0A0U1RQV1; -.
DR   STRING; 9606.ENSP00000489180; -.
DR   BioMuta; ENSG00000142396; -.
DR   MassIVE; A0A0U1RQV1; -.
DR   PeptideAtlas; A0A0U1RQV1; -.
DR   Ensembl; ENST00000610038.5; ENSP00000489180.1; ENSG00000142396.11.
DR   AGR; HGNC:30466; -.
DR   GeneCards; ERVK3-1; -.
DR   HGNC; HGNC:30466; ERVK3-1.
DR   VEuPathDB; HostDB:ENSG00000142396; -.
DR   GeneTree; ENSGT00980000201439; -.
DR   OrthoDB; 9508883at2759; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; A0A0U1RQV1; protein.
DR   Bgee; ENSG00000142396; Expressed in islet of Langerhans and 100 other cell types or tissues.
DR   ExpressionAtlas; A0A0U1RQV1; baseline and differential.
DR   Pfam; PF15695; HERV-K_REC; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0007829|PeptideAtlas:A0A0U1RQV1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER         116
FT                   /evidence="ECO:0000313|Ensembl:ENSP00000489180.1"
SQ   SEQUENCE   116 AA;  12462 MW;  B7DA6B52CB138386 CRC64;
     MLVFLQEMDK PCGCPPGVCD HGTGDRRDPW YSTVGLLPPV RAMSQRNLNA KTEQGPTGVT
     MTSNPITWGQ IKKTTQEAEK LLERQGQAKT PDSMFLAMLA VVSCASIGSG EPPTGN
//
ID   WFDC6_HUMAN             Reviewed;         131 AA.
AC   Q9BQY6; Q3MJ23; Q5JYQ4; Q8NFV6;
DT   16-JUN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   09-APR-2025, entry version 165.
DE   RecName: Full=WAP four-disulfide core domain protein 6;
DE   AltName: Full=Putative protease inhibitor WAP6;
DE   Flags: Precursor;
GN   Name=WFDC6; Synonyms=C20orf171, WAP6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=12206714; DOI=10.1042/bj20020869;
RA   Clauss A., Lilja H., Lundwall A.;
RT   "A locus on human chromosome 20 contains several genes expressing protease
RT   inhibitor domains with homology to whey acidic protein.";
RL   Biochem. J. 368:233-242(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ISOFORM 1).
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- INTERACTION:
CC       Q9BQY6-2; Q15323: KRT31; NbExp=3; IntAct=EBI-12176563, EBI-948001;
CC       Q9BQY6-2; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12176563, EBI-16439278;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BQY6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BQY6-2; Sequence=VSP_007550, VSP_007551;
CC       Name=3;
CC         IsoId=O95925-3; Sequence=External;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, but the highest levels are
CC       found in epididymis, testis and trachea.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF411861; AAN03684.1; -; mRNA.
DR   EMBL; AL031663; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC101600; AAI01601.1; -; mRNA.
DR   EMBL; BC101604; AAI01605.1; -; mRNA.
DR   CCDS; CCDS13358.1; -. [Q9BQY6-2]
DR   RefSeq; NP_543017.1; NM_080827.2. [Q9BQY6-2]
DR   AlphaFoldDB; Q9BQY6; -.
DR   SMR; Q9BQY6; -.
DR   BioGRID; 126742; 11.
DR   IntAct; Q9BQY6; 10.
DR   STRING; 9606.ENSP00000361755; -.
DR   MEROPS; I17.953; -.
DR   BioMuta; WFDC6; -.
DR   DMDM; 32130307; -.
DR   MassIVE; Q9BQY6; -.
DR   PaxDb; 9606-ENSP00000361755; -.
DR   PeptideAtlas; Q9BQY6; -.
DR   Antibodypedia; 76903; 2 antibodies from 2 providers.
DR   DNASU; 140870; -.
DR   Ensembl; ENST00000372670.8; ENSP00000361755.3; ENSG00000243543.10. [Q9BQY6-2]
DR   GeneID; 140870; -.
DR   KEGG; hsa:140870; -.
DR   MANE-Select; ENST00000372670.8; ENSP00000361755.3; NM_080827.2; NP_543017.1. [Q9BQY6-2]
DR   UCSC; uc002xos.2; human. [Q9BQY6-1]
DR   AGR; HGNC:16164; -.
DR   CTD; 140870; -.
DR   GeneCards; EPPIN-WFDC6; -.
DR   GeneCards; WFDC6; -.
DR   HGNC; HGNC:38825; EPPIN-WFDC6.
DR   HGNC; HGNC:16164; WFDC6.
DR   HPA; ENSG00000243543; Tissue enriched (epididymis).
DR   neXtProt; NX_Q9BQY6; -.
DR   OpenTargets; ENSG00000243543; -.
DR   PharmGKB; PA25714; -.
DR   VEuPathDB; HostDB:ENSG00000243543; -.
DR   eggNOG; KOG4295; Eukaryota.
DR   GeneTree; ENSGT00940000164575; -.
DR   HOGENOM; CLU_2468453_0_0_1; -.
DR   OMA; CPMDEID; -.
DR   OrthoDB; 4473401at2759; -.
DR   PhylomeDB; Q9BQY6; -.
DR   PathwayCommons; Q9BQY6; -.
DR   SignaLink; Q9BQY6; -.
DR   BioGRID-ORCS; 140870; 14 hits in 1134 CRISPR screens.
DR   ChiTaRS; WFDC6; human.
DR   GenomeRNAi; 140870; -.
DR   Pharos; Q9BQY6; Tdark.
DR   PRO; PR:Q9BQY6; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9BQY6; protein.
DR   Bgee; ENSG00000243543; Expressed in left testis and 67 other cell types or tissues.
DR   ExpressionAtlas; Q9BQY6; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   Gene3D; 4.10.75.10; Elafin-like; 1.
DR   Gene3D; 4.10.410.10; Pancreatic trypsin inhibitor Kunitz domain; 1.
DR   InterPro; IPR036645; Elafin-like_sf.
DR   InterPro; IPR002223; Kunitz_BPTI.
DR   InterPro; IPR036880; Kunitz_BPTI_sf.
DR   InterPro; IPR051388; Serpin_venom_toxin.
DR   InterPro; IPR008197; WAP_dom.
DR   PANTHER; PTHR46751; EPPIN; 1.
DR   PANTHER; PTHR46751:SF1; WAP FOUR-DISULFIDE CORE DOMAIN PROTEIN 6A; 1.
DR   Pfam; PF00014; Kunitz_BPTI; 1.
DR   Pfam; PF00095; WAP; 1.
DR   SMART; SM00131; KU; 1.
DR   SUPFAM; SSF57362; BPTI-like; 1.
DR   SUPFAM; SSF57256; Elafin-like; 1.
DR   PROSITE; PS50279; BPTI_KUNITZ_2; 1.
DR   PROSITE; PS51390; WAP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disulfide bond; Protease inhibitor;
KW   Proteomics identification; Reference proteome; Secreted;
KW   Serine protease inhibitor; Signal.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..131
FT                   /note="WAP four-disulfide core domain protein 6"
FT                   /id="PRO_0000041383"
FT   DOMAIN          26..73
FT                   /note="WAP; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00722"
FT   DOMAIN          70..128
FT                   /note="BPTI/Kunitz inhibitor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00031"
FT   DISULFID        33..61
FT                   /evidence="ECO:0000250"
FT   DISULFID        48..60
FT                   /evidence="ECO:0000250"
FT   DISULFID        54..69
FT                   /evidence="ECO:0000250"
FT   DISULFID        79..127
FT                   /evidence="ECO:0000250"
FT   DISULFID        102..123
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         75..86
FT                   /note="IYAVCHRRLAPA -> VSLTLYHKEELE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12206714,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007550"
FT   VAR_SEQ         87..131
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12206714,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_007551"
SQ   SEQUENCE   131 AA;  14626 MW;  2F6D06EF43EB7564 CRC64;
     MGLSGLLPIL VPFILLGDIQ EPGHAEGILG KPCPKIKVEC EVEEIDQCTK PRDCPENMKC
     CPFSRGKKCL DFRKIYAVCH RRLAPAWPPY HTGGTIKKTK ICSEFIYGGS QGNNNNFQTE
     AICLVTCKKY H
//
ID   MIDUO_HUMAN             Reviewed;          70 AA.
AC   L0R8F8;
DT   15-MAR-2017, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2013, sequence version 1.
DT   09-APR-2025, entry version 51.
DE   RecName: Full=Mitochondrial ribosome and complex I assembly factor AltMIEF1 {ECO:0000305|PubMed:29083303, ECO:0000305|PubMed:31666358};
DE   AltName: Full=Alternative MIEF1 protein {ECO:0000303|PubMed:29083303};
DE            Short=AltMIEF1 {ECO:0000303|PubMed:29083303};
DE   AltName: Full=MIEF1 microprotein {ECO:0000303|PubMed:30215512};
DE            Short=MIEF1-MP {ECO:0000303|PubMed:30215512};
DE   AltName: Full=alternative transcript upstream of MiD51 {ECO:0000303|PubMed:31666358};
DE            Short=AltMiD51 {ECO:0000303|PubMed:31666358};
GN   Name=MIEF1 {ECO:0000312|HGNC:HGNC:25979};
GN   Synonyms=AltMiD51 {ECO:0000303|PubMed:31666358}, AltMIEF1
GN   {ECO:0000303|PubMed:29083303};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE INITIATION (ISOFORM 2).
RX   PubMed=23950983; DOI=10.1371/journal.pone.0070698;
RA   Vanderperre B., Lucier J.-F., Motard J., Tremblay G., Vanderperre S.,
RA   Wisztorski M., Salzet M., Boisvert F.-M., Roucou X.;
RT   "Direct detection of alternative open reading frames translation products
RT   in human significantly expands the proteome.";
RL   PLoS ONE 8:E70698-E70698(2013).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   PARTIAL PROTEIN SEQUENCE, FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   12-LEU--ARG-14, AND MOTIF.
RX   PubMed=29083303; DOI=10.7554/elife.27860;
RA   Samandi S., Roy A.V., Delcourt V., Lucier J.F., Gagnon J., Beaudoin M.C.,
RA   Vanderperre B., Breton M.A., Motard J., Jacques J.F., Brunelle M.,
RA   Gagnon-Arsenault I., Fournier I., Ouangraoua A., Hunting D.J., Cohen A.A.,
RA   Landry C.R., Scott M.S., Roucou X.;
RT   "Deep transcriptome annotation enables the discovery and functional
RT   characterization of cryptic small proteins.";
RL   Elife 6:0-0(2017).
RN   [4]
RP   NOMENCLATURE.
RX   PubMed=21508961; DOI=10.1038/embor.2011.54;
RA   Palmer C.S., Osellame L.D., Laine D., Koutsopoulos O.S., Frazier A.E.,
RA   Ryan M.T.;
RT   "MiD49 and MiD51, new components of the mitochondrial fission machinery.";
RL   EMBO Rep. 12:565-573(2011).
RN   [5]
RP   ALTERNATIVE INITIATION (ISOFORM 2).
RX   PubMed=25621764; DOI=10.7554/elife.03971;
RA   Andreev D.E., O'Connor P.B., Fahey C., Kenny E.M., Terenin I.M.,
RA   Dmitriev S.E., Cormican P., Morris D.W., Shatsky I.N., Baranov P.V.;
RT   "Translation of 5' leaders is pervasive in genes resistant to eIF2
RT   repression.";
RL   Elife 4:E03971-E03971(2015).
RN   [6]
RP   IDENTIFICATION, FUNCTION, INTERACTION WITH MRPL4; MRPS27 AND NDUFAB1,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF 12-LEU--ARG-14 AND PHE-39, AND MOTIF.
RX   PubMed=30215512; DOI=10.1021/acs.biochem.8b00726;
RA   Rathore A., Chu Q., Tan D., Martinez T.F., Donaldson C.J., Diedrich J.K.,
RA   Yates J.R. III, Saghatelian A.;
RT   "MIEF1 microprotein regulates mitochondrial translation.";
RL   Biochemistry 57:5564-5575(2018).
RN   [7]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=31666358; DOI=10.1074/mcp.ra119.001784;
RA   Dibley M.G., Formosa L.E., Lyu B., Reljic B., McGann D., Muellner-Wong L.,
RA   Kraus F., Sharpe A.J., Stroud D.A., Ryan M.T.;
RT   "The mitochondrial acyl-carrier protein interaction network highlights
RT   important roles for LYRM family members in complex I and mitoribosome
RT   assembly.";
RL   Mol. Cell. Proteomics 19:65-77(2020).
RN   [8] {ECO:0007744|PDB:5OOL, ECO:0007744|PDB:5OOM}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.03 ANGSTROMS), IDENTIFICATION BY MASS
RP   SPECTROMETRY, FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=28892042; DOI=10.1038/nsmb.3464;
RA   Brown A., Rathore S., Kimanius D., Aibara S., Bai X.C., Rorbach J.,
RA   Amunts A., Ramakrishnan V.;
RT   "Structures of the human mitochondrial ribosome in native states of
RT   assembly.";
RL   Nat. Struct. Mol. Biol. 24:866-869(2017).
RN   [9] {ECO:0007744|PDB:7QH6, ECO:0007744|PDB:7QH7}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.9 ANGSTROMS) IN COMPLEX WITH MTLSU, AND
RP   SUBUNIT.
RX   PubMed=35177605; DOI=10.1038/s41467-022-28503-5;
RA   Rebelo-Guiomar P., Pellegrino S., Dent K.C., Sas-Chen A.,
RA   Miller-Fleming L., Garone C., Van Haute L., Rogan J.F., Dinan A.,
RA   Firth A.E., Andrews B., Whitworth A.J., Schwartz S., Warren A.J.,
RA   Minczuk M.;
RT   "A late-stage assembly checkpoint of the human mitochondrial ribosome large
RT   subunit.";
RL   Nat. Commun. 13:929-929(2022).
CC   -!- FUNCTION: Assembly factor involved in the biogenesis of the
CC       mitochondrial-specific ribosomes (mitoribosomes) (PubMed:28892042,
CC       PubMed:30215512, PubMed:31666358). Specifically associates with
CC       intermediates of the mitochondrial ribosome large subunit (mt-LSU) and
CC       is required for proper ribosome assembly, possibly preventing premature
CC       association of the large and small ribosomal subunits (PubMed:28892042,
CC       PubMed:30215512, PubMed:31666358). Thereby, indirectly regulates
CC       mitochondrial translation (PubMed:28892042, PubMed:30215512,
CC       PubMed:31666358). It is also required for complete assembly of the
CC       mitochondrial respiratory chain complex I (PubMed:31666358). May also
CC       function in DNM1L-mediated mitochondrial fission (PubMed:29083303).
CC       {ECO:0000269|PubMed:28892042, ECO:0000269|PubMed:29083303,
CC       ECO:0000269|PubMed:30215512, ECO:0000269|PubMed:31666358}.
CC   -!- SUBUNIT: Interacts with intermediates of the mitochondrial ribosome
CC       large subunit (mt-LSU) (via MALSU1 as part of a complex that also
CC       contains NDUFAB1); regulates mitochondrial ribosomes assembly
CC       (PubMed:28892042, PubMed:30215512, PubMed:31666358, PubMed:35177605).
CC       Interacts with MRPL4 (PubMed:30215512). Interacts with MRPS27
CC       (PubMed:30215512). {ECO:0000269|PubMed:28892042,
CC       ECO:0000269|PubMed:30215512, ECO:0000269|PubMed:31666358,
CC       ECO:0000269|PubMed:35177605}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:28892042, ECO:0000269|PubMed:29083303,
CC       ECO:0000269|PubMed:30215512}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=3;
CC       Name=3; Synonyms=uORF {ECO:0000303|PubMed:25621764}, AltMIEF1
CC       {ECO:0000303|PubMed:29083303}, AltMiD51 {ECO:0000303|PubMed:31666358};
CC         IsoId=L0R8F8-1; Sequence=Displayed;
CC       Name=1; Synonyms=MID51 {ECO:0000303|PubMed:21508961};
CC         IsoId=Q9NQG6-1; Sequence=External;
CC       Name=2;
CC         IsoId=Q9NQG6-2; Sequence=External;
CC   -!- DOMAIN: The LYR motif mediates interaction with NDUFAB1 and is required
CC       for the function in mitochondrial fission.
CC       {ECO:0000269|PubMed:29083303, ECO:0000269|PubMed:30215512}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Product of an upstream open reading frame
CC       of the MIEF1 bicistronic gene. {ECO:0000305|PubMed:25621764}.
CC   -!- SIMILARITY: Belongs to the complex I LYR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL022312; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; HF548110; CCO13821.1; -; Genomic_DNA.
DR   PDB; 5OOL; EM; 3.06 A; v=1-70.
DR   PDB; 5OOM; EM; 3.03 A; v=1-70.
DR   PDB; 7A5H; EM; 3.30 A; v=1-70.
DR   PDB; 7A5J; EM; 3.10 A; v=1-70.
DR   PDB; 7O9K; EM; 3.10 A; v=1-70.
DR   PDB; 7O9M; EM; 2.50 A; v=1-70.
DR   PDB; 7ODR; EM; 2.90 A; v=1-70.
DR   PDB; 7ODS; EM; 3.10 A; v=1-70.
DR   PDB; 7ODT; EM; 3.10 A; v=1-70.
DR   PDB; 7OF0; EM; 2.20 A; v=1-70.
DR   PDB; 7OF2; EM; 2.70 A; v=1-70.
DR   PDB; 7OF3; EM; 2.70 A; v=1-70.
DR   PDB; 7OF5; EM; 2.90 A; v=1-70.
DR   PDB; 7OF7; EM; 2.50 A; v=1-70.
DR   PDB; 7OI6; EM; 5.70 A; v=1-70.
DR   PDB; 7OI7; EM; 3.50 A; v=1-70.
DR   PDB; 7OI8; EM; 3.50 A; v=1-70.
DR   PDB; 7OI9; EM; 3.30 A; v=1-70.
DR   PDB; 7OIC; EM; 3.10 A; v=1-70.
DR   PDB; 7OID; EM; 3.70 A; v=1-70.
DR   PDB; 7OIE; EM; 3.50 A; v=1-70.
DR   PDB; 7PD3; EM; 3.40 A; v=1-70.
DR   PDB; 7PO4; EM; 2.56 A; zb=1-70.
DR   PDB; 7QH6; EM; 3.08 A; v=1-70.
DR   PDB; 7QH7; EM; 2.89 A; v=2-70.
DR   PDB; 8K2B; EM; 3.40 A; v=1-70.
DR   PDB; 8PK0; EM; 3.03 A; v=1-70.
DR   PDB; 8QSJ; EM; 3.00 A; v=1-70.
DR   PDB; 8QU5; EM; 2.42 A; v=1-70.
DR   PDBsum; 5OOL; -.
DR   PDBsum; 5OOM; -.
DR   PDBsum; 7A5H; -.
DR   PDBsum; 7A5J; -.
DR   PDBsum; 7O9K; -.
DR   PDBsum; 7O9M; -.
DR   PDBsum; 7ODR; -.
DR   PDBsum; 7ODS; -.
DR   PDBsum; 7ODT; -.
DR   PDBsum; 7OF0; -.
DR   PDBsum; 7OF2; -.
DR   PDBsum; 7OF3; -.
DR   PDBsum; 7OF5; -.
DR   PDBsum; 7OF7; -.
DR   PDBsum; 7OI6; -.
DR   PDBsum; 7OI7; -.
DR   PDBsum; 7OI8; -.
DR   PDBsum; 7OI9; -.
DR   PDBsum; 7OIC; -.
DR   PDBsum; 7OID; -.
DR   PDBsum; 7OIE; -.
DR   PDBsum; 7PD3; -.
DR   PDBsum; 7PO4; -.
DR   PDBsum; 7QH6; -.
DR   PDBsum; 7QH7; -.
DR   PDBsum; 8K2B; -.
DR   PDBsum; 8PK0; -.
DR   PDBsum; 8QSJ; -.
DR   PDBsum; 8QU5; -.
DR   AlphaFoldDB; L0R8F8; -.
DR   EMDB; EMD-11643; -.
DR   EMDB; EMD-11645; -.
DR   EMDB; EMD-12763; -.
DR   EMDB; EMD-12764; -.
DR   EMDB; EMD-12845; -.
DR   EMDB; EMD-12846; -.
DR   EMDB; EMD-12847; -.
DR   EMDB; EMD-12865; -.
DR   EMDB; EMD-12867; -.
DR   EMDB; EMD-12868; -.
DR   EMDB; EMD-12870; -.
DR   EMDB; EMD-12872; -.
DR   EMDB; EMD-12919; -.
DR   EMDB; EMD-12920; -.
DR   EMDB; EMD-12921; -.
DR   EMDB; EMD-12922; -.
DR   EMDB; EMD-12925; -.
DR   EMDB; EMD-12926; -.
DR   EMDB; EMD-12927; -.
DR   EMDB; EMD-13329; -.
DR   EMDB; EMD-13562; -.
DR   EMDB; EMD-13965; -.
DR   EMDB; EMD-13967; -.
DR   EMDB; EMD-17719; -.
DR   EMDB; EMD-36837; -.
DR   EMDB; EMD-3842; -.
DR   EMDB; EMD-3843; -.
DR   SMR; L0R8F8; -.
DR   IntAct; L0R8F8; 2.
DR   STRING; 9606.ENSP00000490747; -.
DR   BioMuta; MIEF1; -.
DR   jPOST; L0R8F8; -.
DR   MassIVE; L0R8F8; -.
DR   PeptideAtlas; L0R8F8; -.
DR   Pumba; L0R8F8; -.
DR   Antibodypedia; 82186; 1 antibodies from 1 providers.
DR   MANE-Select; ENST00000637854.1; ENSP00000490747.1; NM_001414695.1; NP_001401624.1.
DR   AGR; HGNC:25979; -.
DR   GeneCards; MIEF1; -.
DR   HGNC; HGNC:25979; MIEF1.
DR   HPA; ENSG00000285025; Tissue enriched (skeletal).
DR   MalaCards; MIEF1; -.
DR   neXtProt; NX_L0R8F8; -.
DR   VEuPathDB; HostDB:ENSG00000285025; -.
DR   GeneTree; ENSGT01030000234887; -.
DR   OMA; DFYFASI; -.
DR   OrthoDB; 277888at2759; -.
DR   PathwayCommons; L0R8F8; -.
DR   SignaLink; L0R8F8; -.
DR   ChiTaRS; MIEF1; human.
DR   Pharos; L0R8F8; Tbio.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100335; Expressed in sperm and 206 other cell types or tissues.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0140978; F:mitochondrial large ribosomal subunit binding; IDA:UniProtKB.
DR   GO; GO:0000266; P:mitochondrial fission; IMP:UniProtKB.
DR   GO; GO:1902775; P:mitochondrial large ribosomal subunit assembly; IMP:UniProtKB.
DR   GO; GO:0032981; P:mitochondrial respiratory chain complex I assembly; IMP:UniProtKB.
DR   GO; GO:0070131; P:positive regulation of mitochondrial translation; IDA:UniProtKB.
DR   CDD; cd20272; Complex1_LYR_MIEF1-MP; 1.
DR   InterPro; IPR008011; Complex1_LYR_dom.
DR   InterPro; IPR045300; Complex1_LYR_MIEF1-MP.
DR   Pfam; PF05347; Complex1_LYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing;
KW   Direct protein sequencing; Mitochondrion; Proteomics identification;
KW   Reference proteome; Ribosome biogenesis; Translation regulation.
FT   CHAIN           1..70
FT                   /note="Mitochondrial ribosome and complex I assembly factor
FT                   AltMIEF1"
FT                   /id="PRO_0000439344"
FT   MOTIF           12..14
FT                   /note="LYR motif"
FT                   /evidence="ECO:0000305|PubMed:29083303,
FT                   ECO:0000305|PubMed:30215512"
FT   MUTAGEN         12..14
FT                   /note="LYR->AAA: Decreased function in mitochondrial
FT                   fission. Unable to convert the mitochondrial morphology
FT                   from tubular to fragmented. Abolishes interaction with
FT                   NDUFAB1; when associated with A-39."
FT                   /evidence="ECO:0000269|PubMed:29083303,
FT                   ECO:0000269|PubMed:30215512"
FT   MUTAGEN         39
FT                   /note="F->A: Abolishes interaction with NDUFAB1; when
FT                   associated with 12-A--A-14."
FT                   /evidence="ECO:0000269|PubMed:30215512"
FT   HELIX           6..21
FT                   /evidence="ECO:0007829|PDB:7OF0"
FT   STRAND          24..26
FT                   /evidence="ECO:0007829|PDB:7QH7"
FT   HELIX           28..40
FT                   /evidence="ECO:0007829|PDB:7OF0"
FT   STRAND          43..45
FT                   /evidence="ECO:0007829|PDB:8QU5"
FT   HELIX           50..63
FT                   /evidence="ECO:0007829|PDB:7OF0"
SQ   SEQUENCE   70 AA;  8445 MW;  4910AF3BF93D0CD2 CRC64;
     MAPWSREAVL SLYRALLRQG RQLRYTDRDF YFASIRREFR KNQKLEDAEA RERQLEKGLV
     FLNGKLGRII
//
ID   RTL8C_HUMAN             Reviewed;         113 AA.
AC   A6ZKI3;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 1.
DT   09-APR-2025, entry version 115.
DE   RecName: Full=Retrotransposon Gag-like protein 8C {ECO:0000312|HGNC:HGNC:2569};
DE   AltName: Full=Mammalian retrotransposon derived protein 8C {ECO:0000312|HGNC:HGNC:2569};
GN   Name=RTL8C {ECO:0000312|HGNC:HGNC:2569};
GN   Synonyms=CXX1 {ECO:0000312|HGNC:HGNC:2569}, FAM127A
GN   {ECO:0000312|HGNC:HGNC:2569}, MAR8 {ECO:0000312|HGNC:HGNC:2569}, MAR8C
GN   {ECO:0000312|HGNC:HGNC:2569}, MART8 {ECO:0000312|HGNC:HGNC:2569};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION, AND GENE FAMILY.
RX   PubMed=16093683; DOI=10.1159/000084963;
RA   Brandt J., Veith A.-M., Volff J.-N.;
RT   "A family of neofunctionalized Ty3/gypsy retrotransposon genes in mammalian
RT   genomes.";
RL   Cytogenet. Genome Res. 110:307-317(2005).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=15716091; DOI=10.1016/j.gene.2004.11.022;
RA   Brandt J., Schrauth S., Veith A.-M., Froschauer A., Haneke T.,
RA   Schultheis C., Gessler M., Leimeister C., Volff J.-N.;
RT   "Transposable elements as a source of genetic innovation: expression and
RT   evolution of a family of retrotransposon-derived neogenes in mammals.";
RL   Gene 345:101-111(2005).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- INTERACTION:
CC       A6ZKI3; Q68D86: CCDC102B; NbExp=3; IntAct=EBI-10174072, EBI-10171570;
CC       A6ZKI3; P42772: CDKN2B; NbExp=3; IntAct=EBI-10174072, EBI-711280;
CC       A6ZKI3; O95872: GPANK1; NbExp=3; IntAct=EBI-10174072, EBI-751540;
CC       A6ZKI3; P25791-3: LMO2; NbExp=3; IntAct=EBI-10174072, EBI-11959475;
CC       A6ZKI3; Q86TG7: PEG10; NbExp=5; IntAct=EBI-10174072, EBI-2858265;
CC       A6ZKI3; Q86TG7-2: PEG10; NbExp=10; IntAct=EBI-10174072, EBI-6259410;
CC       A6ZKI3; Q04864-2: REL; NbExp=3; IntAct=EBI-10174072, EBI-10829018;
CC       A6ZKI3; Q96NU1: SAMD11; NbExp=3; IntAct=EBI-10174072, EBI-14067109;
CC       A6ZKI3; Q9UMX0: UBQLN1; NbExp=6; IntAct=EBI-10174072, EBI-741480;
CC       A6ZKI3; Q9UMX0-2: UBQLN1; NbExp=3; IntAct=EBI-10174072, EBI-10173939;
CC       A6ZKI3; Q9UHD9: UBQLN2; NbExp=5; IntAct=EBI-10174072, EBI-947187;
CC   -!- MISCELLANEOUS: RTL8C is one of at least 11 genes called Mar or Mart
CC       related to long terminal repeat retrotransposons. They do not
CC       correspond to functional retrotransposons, but rather to
CC       neofunctionalized retrotransposons genes.
CC       {ECO:0000269|PubMed:16093683}.
CC   -!- SIMILARITY: Belongs to the FAM127 family. {ECO:0000305}.
CC   -!- CAUTION: There seem to be two proteins that can be transcribed from
CC       FAM127A, one with a C-terminal CAAX box (AC O15255) and a smaller
CC       protein (the sequence shown here) that seems to be encoded by a
CC       multicopy gene originating from a retrotransposon. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL136169; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002385; AAH02385.4; -; mRNA.
DR   EMBL; BC002410; AAH02410.4; -; mRNA.
DR   CCDS; CCDS43997.1; -.
DR   RefSeq; NP_001071639.1; NM_001078171.2.
DR   AlphaFoldDB; A6ZKI3; -.
DR   SMR; A6ZKI3; -.
DR   BioGRID; 114446; 52.
DR   IntAct; A6ZKI3; 46.
DR   STRING; 9606.ENSP00000257013; -.
DR   iPTMnet; A6ZKI3; -.
DR   PhosphoSitePlus; A6ZKI3; -.
DR   BioMuta; RTL8C; -.
DR   jPOST; A6ZKI3; -.
DR   MassIVE; A6ZKI3; -.
DR   PaxDb; 9606-ENSP00000257013; -.
DR   PeptideAtlas; A6ZKI3; -.
DR   ProteomicsDB; 1787; -.
DR   Pumba; A6ZKI3; -.
DR   TopDownProteomics; A6ZKI3; -.
DR   Antibodypedia; 30334; 153 antibodies from 16 providers.
DR   DNASU; 8933; -.
DR   Ensembl; ENST00000257013.9; ENSP00000257013.7; ENSG00000134590.14.
DR   GeneID; 8933; -.
DR   KEGG; hsa:8933; -.
DR   MANE-Select; ENST00000257013.9; ENSP00000257013.7; NM_001078171.2; NP_001071639.1.
DR   UCSC; uc004eyd.4; human.
DR   AGR; HGNC:2569; -.
DR   CTD; 8933; -.
DR   DisGeNET; 8933; -.
DR   GeneCards; RTL8C; -.
DR   HGNC; HGNC:2569; RTL8C.
DR   HPA; ENSG00000134590; Low tissue specificity.
DR   MIM; 300213; gene.
DR   neXtProt; NX_A6ZKI3; -.
DR   OpenTargets; ENSG00000134590; -.
DR   PharmGKB; PA162385908; -.
DR   VEuPathDB; HostDB:ENSG00000134590; -.
DR   eggNOG; ENOG502RU23; Eukaryota.
DR   GeneTree; ENSGT00940000154665; -.
DR   HOGENOM; CLU_154949_0_0_1; -.
DR   OMA; KCLIATP; -.
DR   OrthoDB; 9508136at2759; -.
DR   PhylomeDB; A6ZKI3; -.
DR   TreeFam; TF337843; -.
DR   PathwayCommons; A6ZKI3; -.
DR   SignaLink; A6ZKI3; -.
DR   BioGRID-ORCS; 8933; 15 hits in 772 CRISPR screens.
DR   ChiTaRS; RTL8C; human.
DR   GeneWiki; FAM127A; -.
DR   GenomeRNAi; 8933; -.
DR   Pharos; A6ZKI3; Tbio.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000134590; Expressed in Brodmann (1909) area 10 and 208 other cell types or tissues.
DR   InterPro; IPR032549; DUF4939.
DR   Pfam; PF16297; DUF4939; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification; Reference proteome.
FT   CHAIN           1..113
FT                   /note="Retrotransposon Gag-like protein 8C"
FT                   /id="PRO_0000311726"
FT   VARIANT         60
FT                   /note="S -> N (in dbSNP:rs1056977)"
FT                   /id="VAR_053975"
SQ   SEQUENCE   113 AA;  13171 MW;  104B1C2FB5E362EA CRC64;
     MDGRVQLIKA LLALPIRPAT RRWRNPIPFP ETFDGDTDRL PEFIVQTGSY MFVDENTFSS
     DALKVTFLIT RLTGPALQWV IPYIKKESPL LNDYRGFLAE MKRVFGWEED EDF
//
ID   Q3ZM62_HUMAN            Unreviewed;       101 AA.
AC   Q3ZM62;
DT   27-SEP-2005, integrated into UniProtKB/TrEMBL.
DT   27-SEP-2005, sequence version 1.
DT   22-FEB-2023, entry version 42.
DE   SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:AAW56974.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAW56974.1};
RN   [1] {ECO:0000313|EMBL:AAW56974.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Saionz J.R., Skaletsky H., Rozen S., Page D.C.;
RT   "Palindromes on the human X chromosome.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY730281; AAW56974.1; -; mRNA.
PE   2: Evidence at transcript level;
FT   REGION          81..101
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         101
FT                   /evidence="ECO:0000313|EMBL:AAW56974.1"
SQ   SEQUENCE   101 AA;  11374 MW;  8A021A7F2817F0AE CRC64;
     MAQGHSEVGP STSAWSIRRK VDEYLRPSLA SKSVLSVLLS RQLGNHRNDA DLTEWLWTLK
     QAIPGWTWPL PTRHTINPPL PLGRMENPRK WCGSINPSPX A
//
ID   A0A7I2YQU6_HUMAN        Unreviewed;       478 AA.
AC   A0A7I2YQU6;
DT   07-APR-2021, integrated into UniProtKB/TrEMBL.
DT   07-APR-2021, sequence version 1.
DT   02-APR-2025, entry version 20.
DE   SubName: Full=WASP family homolog 6, pseudogene {ECO:0000313|Ensembl:ENSP00000504557.1};
GN   Name=WASH6P {ECO:0000313|Ensembl:ENSP00000504557.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000504557.1, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000504557.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11237011; DOI=10.1038/35057062;
RG   International Human Genome Sequencing Consortium;
RA   Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J.,
RA   Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K.,
RA   Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P.,
RA   McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J.,
RA   Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C.,
RA   Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J.,
RA   Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C.,
RA   Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I.,
RA   Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S.,
RA   Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S.,
RA   Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S.,
RA   Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A.,
RA   Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R.,
RA   Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A.,
RA   Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W.,
RA   Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T.,
RA   Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E.,
RA   Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B.,
RA   Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L.,
RA   Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y.,
RA   Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C.,
RA   Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W.,
RA   Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P.,
RA   Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M.,
RA   Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A.,
RA   Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A.,
RA   Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M.,
RA   Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R.,
RA   Raymond C., Shimizu N., Kawasaki K., Minoshima S., Evans G.A.,
RA   Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J.,
RA   Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N.,
RA   Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L.,
RA   Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G.,
RA   Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R.,
RA   Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G.,
RA   Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W.,
RA   Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J.,
RA   Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M.,
RA   McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J.,
RA   Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E.,
RA   Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J.,
RA   Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F.,
RA   Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A.,
RA   Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K.,
RA   Shizuya H., Choi S., Chen Y.J.;
RT   "Initial sequencing and analysis of the human genome.";
RL   Nature 409:860-921(2001).
RN   [2] {ECO:0000313|Ensembl:ENSP00000518618.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12815422; DOI=10.1038/nature01722;
RA   Skaletsky H., Kuroda-Kawaguchi T., Minx P.J., Cordum H.S., Hillier L.W.,
RA   Brown L.G., Repping S., Pyntikova T., Ali J., Bieri T., Chinwalla A.,
RA   Delehaunty A., Delehaunty K., Du H., Fewell G., Fulton L., Fulton R.,
RA   Graves T.A., Hou S.-F., Latrielle P., Leonard S., Mardis E., Maupin R.,
RA   McPherson J., Miner T., Nash W., Nguyen C., Ozersky P., Pepin K., Rock S.,
RA   Rohlfing T., Scott K., Schultz B., Strong C., Tin-Wollam A., Yang S.-P.,
RA   Waterston R.H., Wilson R.K., Rozen S., Page D.C.;
RT   "The male-specific region of the human Y chromosome is a mosaic of discrete
RT   sequence classes.";
RL   Nature 423:825-837(2003).
RN   [3] {ECO:0000313|Ensembl:ENSP00000504557.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15496913; DOI=10.1038/nature03001;
RG   International Human Genome Sequencing Consortium;
RT   "Finishing the euchromatic sequence of the human genome.";
RL   Nature 431:931-945(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000504557.1, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Glockner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Muller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'Dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5] {ECO:0000313|Ensembl:ENSP00000504557.1}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (DEC-2024) to UniProtKB.
CC   -!- SUBCELLULAR LOCATION: Early endosome membrane
CC       {ECO:0000256|ARBA:ARBA00004146}. Recycling endosome membrane
CC       {ECO:0000256|ARBA:ARBA00004565}.
CC   -!- SIMILARITY: Belongs to the WASH1 family.
CC       {ECO:0000256|ARBA:ARBA00005602}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ271736; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   SMR; A0A7I2YQU6; -.
DR   Ensembl; ENST00000359512.8; ENSP00000504557.1; ENSG00000182484.15.
DR   Ensembl; ENST00000711272.1; ENSP00000518618.1; ENSG00000292372.1.
DR   HGNC; HGNC:31685; WASH6P.
DR   GeneTree; ENSGT00390000016717; -.
DR   OMA; SMDSPYE; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000182484; Expressed in lower esophagus mucosa and 94 other cell types or tissues.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0071203; C:WASH complex; IEA:InterPro.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0043014; F:alpha-tubulin binding; IEA:InterPro.
DR   GO; GO:0034314; P:Arp2/3 complex-mediated actin nucleation; IEA:InterPro.
DR   InterPro; IPR028290; WASH1.
DR   InterPro; IPR021854; WASH1_WAHD.
DR   PANTHER; PTHR23331; CXYORF1; 1.
DR   PANTHER; PTHR23331:SF3; WAS PROTEIN FAMILY HOMOLOG 4-RELATED; 1.
DR   Pfam; PF11945; WASH_WAHD; 1.
PE   1: Evidence at protein level;
KW   Actin-binding {ECO:0000256|ARBA:ARBA00023203};
KW   Proteomics identification {ECO:0007829|PeptideAtlas:A0A7I2YQU6,
KW   ECO:0007829|ProteomicsDB:A0A7I2YQU6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          62..310
FT                   /note="WASH1 WAHD"
FT                   /evidence="ECO:0000259|Pfam:PF11945"
FT   REGION          310..372
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          387..420
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          435..478
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        315..327
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        395..411
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        437..449
FT                   /note="Gly residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        469..478
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   478 AA;  51622 MW;  DEFB63C3E2D6E04B CRC64;
     MSGVMCLKAS DTWASGIRSQ PQGCLGKWRS MRCKHTRMHL AHLGNSRQLI SLGPPRTRED
     GSRISQQVEQ SRSQVQAIGE KVSLAQAKIE KIKGSKKAIK VFSSAKYPAP ERLQEYGSIF
     TGAQDPGLQR RPRHRIQSKH RPLDERALQE KLKDFPVCVS TKPEPEDDAE EGLGGLPSNI
     SSVSSLLLFN TTENLYKKYV FLDPLAGAVT KTHVMLGAET EEKLFDAPLS ISKREQLEQQ
     VPENYFYVPD LGQVPEIDVP SYLPDLPSIA NDLMYSADLG PGIAPSAPGT IPELPTFHTE
     VAEPLKADLQ DGVLTPPPPP PPPPPAPEVL ASAPPLPPST AAPVGQGARQ DDGSSSASPS
     VQGAPREVVD PSGGWATLLE SIRQAGGIGK AKLRSMKERK LEKKKQKEQE QVRATSQGGH
     LMSDLFNKLV MRRKGISGKG PGAGEGPGGA FARVSDSIPP VPPPQQPQAE EDEDDWES
//
